text stringlengths 102 99.6k | url stringlengths 31 426 | crawl_date timestamp[us, tz=UTC]date 2022-04-01 00:29:49 2022-09-19 04:34:15 |
|---|---|---|
Special Weather Statement issued April 10 at 3:09PM MDT by NWS Pocatello ID
Expect 1 to 4 inches of snow with 2.5 inches expected for
Montpelier and around 4 inches for higher elevations. Winds will
be breezy as well with gusts of 25 to 30 mph. Gusts could be as
high as 40 to 45 mph with frontal passage Monday evening. Blowing
and drifting of snow will likely reduce visibility. | https://localnews8.com/weather/alerts-weather/2022/04/10/special-weather-statement-issued-april-10-at-309pm-mdt-by-nws-pocatello-id/ | 2022-04-10T21:33:31Z |
Directory provides vetted list of Financial Institutions (FIs) that serve the cannabis industry ahead of annual conference for industry executives
WASHINGTON, Aug. 29, 2022 /PRNewswire/ -- "We need a bank - who will work with us?" is a common question across the cannabis industry. The Cannabis Banking Directory, published by the PBC Conference team, is a direct response to this question. Dubbed The Green Pages, the Directory lists 40 Financial Institutions (FIs) that serve the cannabis industry and gave PBC Conference approval to be listed. Additional FIs chose to not be listed for a variety of reasons. This inaugural edition is a free resource (https://www.pbcconference.com/cannabis-banking-directory) and will help make it easier for cannabis operators and all cannabis-related businesses (CRBs) to find access to banking options across the nation.
PBC Conference CEO, Joshua Radbod, sums up his organization's core mission as "helping Financial Institutions, CRBs, Government and Partners find each other, connect, and grow together."
The Cannabis Banking Directory is one of several industry resources offered by PBC. Their premier offering is a two-day conference held in Washington, D.C. that brings together executives in the cannabis banking industry, as well as those working across cannabis compliance, legislation, regulation, and in ancillary businesses that address seed-to-sale tracking, cannabis data, 280E taxes, HR & Payroll, and insurance.
Attendees hear the latest from Regulators and Legislators during Keynote Speeches by Congresswomen, a Senator, IRS Commissioners, an NFL Athlete, a Lieutenant Governor, and a National Credit Union Administration (NCUA) Board Member. After participating in engaging panel sessions with cannabis industry executives, attendees browse leading solutions in the exhibit area, and end each day networking with clients, partners, and peers during PBC hosted happy hours.
About: PBC Conference was founded in 2018 as an executive-level annual conference for cannabis payments, banking, and compliance and has since expanded to offer additional industry resources (Cannabis Banking Ecosystem Report, Cannabis Banking Directory, and strategic advisory services (PBC Strategy). This year's PBC Conference will be held on September 7th – 8th, 2022, in Washington D.C. at the Capital Hilton Hotel. All-Access Passes include two days of engaging content from keynotes and panel sessions, an exhibit area with leading vendors and service providers, PBC Awards ceremony, and networking during coffee breaks and two happy hours. More information and registration at www.pbcconference.com
View original content:
SOURCE PBC Conference | https://www.kxii.com/prnewswire/2022/08/29/pbc-publishes-cannabis-banking-directory-free-industry-resource/ | 2022-08-29T19:04:37Z |
New appointment supports customers and their technology implementation to meet the needs of modern clinical research at a global scale
CARY, N.C., Aug. 2, 2022 /PRNewswire/ -- THREAD®, a leading technology and consulting service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), today announced the appointment of Kim Boericke as chief delivery officer. In this role, Boericke will lead the company's Technology Enablement Consulting Services. A 2021 Stevie® Award winner for Female Executive of the Year, Boericke brings more than 25 years of experience in operations within the drug development industry and a proven track record designing, building and strategically evolving organizations throughout her career.
In her new role, Boericke will lead THREAD's global team of consulting services experts focused on technology implementation for customers. She will oversee operational design, launch and technology support to help scale THREAD's unified patient-centric platform across the company's expanding global portfolio.
"Our customers are focused on designing, operating and scaling the most patient-centric research," said Boericke. "I am thrilled to join THREAD's team of experts focused on helping our customers deliver studies that reduce patient burden, better support sites and provide a more inclusive study design for patients around the world."
Prior to joining THREAD, Boericke served in executive leadership positions at leading global contract research organizations and academic research organizations where she enabled sponsors to deliver their research programs through a combination of technology and consulting services.
A champion of patient centricity throughout her career, Boericke also has been active in corporate initiatives focused on diversity, equity and inclusion, including as executive sponsor for the Network of Women (NOW) and PRIDE, and is currently an independent board director for the Mapi Research Trust.
"Kim brings senior-level operational expertise, customer focus and industry stakeholder views to THREAD," said John Reites, CEO, THREAD. "Her appointment represents an important addition to THREAD's leadership team to enrich our market leadership position as we deliver the most patient-centric research approaches for our customers."
Visit the THREAD website for Boericke's full biography and to learn more about THREAD's leadership team.
About THREAD
THREAD® is the industry-leading decentralized clinical trials technology and consulting service provider, helping biopharma and CROs decentralize clinical research and enable electronic clinical outcome assessments (eCOA) for sites, participants, caregivers and home health professionals. Through its unified platform, THREAD is making studies 30% more efficient and five times more inclusive and diverse. Backed by health care investors Water Street Healthcare Partners and JLL Partners, THREAD is recognized as a leader by Everest Group's Decentralized Clinical Trial Product PEAK Matrix® Assessment 2021, Frost & Sullivan's 2021 Customer Value Leadership Award as well as a long list of accolades. Visit THREADresearch.com to learn more.
View original content to download multimedia:
SOURCE THREAD | https://www.mysuncoast.com/prnewswire/2022/08/02/kim-boericke-joins-thread-executive-leadership-team-chief-delivery-officer/ | 2022-08-02T12:53:13Z |
Police: 2 killed, 4 wounded in shooting at Indiana nightclub
Published: Jun. 12, 2022 at 2:24 PM CDT|Updated: 17 minutes ago
GARY, Ind. (AP) — Police say two people were killed and four others were wounded in a shooting at an Indiana nightclub.
Officers responding to reports of shots fired early Sunday in Gary, southeast of Chicago, found two people who had been shot and were unresponsive.
Police say a 34-year-old man was near the entrance to Playo’s NightClub and a 26-year-old woman was found inside.
Both were declared dead at a local hospital.
Four other people were also wounded, including one who was in critical condition.
Authorities have not released the victims’ names or information about what may have led up to the shooting.
Copyright 2022 The Associated Press. All rights reserved. | https://www.wibw.com/2022/06/12/police-2-killed-4-wounded-shooting-indiana-nightclub/ | 2022-06-12T19:43:53Z |
An attorney working as a senior investigator for the U.S. House committee investigating the Jan. 6 insurrection will leave the post amid calls urging him to run for a Missouri U.S. Senate seat as an independent.
John F. Wood’s resignation is effective Friday. The resignation was confirmed Wednesday by Steve Crim, a political consultant working with the group formed to back Wood as a Senate candidate, johnwoodformo.org.
Crim said Wood has not declared a Senate run, but is exploring the possibility.
“We are encouraged by John’s decision to leave the select committee on Friday as an important next step in providing Missourians a principled, common-sense choice this November,” Crim said in a statement.
The committee launched a website on Monday urging Wood to run for retiring GOP Sen. Roy Blunt’s seat. The website called Wood a “principled leader who has put country over party when the stakes are highest, and is committed to serving the people of our state with integrity.”
The launch came the same day a leading Republican candidate, former Gov. Eric Greitens, released a campaign video showing him brandishing a shotgun and declaring that he’s hunting RINOs, which stands for Republicans in Name Only. The ad’s violent imagery drew strong criticism, including from some conservatives, though Greitens contended it was meant to be humorous. Facebook took down the ad.
Former Republican U.S. Sen. John Danforth of suburban St. Louis also has urged Wood to run as a right-leaning independent. Wood once worked for Danforth’s staff.
Wood, 52, served as U.S. attorney for Missouri’s Western District from 2007 to 2009 and prior to that held key roles in the George W. Bush administration. He was working as general counsel for the U.S. Chamber of Commerce when he stepped down in September to become senior investigative counsel for the Jan. 6 committee.
Republicans are skeptical of a third-party bid in Missouri, but some acknowledged there is no backup plan if Greitens wins the primary.
Danforth plans to contribute $5 million from his political action committee to advertise in support of a campaign and is seeking to “raise substantially more to build on that donation,” a person familiar with Danforth’s decision told The Associated Press Wednesday. The person was not authorized to speak on behalf of Danforth and confirmed the amount on condition of anonymity.
To get on the November ballot as an independent, Wood would need to submit petitions signed by 10,000 registered voters by Aug. 1.
Twenty-one Republicans are competing in the August primary election. Greitens is considered a frontrunner despite resigning as governor in 2018 in the midst of an investigation into whether he used a compromising photo to blackmail a woman from speaking about their extramarital affair.
Many Republican leaders fear Greitens could win the nomination but lose to a Democrat in November, ceding what should be a safe Republican Senate seat in an election where control of the Senate is on the line.
Other GOP contenders include Attorney General Eric Schmitt, U.S. Reps. Vicky Hartzler and Billy Long, Missouri Senate President Pro Tem Dave Schatz and St. Louis attorney Mark McCloskey. Schatz is positioning himself as a “Reagan Republican.” The others are strong supporters of former President Donald Trump, who has not yet endorsed a candidate in the race.
Leading Democratic contenders include former Marine Lucas Kunce and Trudy Busch Valentine, who is part of the Busch brewery family.
___
AP journalists Lisa Mascaro in Washington, D.C. and Tom Beaumont in Des Moines, Iowa, contributed to this report. | https://cw33.com/news/politics/ap-politics/lawyer-leaving-1-6-panel-amid-talk-of-missouri-senate-run/ | 2022-06-23T00:13:14Z |
The 2022 EUC Management and Governance Market Update Report by Bloor Research measures EUC applications
AUSTIN, Texas, Aug. 23, 2022 /PRNewswire/ -- Mitratech, a leading global provider of legal, compliance, and HR software, is excited to announce that its ClusterSeven product has been chosen as a Champion in the 2022 EUC Management and Governance Market Update Report by Bloor Research.
The report measures EUC (end-user computing) management and the governance of risk prevention applications against the following criteria:
- Inventory: ability to identify and catalog an organization's EUCs
- Risk assessment: measures the EUC risk level
- Regulations and oversight: the ability of a solution to meet regulators' expectations
- Spreadsheets: the most common type of EUC
- Controls: measures how effective the solution is in providing transparency
- Automation: the measure of a solution's automation abilities
"ClusterSeven is a mature product that works alongside and integrates with the broader Mitratech suite of GRC solutions," said Daniel Howard, Senior Analyst at Bloor Research. "The company's innovative approach to combining multiple technologies in order to create a comprehensive GRC suite resulted in ClusterSeven being named a Champion in the 2022 EUC Management and Governance Market Update Report."
ClusterSeven's Shadow IT Manager lets users choose from a full range of components capable of automating and accelerating EUC management. Effective spreadsheet risk management allows organizations to make use of their users' favorite applications, while still having the same control, transparency, and auditability found in their corporate IT systems.
"We are delighted that ClusterSeven has been recognized as a Champion in the latest Bloor report." Said Henry Umney, managing director of GRC Strategy at Mitratech." As the pioneer in taking EUC and Spreadsheet solutions from the desktop to the enterprise, our unrivaled experience, and extensive client base ensures that we continue to innovate and remain a thought leader delivering cutting-edge solutions."
The full report can be downloaded here:
Mitratech is a proven global technology partner for corporate legal, risk, compliance, and HR professionals seeking to maximize productivity, control expense, and mitigate risk by deepening organizational alignment, increasing visibility, and spurring collaboration across an enterprise. Mitratech serves over 2,000 organizations worldwide spanning more than 160 countries.
For more info, visit: www.mitratech.com
View original content to download multimedia:
SOURCE Mitratech Holdings Inc | https://www.kxii.com/prnewswire/2022/08/23/bloor-research-recognizes-mitratechs-clusterseven-champion-2022-market-update/ | 2022-08-23T15:13:25Z |
– Companies plan to discuss results with regulatory authorities –
TOKYO and BOTHELL, Wash., July 26, 2022 /PRNewswire/ -- Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen Inc. (Nasdaq:SGEN) today announced positive topline results from the phase 1b/2 EV-103 clinical trial (also known as KEYNOTE-869) Cohort K evaluating PADCEV® (enfortumab vedotin-ejfv) in combination with Merck's anti-PD-1 therapy KEYTRUDA® (pembrolizumab) as first-line treatment in patients with unresectable locally advanced or metastatic urothelial cancer (la/mUC) who are ineligible to receive cisplatin-based chemotherapy. Merck is known as MSD outside the United States and Canada.
In patients treated with enfortumab vedotin and pembrolizumab, results demonstrated a 64.5% confirmed objective response rate (ORR) (95% CI: 52.7 to 75.1) per blinded independent central review (BICR), the primary endpoint of Cohort K. The median duration of response (DOR) per BICR was not reached. The most frequently reported treatment-emergent adverse events Grade 3 or greater that occurred in more than 5% of patients were rash maculo-papular, anemia, lipase increased, urinary tract infection, hyperglycemia, fatigue, neutropenia, hematuria, diarrhea, acute kidney injury, hyponatremia, chronic kidney disease, weight decreased, syncope, hypophosphatemia, pneumonitis, sepsis, and alanine aminotransferase increased. Overall, the results are generally consistent with previously reported efficacy and safety results of the EV-103 dose-escalation cohort and expansion Cohort A.1 Additional Cohort K results will be reported at an upcoming scientific congress.
EV-103 Cohort K is a randomized cohort investigating enfortumab vedotin alone or in combination with pembrolizumab as first-line treatment in patients with unresectable la/mUC who are ineligible to receive cisplatin-based chemotherapy. Secondary endpoints include ORR per investigator assessment; DOR, disease control rate and progression-free survival per BICR and investigator assessment; overall survival; and assessment of safety.
Please see Important Safety Information at the end of this press release, including BOXED WARNING for enfortumab vedotin.
"Approximately half of patients with advanced urothelial carcinoma are ineligible for cisplatin-based chemotherapy," said Ahsan Arozullah, M.D., M.P.H., Senior Vice President and Head of Development Therapeutic Areas, Astellas. "We intend to discuss Cohort K results with regulatory authorities as we seek to develop a new first-line treatment combination for these patients."
"We are encouraged by the positive topline results of Cohort K for the combination of enfortumab vedotin and pembrolizumab in first-line locally advanced or metastatic urothelial cancer, and we look forward to sharing results at an upcoming medical meeting," said Roger Dansey, M.D., interim CEO and Chief Medical Officer, Seagen.
Astellas, Seagen and Merck are investigating enfortumab vedotin plus pembrolizumab as part of an extensive collaboration, which also includes three Phase 3 studies: the EV-302/KEYNOTE-A39 trial intended to confirm these results, as well as EV-304/KEYNOTE-B15 and EV-303/KEYNOTE-905 in muscle-invasive bladder cancer.
In February 2020, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for enfortumab vedotin in combination with pembrolizumab for patients with unresectable la/mUC who are ineligible to receive cisplatin-based chemotherapy in the first-line setting. The designation is based on results from the dose-escalation cohort and expansion Cohort A of the phase 1b/2 trial, EV-103 (NCT03288545), evaluating patients with la/mUC who are ineligible to receive cisplatin-based chemotherapy treated in the first-line setting with enfortumab vedotin in combination with pembrolizumab.
About Bladder and Urothelial Cancer
It is estimated that approximately 83,730 people in the U.S. were diagnosed with bladder cancer in 2021.2 Urothelial cancer accounts for 90% of all bladder cancers and can also be found in the renal pelvis, ureter and urethra.3 Globally, approximately 573,000 new cases of bladder cancer and 212,000 deaths are reported annually.4
About the EV-103 Trial (Cohort K)
The EV-103 trial (NCT03288545) is an ongoing, multi-cohort, open-label, multicenter phase 1b/2 trial of enfortumab vedotin alone or in combination with pembrolizumab and/or chemotherapy in first- or second-line settings in patients with locally advanced or metastatic urothelial cancer (la/mUC) and in patients with muscle-invasive bladder cancer.
Cohort K of the EV-103 trial is investigating enfortumab vedotin alone (n=73) or in combination with pembrolizumab (n=76) in adult patients with unresectable la/mUC who are ineligible for cisplatin-based chemotherapy and have received no prior treatment for la/mUC. The enfortumab vedotin monotherapy study arm is intended to characterize the activity of enfortumab vedotin alone in this patient population. Key outcome measures of EV-103 Cohort K are objective response rate (ORR) per blinded independent central review (BICR) using RECIST 1.1 and assessment of safety.
About PADCEV
PADCEV (enfortumab vedotin-ejfv) is a first-in-class antibody-drug conjugate (ADC) that is directed against Nectin-4, a protein located on the surface of cells and highly expressed in bladder cancer.5 Nonclinical data suggest the anticancer activity of PADCEV is due to its binding to Nectin-4 expressing cells followed by the internalization and release of the anti-tumor agent monomethyl auristatin E (MMAE) into the cell, which result in the cell not reproducing (cell cycle arrest) and in programmed cell death (apoptosis).6
- PADCEV can cause severe and fatal cutaneous adverse reactions including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), which occurred predominantly during the first cycle of treatment, but may occur later.
- Closely monitor patients for skin reactions.
- Immediately withhold PADCEV and consider referral for specialized care for suspected SJS or TEN or severe skin reactions.
- Permanently discontinue PADCEV in patients with confirmed SJS or TEN; or Grade 4 or recurrent Grade 3 skin reactions.
Indication
PADCEV® is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer (mUC) who:
- have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor and platinum-containing chemotherapy, or
- are ineligible for cisplatin-containing chemotherapy and have previously received one or more prior lines of therapy.5
Skin reactions Severe cutaneous adverse reactions, including fatal cases of SJS or TEN, occurred in patients treated with PADCEV. SJS and TEN occurred predominantly during the first cycle of treatment but may occur later. Skin reactions occurred in 55% of the 680 patients treated with PADCEV in clinical trials. Twenty-three percent (23%) of patients had maculo-papular rash and 33% had pruritus. Grade 3-4 skin reactions occurred in 13% of patients, including maculo-papular rash, rash erythematous, rash or drug eruption, symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), dermatitis bullous, dermatitis exfoliative, and palmar-plantar erythrodysesthesia. In clinical trials, the median time to onset of severe skin reactions was 0.6 months (range: 0.1 to 6.4). Among patients experiencing a skin reaction leading to dose interruption who then restarted PADCEV (n=59), 24% of patients restarting at the same dose and 16% of patients restarting at a reduced dose experienced recurrent severe skin reactions. Skin reactions led to discontinuation of PADCEV in 2.6% of patients. Monitor patients closely throughout treatment for skin reactions. Consider topical corticosteroids and antihistamines, as clinically indicated. Withhold PADCEV and refer for specialized care for suspected SJS or TEN or for severe (Grade 3) skin reactions. Permanently discontinue PADCEV in patients with confirmed SJS or TEN, or for Grade 4 or recurrent Grade 3 skin reactions.
Hyperglycemia and diabetic ketoacidosis (DKA), including fatal events, occurred in patients with and without pre-existing diabetes mellitus, treated with PADCEV. Patients with baseline hemoglobin A1C ≥8% were excluded from clinical trials. In clinical trials, 14% of the 680 patients treated with PADCEV developed hyperglycemia; 7% of patients developed Grade 3-4 hyperglycemia. The incidence of Grade 3-4 hyperglycemia increased consistently in patients with higher body mass index and in patients with higher baseline A1C. Five percent (5%) of patients required initiation of insulin therapy for treatment of hyperglycemia. The median time to onset of hyperglycemia was 0.6 months (range: 0.1 to 20.3). Hyperglycemia led to discontinuation of PADCEV in 0.6% of patients. Closely monitor blood glucose levels in patients with, or at risk for, diabetes mellitus or hyperglycemia. If blood glucose is elevated (>250 mg/dL), withhold PADCEV.
Pneumonitis Severe, life-threatening or fatal pneumonitis occurred in patients treated with PADCEV. In clinical trials, 3.1% of the 680 patients treated with PADCEV had pneumonitis of any grade and 0.7% had Grade 3-4. In clinical trials, the median time to onset of pneumonitis was 2.9 months (range: 0.6 to 6). Monitor patients for signs and symptoms indicative of pneumonitis, such as hypoxia, cough, dyspnea or interstitial infiltrates on radiologic exams. Evaluate and exclude infectious, neoplastic and other causes for such signs and symptoms through appropriate investigations. Withhold PADCEV for patients who develop persistent or recurrent Grade 2 pneumonitis and consider dose reduction. Permanently discontinue PADCEV in all patients with Grade 3 or 4 pneumonitis.
Peripheral neuropathy (PN) occurred in 52% of the 680 patients treated with PADCEV in clinical trials, including 39% with sensory neuropathy, 7% with muscular weakness and 6% with motor neuropathy; 4% experienced Grade 3-4 reactions. PN occurred in patients treated with PADCEV with or without preexisting PN. The median time to onset of Grade ≥2 PN was 4.6 months (range: 0.1 to 15.8 months). Neuropathy led to treatment discontinuation in 5% of patients. Monitor patients for symptoms of new or worsening peripheral neuropathy and consider dose interruption or dose reduction of PADCEV when PN occurs. Permanently discontinue PADCEV in patients who develop Grade ≥3 PN.
Ocular disorders were reported in 40% of the 384 patients treated with PADCEV in clinical trials in which ophthalmologic exams were scheduled. The majority of these events involved the cornea and included events associated with dry eye such as keratitis, blurred vision, increased lacrimation, conjunctivitis, limbal stem cell deficiency, and keratopathy. Dry eye symptoms occurred in 34% of patients, and blurred vision occurred in 13% of patients, during treatment with PADCEV. The median time to onset to symptomatic ocular disorder was 1.6 months (range: 0 to 19.1 months). Monitor patients for ocular disorders. Consider artificial tears for prophylaxis of dry eyes and ophthalmologic evaluation if ocular symptoms occur or do not resolve. Consider treatment with ophthalmic topical steroids, if indicated after an ophthalmic exam. Consider dose interruption or dose reduction of PADCEV for symptomatic ocular disorders.
Infusion site extravasation Skin and soft tissue reactions secondary to extravasation have been observed after administration of PADCEV. Of the 680 patients, 1.6% of patients experienced skin and soft tissue reactions, including 0.3% who experienced Grade 3-4 reactions. Reactions may be delayed. Erythema, swelling, increased temperature, and pain worsened until 2-7 days after extravasation and resolved within 1-4 weeks of peak. Two patients (0.3%) developed extravasation reactions with secondary cellulitis, bullae, or exfoliation. Ensure adequate venous access prior to starting PADCEV and monitor for possible extravasation during administration. If extravasation occurs, stop the infusion and monitor for adverse reactions.
Embryo-fetal toxicity PADCEV can cause fetal harm when administered to a pregnant woman. Advise patients of the potential risk to the fetus. Advise female patients of reproductive potential to use effective contraception during PADCEV treatment and for 2 months after the last dose. Advise male patients with female partners of reproductive potential to use effective contraception during treatment with PADCEV and for 4 months after the last dose.
Most Common Adverse Reactions, Including Laboratory Abnormalities (≥20%)
Rash, aspartate aminotransferase (AST) increased, glucose increased, creatinine increased, fatigue, PN, lymphocytes decreased, alopecia, decreased appetite, hemoglobin decreased, diarrhea, sodium decreased, nausea, pruritus, phosphate decreased, dysgeusia, alanine aminotransferase (ALT) increased, anemia, albumin decreased, neutrophils decreased, urate increased, lipase increased, platelets decreased, weight decreased and dry skin.
EV-301 Study: 296 patients previously treated with a PD-1/L1 inhibitor and platinum-based chemotherapy.
Serious adverse reactions occurred in 47% of patients treated with PADCEV; the most common (≥2%) were urinary tract infection, acute kidney injury (7% each) and pneumonia (5%). Fatal adverse reactions occurred in 3% of patients, including multiorgan dysfunction (1.0%), hepatic dysfunction, septic shock, hyperglycemia, pneumonitis and pelvic abscess (0.3% each). Adverse reactions leading to discontinuation occurred in 17% of patients; the most common (≥2%) were PN (5%) and rash (4%). Adverse reactions leading to dose interruption occurred in 61% of patients; the most common (≥4%) were PN (23%), rash (11%) and fatigue (9%). Adverse reactions leading to dose reduction occurred in 34% of patients; the most common (≥2%) were PN (10%), rash (8%), decreased appetite and fatigue (3% each). Clinically relevant adverse reactions (<15%) include vomiting (14%), AST increased (12%), hyperglycemia (10%), ALT increased (9%), pneumonitis (3%) and infusion site extravasation (0.7%).
EV-201, Cohort 2 Study: 89 patients previously treated with a PD-1/L1 inhibitor and not eligible for platinum-based chemotherapy.
Serious adverse reactions occurred in 39% of patients treated with PADCEV; the most common (≥3%) were pneumonia, sepsis and diarrhea (5% each). Fatal adverse reactions occurred in 8% of patients, including acute kidney injury (2.2%), metabolic acidosis, sepsis, multiorgan dysfunction, pneumonia and pneumonitis (1.1% each). Adverse reactions leading to discontinuation occurred in 20% of patients; the most common (≥2%) was PN (7%). Adverse reactions leading to dose interruption occurred in 60% of patients; the most common (≥3%) were PN (19%), rash (9%), fatigue (8%), diarrhea (5%), AST increased and hyperglycemia (3% each). Adverse reactions leading to dose reduction occurred in 49% of patients; the most common (≥3%) were PN (19%), rash (11%) and fatigue (7%). Clinically relevant adverse reactions (<15%) include vomiting (13%), AST increased (12%), lipase increased (11%), ALT increased (10%), pneumonitis (4%) and infusion site extravasation (1%).
Drug Interactions
Effects of other drugs on PADCEV (Dual P-gp and Strong CYP3A4 Inhibitors)
Concomitant use with a dual P-gp and strong CYP3A4 inhibitors may increase unconjugated monomethyl auristatin E exposure, which may increase the incidence or severity of PADCEV toxicities. Closely monitor patients for signs of toxicity when PADCEV is given concomitantly with dual P-gp and strong CYP3A4 inhibitors.
Specific Populations
Lactation Advise lactating women not to breastfeed during treatment with PADCEV and for at least 3 weeks after the last dose.
Hepatic impairment Avoid the use of PADCEV in patients with moderate or severe hepatic impairment.
For more information, please see the full Prescribing Information including BOXED WARNING for PADCEV here.
About Astellas
Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Furthermore, we are also looking beyond our foundational Rx focus to create Rx+® healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. For more information, please visit our website at https://www.astellas.com/en.
About Seagen
Seagen Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people's lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company's marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.
About the Astellas, Seagen and Merck Collaboration
Astellas and Seagen entered a clinical collaboration agreement with Merck to evaluate the combination of Astellas' and Seagen's PADCEV® (enfortumab vedotin-ejfv) and Merck's KEYTRUDA® (pembrolizumab) in patients with previously untreated metastatic urothelial cancer. KEYTRUDA is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA.
Astellas Cautionary Notes
In this press release, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas. These statements are based on management's current assumptions and beliefs in light of the information currently available to it and involve known and unknown risks and uncertainties. A number of factors could cause actual results to differ materially from those discussed in the forward-looking statements. Such factors include, but are not limited to: (i) changes in general economic conditions and in laws and regulations, relating to pharmaceutical markets, (ii) currency exchange rate fluctuations, (iii) delays in new product launches, (iv) the inability of Astellas to market existing and new products effectively, (v) the inability of Astellas to continue to effectively research and develop products accepted by customers in highly competitive markets, and (vi) infringements of Astellas' intellectual property rights by third parties.
Information about pharmaceutical products (including products currently in development), which is included in this press release, is not intended to constitute an advertisement or medical advice.
Seagen Forward-Looking Statements
Certain statements made in this press release are forward-looking, such as those, among others, relating to the therapeutic potential of PADCEV alone or in combination, its possible efficacy, safety and therapeutic uses, plans to discuss Cohort K results with regulatory authorities and clinical development plans including planned and ongoing clinical trials. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include, without limitation, the possibility that the data from the EV-103 trial may not be sufficient to support any regulatory approval; the risk of adverse events, including the potential for newly-emerging safety signals; adverse regulatory actions; delays, setbacks or failures in clinical development activities, the submission of regulatory applications and the regulatory review process for a variety of reasons, including the inherent difficulty and uncertainty of pharmaceutical product development; possible required modifications to clinical trials; the inability to provide information and institute safety mitigation measures as may be required by the FDA or other regulatory authorities from time to time; failure to properly conduct or manage clinical trials; and failure of clinical results to support continued development or regulatory approvals. More information about the risks and uncertainties faced by Seagen is contained under the caption "Risk Factors" included in the company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 filed with the Securities and Exchange Commission. Seagen disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
1 C.J. Hoimes, J.E. Rosenberg et.al. EV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma. Annals of Oncology 30 (Supplement 5): v356–v402, 2019.
2 American Cancer Society. Cancer Facts & Figures 2021. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf. Accessed July 25, 2022.
3 American Society of Clinical Oncology. Bladder cancer: introduction (9-20). https://www.cancer.net/cancer-types/bladder-cancer/introduction. Accessed July 25, 2022.
4 International Agency for Research on Cancer. Cancer Tomorrow: Bladder. http://gco.iarc.fr/tomorrow. Accessed July 25, 2022.
5 Challita-Eid P, Satpayev D, Yang P, et al. Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models. Cancer Res 2016;76(10):3003-13.
6 PADCEV [package insert]. Northbrook, IL: Astellas Pharma US, Inc.
View original content to download multimedia:
SOURCE Astellas Pharma Inc. | https://www.wibw.com/prnewswire/2022/07/26/astellas-seagen-announce-positive-topline-results-padcev-enfortumab-vedotin-ejfv-with-keytruda-pembrolizumab-first-line-treatment-advanced-urothelial-cancer/ | 2022-07-26T08:54:03Z |
NEW YORK, April 18, 2022 /PRNewswire/ -- Global law firm Ropes & Gray today announced that Daniel Forman has joined the firm's 500-lawyer New York office as a partner in the capital markets practice. Daniel's arrival deepens the firm's bench of partners who advise leading corporate issuers, private equity firms and investment banks on their largest and most complex securities work.
Law360 named Ropes & Gray a 2021 "Capital Markets Practice Group of the Year." Last year, Ropes & Gray steered clients in nearly 150 public offerings that raised an aggregate of more than $55 billion, and closed on 78 IPOs totaling over $30 billion.
"Daniel's deep client experience complements our capital markets practice, recognized as among the best in the world," said Julie Jones, chair.
Daniel represents issuers, sponsors, investors and underwriters in a broad range of capital markets transactions, including IPOs, secondary equity offerings, debt offerings, tender offers, debt restructurings and private placements, as well as advising on corporate governance, securities law compliance, and general corporate matters.
Daniel is a member of the Securities Regulation Committee of the New York City Bar Association and has served as an adjunct professor of law at the Benjamin N. Cardozo School of Law, teaching an upper-level contract drafting course and assisting with professional skills development programs.
"Ropes & Gray's capital markets lawyers had two consecutive years of record-setting activity levels executing some of the most complex transactions in the market. Daniel is known to handle challenging and complex transactions for clients. He will enhance our ability to deliver these results for our clients," said managing partner David Djaha.
"Daniel is a versatile capital markets partner with significant experience leading issuers and underwriters in a broad range of transactions across industry sectors," said Paul Tropp, co-head of the firm's capital markets practice. "He also brings significant experience in the specialty finance market, counseling clients in transactions involving PIPEs, real estate investment trusts, registered direct offerings and business development companies."
"Ropes & Gray's award-winning capital markets group is known for market-leading deals," Daniel said. "I'm excited to join a growing practice and collaborate with attorneys in adjacent practices across the firm."
Daniel is one of seven partners to join Ropes & Gray in New York in 2022. Already this year, the firm welcomed capital markets partner Faiza Rahman, IP transactions partner Edward Sadtler, M&A partner Suni Sreepada, asset management partner Jennifer Graff, employee benefits and executive compensation partner Richard Kidd and finance partner Christopher Poggi.
Website | LinkedIn | Twitter | Videos | Podcasts
To view our privacy policy, please click here.
Media Contact:
Eric Goldman
Senior Public Relations Specialist
Office: +1-212-596-9089
Cell: +1-917-224-9861
Eric.Goldman@ropesgray.com
View original content to download multimedia:
SOURCE Ropes & Gray | https://www.wibw.com/prnewswire/2022/04/18/daniel-forman-joins-ropes-amp-gray-new-york-partner-capital-markets-practice/ | 2022-04-18T18:19:58Z |
Which Epson printer is best?
While the world continues to barrel toward an all-digital future, there is still a considerable need for good printers, especially when it comes to business of both the big and small variety. When searching for a good printer, one of the best brands you can select from is Epson, thanks to its large variety of models for different needs and great price points.
The best Epson printer you can buy is the Epson EcoTank ET-4760 Wireless Color All-in-One. This printer comes packed with the ability to scan, fax and copy in addition to basic printing, and it uses refillable ink sections instead of replaceable ink cartridges.
What to know before you buy an Epson printer
Inkjet vs. laser
Epson printers come in one of two varieties: inkjet or laser.
- Inkjet: Inkjet Epson printers still utilize cartridges of ink for printing, one per color, including black. They don’t print as quickly as laser Epson printers, but they do cost considerably less on average than laser Epson printers. If you only occasionally use a printer, then inkjet options are more likely better for your needs.
- Laser: Laser Epson printers use toner rather than ink. They generally last longer than inkjet varieties due to having fewer internal components, meaning a decreased chance of a component breaking. Laser printers are generally better for those with large printing needs and especially for businesses.
All-in-one functionality
Many Epson printers cover multiple business-related needs, which also serves to futureproof them to a certain extent. All-in-one refers to the inclusion of scanning and copying functions as well as the ability to fax should you have a phone line to connect to your printer. They do cost more than an Epson printer that only prints, so make sure you’ll need the added function before you spend the extra money.
What to look for in a quality Epson printer
Connection types
Epson printers contain up to four different connection types, though any given Epson printer may only feature some rather than all.
- USB: All Epson printers include the option to connect to a computer with a USB cable. It is the simplest and fastest method of connection.
- Ethernet and/or Wi-Fi: All-in-one Epson printers include the option to connect your printers to your internet network using both a wireless connection over Wi-Fi and using a wired connection with an Ethernet cable. Some printer-only Epson printers might also include one or both of these connection types as well.
- NFC: NFC, or Near-Field Communication, is one of the newest methods of communication between computers. Many Android tablets and phones, plus iPhone 7s and newer, have NFC chips, which NFC compatible Epson printers should be able to read.
How much you can expect to spend on an Epson printer
Epson printers don’t fall into the same “the price of this printer is lower; therefore, the quality is lesser” category; instead, the cost of the printer usually dictates the jobs it is intended to perform. Epson printers that cost less than $100 are meant to function as occasional use machines, while Epson printers that cost more than $200 are best when used by business-minded individuals or large offices. Between those ranges, you can find Epson printers best for most average situations.
Epson printer FAQ
Do Epson printers work with Apple products like Macs?
A. Absolutely. Most newer Apple computers, including the various Macs, have the necessary Epson drivers built-in, so you don’t need to do anything other than connect the two machines. Some of Epson’s more advanced features might need some additional downloads of driver, software or both, but those are available on Epson’s website for both Mac and Windows.
Can you use the fax function in all-in-one Epson devices without a landline?
A. No. Fax machines of any kind require access to a landline to send and receive faxes. If you choose an all-in-one machine, that means you should have a port to connect a phone cable located somewhere on your printer. You can always use an online faxing service for a fee should you not have a phone line in your office or home.
How often do Epson printers need to have their ink or toner replaced?
A. That mostly depends on how often you use your machine, as most ink and toner are rated to last on a measurement of pages rather than time. Those times are usually around 250 pages for inkjet cartridges and more than 2,000 pages for toner cartridges. That said, ink and toner can dry out if not used for long periods of time, which can quickly lower the number of pages they are functionally able to print.
What’s the best Epson printer to buy?
Top Epson printer
Epson EcoTank ET-4760 Wireless Color All-in-One
What you need to know: This all-in-one Epson printer is very fast and doesn’t require cartridges to use.
What you’ll love: Voice control and a color touch screen make this Epson one of the easiest to control.
What you should consider: This is one of Epson’s priciest available options.
Where to buy: Sold by Amazon and Best Buy
Top Epson printer for the money
Epson EcoTank ET-2850 Wireless Color All-in-One
What you need to know: A smaller, lower-quality version of the top option, which nonetheless remains one of Epson’s best selections
What you’ll love: The decreased size can be one of its best features if you have a smaller office or little counter space.
What you should consider: One of the bigger sacrifices this Epson printer makes is the speed at which it operates.
Where to buy: Sold by Amazon
Worth checking out
Epson WorkForce Pro WF-4740 Wireless All-in-One
What you need to know: This Epson model is perfect for any business-related need, such as at-home work or shared office spaces.
What you’ll love: Smart devices such as Amazon Alexa and Google Nest can control this printer, and it’s capable of faxing.
What you should consider: Not only does this model still rely on ink cartridges, it uses them up fast.
Where to buy: Sold by Amazon
Want to shop the best products at the best prices? Check out Daily Deals from BestReviews.
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Jordan Woika writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved. | https://cw33.com/reviews/br/office-br/office-supplies-br/best-epson-printer/ | 2022-07-08T07:21:30Z |
(NEXSTAR) – Barbie is releasing its first-ever doll with hearing aids in June as part of toymaker Mattel’s push to make its lineup more diverse and inclusive.
The latest additions to the company’s Fashionista line will also feature a Barbie with a prosthetic leg and dolls in a variety of body types “including smaller bust, curvy and original,” according to an email from a Mattel spokesperson.
A Ken doll with vitiligo is new this year, two years after the release of the Barbie with vitiligo, which was one of the top five best-selling Fashionista dolls in its first year, according to Mattel.
To make sure that the hearing aids were portrayed accurately, Mattel consulted with an audiology expert, Dr. Jen Richardson.
“As an educational audiologist with over 18 years of experience working in hearing loss advocacy, it’s inspiring to see those who experience hearing loss reflected in a doll,” Richardson said. “I’m beyond thrilled for my young patients to see and play with a doll who looks like them.”
The company’s Global Head of Barbie and Dolls, Lisa McKnight, said it’s important for children to see themselves in the toys they play with, as well as to play with dolls that don’t look like them to help foster a sense of inclusion.
“Barbie wholeheartedly believes in the power of representation, and as the most diverse doll line on the market, we are committed to continuing to introduce dolls featuring a range of skin tones, body types and disabilities to reflect the diversity kids see in the world around them,” McKnight said.
The latest Barbie Fashionistas will retail at $9.99 from retailers nationwide. | https://cw33.com/news/national/nexstar-media-wire/mattel-unveils-first-ever-barbie-doll-with-hearing-aids/ | 2022-05-13T08:25:31Z |
Police identify Tenn. assault suspect after he left wallet in abandoned, stolen car
BARTLETT, Tenn. (WMC/Gray News) - Bartlett police charged a man with aggravated assault after he left his wallet in a stolen car that he abandoned following a wreck in a field, allowing officers to identify him.
The Memphis Police Department received an assault call early Sunday morning around midnight and were called to the Burger King at 1920 Whitten Road, where the victims told police what happened.
While sitting in their car at Main Event, the victims said a man in a stolen Honda fired shots at them and struck their car.
The victims then followed the suspect into Bartlett, where the suspect shot and hit another car before wrecking into a field near Kirby Whitten Road and Snowshoe Drive, police say.
At some point, the suspect abandoned the car and fled.
The Bartlett Police Department searched the area for the suspect, but did not locate him.
Police then checked the interior of the stolen car and discovered a wallet with the identification of 32-year-old Joseph Sanders and a stolen handgun.
Officers also found video that captured images of Sanders as he fled the area.
Bartlett issued warrants on Sanders for the crimes that occurred in their jurisdiction, and he was located at an address in Tipton County and transported to the Memphis Multi-Agency Gang Unit offices.
Sanders was charged with two counts of aggravated assault, being a convicted felon in possession of a handgun, and vandalism.
His bond is set to $50,000.
Copyright 2022 WMC via Gray Media Group. All rights reserved. | https://www.mysuncoast.com/2022/08/20/police-identify-tenn-assault-suspect-after-he-left-wallet-abandoned-stolen-car/ | 2022-08-20T04:19:41Z |
ATLANTA, Sept. 2, 2022 /PRNewswire/ -- Graitec, global BIM and modeling experts dedicated to empowering construction and manufacturing professionals to digitize and industrialize their processes, is excited to announce that Scott McMaster is joining as Executive Vice-President, North America. In addition, he will serve as a member of the corporate Graitec Group Executive Committee.
Formerly Managing Director with NTT Cloud Communications Americas, McMaster brings a dynamic and results-oriented leadership approach to the newly expanded Graitec Group in North America. As an international executive with over 20 years of experience leading and developing teams in the B2B sector, McMaster will help build on the strengths of Applied Software and Graitec, to devise strategic capabilities and high-performance teams to drive better business outcomes for our clients.
Manuel Liedot, Graitec CEO, said, "Graitec is a leader in helping customers across the construction and manufacturing value chain transform their business, from innovation to digitalization to industrialization. Scott will guide our efforts in North America to be the 'feet on the street', providing value and helping customers' overcome business challenges and transform how they operate."
"As partners with our Graitec customers, we bring additional value to their business journey," McMaster said August 24 during the Graitec/Applied Software ONE Event in Atlanta, GA. "The depth of software and service solutions offered with the combined portfolio of Graitec and Applied Software establishes value that will transform our customers' journey. I am excited to be part of this truly exceptional team to help expand the future growth of Graitec and help build a sustainable tomorrow."
On April 13, 2022, Applied Software became the newest member of the worldwide Graitec Group, which serves customers from offices in 14 countries and in 9 languages.
Applied Software, a full-service premier systems integrator for AEC, MEP, fabrication, and manufacturing companies, is on a mission to transform industries by empowering clients and championing innovation with real-world expert consultants. With a broad range of world-class solutions, services and training, Applied, now part of the worldwide Graitec Group, has been helping clients achieve a competitive advantage since 1982. For more information visit www.asti.com.
For more information: Todd Weyandt
tweyandt@asti.com
404.534.1843
View original content to download multimedia:
SOURCE Applied Software | https://www.wibw.com/prnewswire/2022/09/02/graitec-group-applied-software-welcome-scott-mcmaster-evp/ | 2022-09-02T17:10:19Z |
TORONTO, Aug. 17, 2022 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (CSE: TGOD) (OTC: TGODF), a sustainable global cannabis company will release its Q2 2022 consolidated financial results after market close on August 29, 2022, and hold a conference call with analysts on Wednesday August 31st, beginning at 10:00 a.m. (ET). An audiocast of the conference call will be available on a listen-only basis at: https://app.webinar.net/9jGq5RB5xp2
Scheduled speakers are Sean Bovingdon, Chief Executive Officer & Interim Chief Financial Officer, and Shane Dungey, Vice President, Investor Relations, followed by a question-and-answer period with analysts.
CONFERENCE CALL INFORMATION:
Date: August 31, 2022 | Time: 10:00 a.m. Eastern Time
Participant Dial-In
Local – Toronto: 1-416-764-8688
Toll Free – North America: 1-888-390-0546
Conference ID – 05534890
A replay of the call will also be available until September 7, 2022, by dialing 1-416-764-8677 or 1-888-390-0541 (Passcode: 534890#).
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (CSE: TGOD) (OTC: TGODF) is a sustainable, global cannabis company with a focus on innovation, quality, consistency, integrity and transparency. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale. The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. In Canada, TGOD serves the recreational market with a brand portfolio including The Green Organic Dutchman, Highly Dutch Organics, Ripple by TGOD and Cruuzy brands, and the medical markets in Canada, South Africa, Australia, and Germany. All cannabis utilized in products for The Green Organic Dutchman and Highly Dutch Organics brands is grown through a certified organic process, which includes living soil, filtered rainwater, sunlight, and natural inputs.
TGOD's Common Shares and certain warrants issued under the indentures dated December 19, 2019, June 12, 2020, October 23, 2020, and December 10, 2020, trade on the Canadian Securities Exchange ("CSE") under the symbol "TGOD", "TGOD.WS", "TGOD.WR", "TGOD.WA", and "TGOD.WB" respectively. TGOD's Common Shares trade in the U.S. on the OTCQX under the symbol "TGODF". For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.
Neither the CSE nor the CSE's Regulation Services Provider (as that term is defined in the policies of CSE) accept responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:
SOURCE The Green Organic Dutchman Holdings Ltd. | https://www.wibw.com/prnewswire/2022/08/17/green-organic-dutchman-release-q2-financial-results-august-29th-2022/ | 2022-08-17T22:49:51Z |
EXPLAINER: How health care for vets became fight in Congress
WASHINGTON (AP) — A bill that would enhance health care and disability benefits for millions of veterans exposed to toxic burn pits hit a snag in the Senate last week, angering advocates like comedian Jon Stewart who say help from the government is long overdue.
Lawmakers have been hearing increasingly from constituents with respiratory illnesses and cancers that they attribute to serving near burn pits in Iraq and Afghanistan. The military used the pits to dispose of such things as chemicals, cans, tires, plastics and medical and human waste.
Veterans groups say servicemembers who were exposed to the pits have waited long enough for enhanced health benefits, and lawmakers largely agree. The Senate is ultimately expected to send the measure to President Joe Biden’s desk. It’s just a question of when.
Where the issue stands:
HOW WOULD THE BILL HELP IRAQ AND AFGHANISTAN VETERANS?
First, veterans who served near burn pits will get 10 years of health care coverage through the Department of Veterans Affairs upon their separation from the military rather than five.
Second, the legislation directs the VA to presume that certain respiratory illnesses and cancers were related to burn pit exposure. This takes the burden of proof off the veteran, allowing them to obtain disability payments to compensate for their injury without having to show the illness was a result of their service.
Roughly 70% of disability claims related to burn pit exposure are denied by the VA due to lack of evidence, scientific data and information from the Defense Department.
IS THERE HELP FOR OTHER VETERANS?
Yes. For example, hundreds of thousands of Vietnam War-era veterans and survivors also stand to benefit. The bill adds hypertension, or high blood pressure, as a presumptive disease associated with Agent Orange exposure. The Congressional Budget Office projected that about 600,000 of 1.6 million living Vietnam vets would be eligible for increased compensation, though only about half would have severe enough diagnoses to warrant receiving it.
Also, veterans who served in Thailand, Cambodia, Laos, Guam, American Samoa and Johnston Atoll will be presumed to have been exposed to Agent Orange. That’s another 50,000 veterans and survivors of deceased veterans who would get compensation for illnesses presumed to have been caused by their exposure to the herbicide, the CBO projected.
HOW MUCH WILL THE BILL COST?
The bill is projected to increase federal deficits by about $277 billion over 10 years, the CBO said. Lawmakers did not include offsetting spending cuts or tax increases to help pay for the spending.
WHERE DO THINGS STAND IN CONGRESS?
Both the House and Senate have approved the bill overwhelmingly. The Senate did so in June, but the the bill contained a revenue-related provision that must originate in the House, requiring a do-over to make a technical fix.
The House approved the fixed bill by a vote of 342-88. So, now the measure is back before the Senate, where the previous iteration had passed by a vote of 84-14. Biden says he will sign it.
SO WHY HASN’T THE SENATE APPROVED IT YET?
When the CBO scored the bill, it projected that nearly $400 billion slated to be spent on health services would move from discretionary spending to mandatory spending, which is mostly sheltered from the bruising battles that occur each year over where to spend money in appropriations bills.
The Committee for a Responsible Federal Budget, a nonpartisan fiscal watchdog, said a reclassification of nearly $400 billion from discretionary to mandatory would “both reduce the pressure to keep those costs under control and make it easier for appropriators to spend more elsewhere in the budget without offsets.”
Those dynamics also applied to the bill when the Senate approved it in June. Nevertheless, senators voted for the measure overwhelmingly.
But, last week more than two dozen Republicans who voted for the bill in June voted against advancing it this time. They sided with Republican Sen. Pat Toomey of Pennsylvania, who is seeking a vote on an amendment that he says would not reduce spending on veterans but would prevent spending increases in other nondefense programs down the road.
Senate Majority Leader Chuck Schumer has offered to let the Senate vote on the Toomey amendment with 60 votes needed for passage, the same number that is needed to advance the bill itself.
It’s unclear how the delay will be resolved, though Senate GOP leader Mitch McConnell predicted Monday that the bill will pass this week.
Advocacy groups for veterans, a key voting bloc in the upcoming midterm elections, are furious and ramping up the political pressure on lawmakers to act. At a Capitol Hill news conference the day after last week’s procedural vote, speakers used terms such as “villains” and “reprehensible” to describe the Republican senators who voted against advancing the measure last week but voted for almost the exact same bill in June.
“Veterans are angry and confused at the sudden change from those they thought had their backs,” said Cory Titus of the group Military Officers Association of America.
“You just screwed veterans yesterday,” added Tom Porter of the group Iraq and Afghanistan Veterans of America. “Now, we’re going to hold them accountable.”
Copyright 2022 The Associated Press. All rights reserved. | https://www.kxii.com/2022/08/02/explainer-how-health-care-vets-became-fight-congress/ | 2022-08-02T11:46:48Z |
Diana Ross, Boys II Men among those appearing at Pro Football Hall of Fame VIP parties
Stars in entertainment were out during last weekend's Pro Football Hall of Fame Enshrinement Festival.
In addition to concerts featuring Journey and Donnie Iris along with a comedy show with Dave Chappelle, the weekend featured private VIP parties with enshrinees throughout the weekend.
And the musical guests this weekend didn't disappoint.
Pop icon Diana Ross appeared at an enshrinement party for Cliff Branch, while Boys II Men took part during a weekend enshrinement party for Bryant Young.
Here is a look at some of the highlights from the weekend's enshrinement parties from social media posts from guests at the events.
Pop icon Diana Ross makes a surprise appearance at Cliff Branch's party
Guests at Oakland Raiders' enshrinee Cliff Branch's party were shocked to see Ross take the stage and sing.
Ross was reportedly one of Branch's favorite singers and sang a 40-minute set, including “I’m Coming Out,” “My World is Empty Without You,” “You Can’t Hurry Love,” “Stop! In The Name of Love,” “Upside Down” and “Ain’t No Mountain High Enough,” her cover of Gloria Gaynor’s “I Will Survive” and an encore of “Thank You."
Las Vegas singer David Perrico and the Raiders House Band also played during the night, along with songs from former Oakland Raider Henry Lawrence.
Another San Francisco 49ers enshrinement party appearance for Boys II Men
Six years after opening up for Huey Lewis at former San Francisco 49ers owner Ed DeBartolo Jr.'s enshrinement party, Boys II Men made it back to Stark County to play at new enshrinee Bryant Young's party.
Hall of Famer Terrell Owens also appeared at the event and took some ribbing from band members for also playing for the Dallas Cowboys in addition to the 49ers.
Former St. Louis Rams offensive lineman Adam Timmerman also visited to congratulate Young. Timmerman reportedly urged Hall of Fame voters to vote for Young.
Former Pittsburgh Steelers running back and fellow Notre Dame player Jerome Bettis also praised Boys II Men for appearing at the party.
Former Cleveland Cavalier Phil Hubbard also appeared at Young's party.
Charlie Berens delivers the laughs at LeRoy Butler's enshrinement party
Comedian Charlie Berens entertained attendees at LeRoy Butler's enshrinement party.
Tony Boselli brings a touch of Tournament Players Club at Sawgrass in Stark County during his party
Tony Boselli created an island green, similar to the famed 17th hole at Tournament Players Club at Sawgrass, where he and guests could chip golf balls. | https://www.cantonrep.com/story/news/2022/08/09/diana-ross-boys-ii-men-pro-football-hall-of-fame-parties/65396895007/ | 2022-08-09T16:19:07Z |
NEW YORK, June 27, 2022 /PRNewswire/ -- Attention Spero Therapeutics, Inc. ("Spero") (NASDAQ: SPRO) shareholders:
The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between October 28, 2021 and May 2, 2022.
If you suffered a loss on your investment in Spero, contact us about potential recovery by using the link below. There is no cost or obligation to you.
ABOUT THE ACTION: The class action against Spero includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the data submitted in support of the New Drug Application ("NDA") for the Company's product candidate, Tebipenem HBr, were insufficient to obtain approval from the U.S. Food and Drug Administration ("FDA"); (ii) accordingly, it was unlikely that the FDA would approve the Tebipenem HBr NDA in its current form; (iii) the foregoing would necessitate a significant workforce reduction and restructuring of Spero's operations; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
DEADLINE: July 25, 2022
Aggrieved Spero investors only have until July 25, 2022 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: vw@wongesq.com
View original content:
SOURCE The Law Offices of Vincent Wong | https://www.wibw.com/prnewswire/2022/06/27/class-action-alert-law-offices-vincent-wong-remind-spero-investors-lead-plaintiff-deadline-july-25-2022/ | 2022-06-27T21:34:44Z |
‘A Strange Loop’ earns a leading 11 Tony Award nominations
NEW YORK (AP) — “A Strange Loop,” Michael R. Jackson’s critically cheered theater meta-journey earned a leading 11 Tony Award nominations Monday as Broadway joined the national discussion of race by embracing an envelope-pushing Black-written and Black-led musical.
Jackson’s 2020 Pulitzer Prize drama winner about a Black gay man writing a show about a Black gay man earned nods for best musical, best leading man in newcomer Jaquel Spivey and best featured actress for L Morgan Lee, who becomes the first openly transgender performer to be nominated for a Tony Award.
Jesse Williams, the “Grey’s Anatomy” star making his Broadway debut, got a nomination for “Take Me Out,” as did his co-star Jesse Tyler Ferguson of “Modern Family” fame. Playwright Lynn Nottage has two reasons to smile Monday morning: Her book for the musical “MJ was nominated for best book and her play “Clyde’s” got a nod for best play.
Right behind “A Strange Loop” is a tie with 10 nominations each for “MJ,” a bio musical of the King of Pop stuffed with his biggest hits, and “Paradise Square,” a musical about Irish immigrants and Black Americans jostling to survive in New York City around the time of the Civil War.
The rest of the best new musical category includes “Six,” the corrective feminist take on the six wives of England’s Henry VIII, “Girl From the North Country,” which uses the songs of Bob Dylan to weave a Depression-era story in the Midwest and “Mr. Saturday Night,” a reworking of Billy Crystal’s film about a bitter, old insult comic chasing a last laugh.
Two of the best play nominees are about economics — “Skeleton Crew,” Dominique Morisseau’s play about blue-collar job insecurity in a Detroit auto stamping plant in 2008, and “The Lehman Trilogy,” Stefano Massini’s play spanning 150 years about what led to the collapse of financial giant Lehman Brothers.
There’s also “Clyde’s,” Nottage’s play about a group of ex-cons trying to restart their lives at a truck stop diner, and “Hangmen,” Martin McDonagh’s look at an executioner-turned-pub owner forced to grapple with his past when capital punishment is made illegal in the United Kingdom. “The Minutes,” Tracey Letts’ depiction of a small-town city council meeting that exposes backstabbing, greed and the larger delusions in American history, also earned a best play nod.
There were four musical revivals during the season, but only three got nominations: “The Music Man” which celebrates America’s soul with a traveling con man in a small Iowa town starring Hugh Jackman and Sutton Foster, who each have two Tonys and were each nominated this time as well.
The two other entries in the musical revival category are “Caroline, Or Change,” Tony Kushner and Jeanine Tesori’s show that explores America’s racial, social and economic divisions in 1963 Louisiana, and “Company,” Stephen Sondheim’s exploration of a single person’s conflicted feelings about commitment, this time with a gender-switching of the lead character. That left “Funny Girl,” the classic American show starring Beanie Feldstein about the rise of a comic star of the Ziegfeld Follies, out of the running — it got only one nod, for Jared Grimes as best featured actor.
Nominations for best play revival are “Trouble in Mind,” Alice Childress’ play about a Broadway play that explores the racial divide in the 1950s, and “How I Learned to Drive,” Vogel’s Pulitzer Prize-winning memory play told by the survivor of childhood sexual abuse, starring two nominees: Mary-Louise Parker and David Morse. The others are “Take Me Out,” Richard Greenberg’s exploration of what happens when a baseball superstar comes out as gay, and “for colored girls who have considered suicide/when the rainbow is enough,” playwright Ntozake Shange’s exploration of Black womanhood. That work also made history: Camille A. Brown the first Black woman to direct and choreograph a Broadway play since 1955 earned nominations in both categories.
The season — with a whopping 34 new productions — represents a full return to theaters after nearly two years of a pandemic-mandated shutdown. It is also notable for a wave of plays by Black playwrights, reflecting the impact on Broadway of the global conversation about race following the killing of George Floyd in 2020.
Neither Matthew Broderick nor his wife Sarah Jessica Parker earned nominations for a revival of “Plaza Suite,” but Patti LuPone got one for “Company” and so did LaChanze for “Trouble in Mind.” Ruth Negga earned a nomination for “Macbeth,” but her co-star Daniel Craig came up empty. Tony-winner Phylicia Rashad got her first nomination in 17 years with “Skeleton Crew.”
The musical “Mrs. Doubtfire” earned only one nod, for Rob McClure, stepping into the Robin Williams role of an actor who poses as his children’s portly, Scottish nanny in order to spend time with them after a divorce.
The nominees for best actress in a musical nominees are Sharon D. Clarke of “Caroline, Or Change,” Foster in “The Music Man,” Joaquina Kalukango for “Paradise Square,” Carmen Cusack in “Flying Over Sunset” and Mare Winningham in “Girl From the North Country.”
Joining Spivey, Jackman and McClure in the best actor in a musical category are Crystal for “Mr. Saturday Night” and Myles Frost, whose King of Pop in “MJ” was a moonwalking triumph. The best actor in a play category is dominated by the three leads in “The Lehman Trilogy” — Simon Russell Beale, Adam Godley and Adrian Lester. The rest are Morse, Sam Rockwell from “American Buffalo,” Ruben Santiago-Hudson in “Lackawanna Blues” and David Threlfall from “Hangmen.”
The eligibility cutoff date for the 2021-2022 season was delayed to May 4 after several Broadway shows had to cancel performances due to COVID-19 cases reported among cast and crew.
The Tony Awards will be held at Radio City Music Hall on June 12. The ceremony will air live on CBS and Paramount+ starting at 8 p.m. ET. Film and stage star Ariana DeBose will host.
___
This story corrects actress in a musical nominees to remove Katrina Lenk.
___
Mark Kennedy is at http://twitter.com/KennedyTwits
Copyright 2022 The Associated Press. All rights reserved. | https://www.wibw.com/2022/05/09/strange-loop-earns-leading-11-tony-award-nominations/ | 2022-05-09T14:10:37Z |
- Quantitative three-pronged program to improve bone and total body health –
ASHBURN, Va., Sept. 16, 2022 /PRNewswire/ -- Osteoporosis is a complex and multifactorial disorder that is growing in prevalence. More than half of Medicare-aged women and more than a fifth of comparable age men have one or more osteoporotic fractures confirmed during their lifetime. Recovery from large bone fractures is slow and leads to a more sedentary and less engaged life with greater morbidity and accelerated mortality.
Thought-leading scientist and integrative healthcare pioneer, Russell Jaffe, MD, PhD, and natural bone health expert Susan Brown, PhD, CNS, with contributors Jayashree Mani, MS, CCN and Marcy Jaffe, MPA, MBA, explore the components of bone health – from submolecular to macromolecular – and offer a quantitative approach to epigenetic factors, providing simple clinically-useful integrative tests and a targeted action plan that includes diet, hydration, supplementation and lifestyle recommendations that will protect bone, joint and muscle health as we age.
The book covers an "Alkaline Way" approach to bone and body health consisting of:
- Measuring and Correcting Net Acid Excess
- Measuring and Reducing Inflammation and Oxidative Stress
- Evaluating Neurohormone Status
Dr. Brown notes, "While the average woman loses roughly 45% of her bone density between the ages of 35 and 85, we see clients stabilize bone mass quickly, with bone mass gains over the longer term being more the rule than the exception. Those who diligently work through the steps of our program put control back into their control systems, gain bone strength, and reduce fracture risk."
Natural Bone Health: A Practitioner's Guide to Healthy Bone, Joints and Muscles is now available for purchase on Amazon.com and at https://www.perqueintegrativehealth.com/natural-bone-health-a-practitioners-guide-to-healthy-bone-joints-and-muscles/
Russell Jaffe, MD, Ph.D., CCN, is an internist and immunologist. He is board-certified in clinical pathology, with subspecialty board certification in chemical pathology. Russ is a Fellow of the following medical societies: ASCP, ACAAI, ACN, ASIP, and FRSM. Dr. Jaffe helped advance several adjunctive healthcare approaches including medical acupuncture (TCM), certified clinical nutrition (CCN), health coaching, and predictive biomarkers. Enabling primary, proactive prevention in clinical practice is part of Dr. Jaffe's mission to speed the transition from sick care to healthful caring in policy, practice and research. With over 100 peer reviewed publications, invited chapters, and books, Dr. Jaffe speaks at continuing professional education conferences and in technology innovation forums. Dr. Jaffe is director of ELISA/ACT Biotechnologies (Sterling, VA), PERQUE (Ashburn, VA), RMJ Holdings (Vienna, VA) and serves as a founding Fellow of the Health Studies Collegium. He works and lives in Virginia.
Susan E. Brown, Ph.D., CNS, is a medical anthropologist and certified clinical nutritionist (CCN). She directs the Better Bones Foundation and Center for Better Bones in East Syracuse, NY. Dr. Brown conducts primary research, and lectures widely on osteoporosis, teaching her natural Better Bones, Better Body Program for the regeneration of bone health. Dr. Brown's publications include The Acid Alkaline Food Guide (Square One Publishers 2006, 2013) Better Bones, Better Body: Beyond Estrogen and Calcium: A Comprehensive Self-Help Program for Preventing, Halting & Overcoming Osteoporosis (New Canaan: Keats, 1996, 2000); The Mend Clinic Book of Natural Remedies for Menopause and Beyond (Dell, 1997), co-authored with Dr. Paula Maas. Information on Dr. Brown's works can be found at www.betterbones.com. Susan works and lives in East Syracuse, New York.
Jayashree Mani MS, CCN is a Certified Clinical Nutritionist and has focused on diabetes, weight management, integrative nutrition and lifestyle management. She has been providing nutritional counseling and education to patients in various medical settings for more than 20 years. With her expertise in the field of autoimmunity, she has also co-authored chapters and articles in key reference books and scientific journals and is a Certified Nutrition Specialist supervisor. Jayashree is also involved in product formulation and actively educating practitioners and helping patients achieve lifetime wellness. Jayashree works and lives in northern Virginia.
Marcy Jaffe, MPA, MBA, serves as a health advocate with Thinking of You since 1997: http://www.vitamins-today.com. She successfully achieves improved bone health outcomes one client at a time, through increasing magnesium reserves and recommending the Alkaline Way Lifestyle. Marcy successfully completed the PIH Academy Course 1 Certification in 2019. Marcy works and lives in small towns of western Washington and southern Arizona.
View original content to download multimedia:
SOURCE PERQUE Integrative Health | https://www.kxii.com/prnewswire/2022/09/16/wellness-pioneer-russell-jaffe-md-phd-ccn-bone-health-expert-susan-brown-phd-cns-launch-book-natural-bone-health-practitioners-guide-healthy-bone-joints-muscles/ | 2022-09-16T13:55:07Z |
- Transaction has completed following shareholder and court approvals
- Novamind shareholders and RSU holders have been issued 0.84 Numinus shares per Novamind share
- As a result of the acquisition, Novamind has ceased trading on the Canadian Securities Exchange (CSE)
- Reid Robison has been appointed Chief Clinical Officer and Paul Thielking has been appointed Chief Science Officer
- Michael Tan has been promoted to President and Chief Operating Officer
VANCOUVER, BC, June 10, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus", the "Company") (TSX: NUMI) (OTCQX: NUMIF) is pleased to announce the acquisition (the "Transaction") of Novamind Inc. ("Novamind") has completed, following Novamind's receipt of a final order from the BC Supreme Court. As a result of the acquisition, Numinus now operates 13 wellness clinics, four clinical research facilities and a dedicated psychedelics research lab – positioning the company as a leading integrated mental wellness company providing ketamine- and psychedelic-assisted therapies.
This acquisition significantly grows Numinus' client service offerings, geographic reach, and revenues. Numinus and Novamind clients will benefit from access to a greater variety of services and treatments over the coming months, including the expansion of virtual therapy services at US-based clinics and increased group therapy offerings in Canada. The transaction has also provided a strong US platform for potential continued growth in partnership and acquisition opportunities. On a proforma basis, the combined business generated C$11.9 million of annual revenues (trailing four quarters reported, as at June 10, 2022).
"This acquisition elevates our collective service offering, and we look forward to helping an even greater number of people access effective and safe treatments to support mental wellness," said Payton Nyquvest, Founder and CEO, Numinus. "We warmly welcome the Novamind team to Numinus and believe our shared values and focus on client service will ensure a seamless integration as we continue to grow as one unified company."
Executive Appointments
Numinus is also pleased to announce the appointments of Dr. Reid Robison (MD) as Chief Clinical Officer and Dr. Paul Thielking (MD) as Chief Science Officer, who both join the Company from Novamind.
Dr. Robison was most recently Chief Medical Officer at Novamind. He is a board-certified psychiatrist and co-founder of Cedar Psychiatry and serves as the Medical Director for the Center for Change, a leading center for the treatment of eating disorders. He was previously a coordinating investigator for a study on MDMA-assisted therapy for eating disorders, sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). As an early adopter and researcher of the use of ketamine in psychiatry, Dr. Robison also led a pivotal intravenous ketamine study for treatment-resistant depression by Janssen, leading up to that company's recent FDA-approval of Spravato™. To date, Dr. Robison has guided thousands of ketamine-assisted therapy sessions and hundreds of Spravato™ dosing sessions. Dr. Robison is an adjunct professor at both the University of Utah and Brigham Young University.
Dr. Thielking was most recently Chief Scientific Officer at Novamind and is board certified in psychiatry, hospice and palliative medicine, and integrative medicine. He is the principal investigator for a psilocybin-enhanced group psychotherapy intervention for cancer patients with depression and a co-investigator on a study for ketamine-assisted psychotherapy for opioid use disorder. He has extensive experience with creating group therapy interventions for patients with serious illness and has successfully integrated ketamine-assisted psychotherapy services within an academic outpatient oncology clinic for cancer patients with depression. Dr. Thielking was director of psycho-oncology at the University of Utah Huntsman Cancer Institute for five years and previously an associate professor in the department of psychiatry at the University of Utah. He is a graduate of the California Institute of Integrative Studies' Certification of Psychedelic Therapy and Research program.
Numinus is also pleased to announce that as a result of his growing responsibilities, Michael Tan has been promoted to President and Chief Operating Officer. In his new role, Mr. Tan will oversee all Company operations and will lead strategic directives to drive revenue growth through future footprint and product line expansions. Mr. Tan has been instrumental in Numinus' growth, and joined the Company in 2019.
As a result of the increased medical and research expertise added to Numinus' expanded executive team, Dr. Evan Wood, Chief Medical Officer, will now be able to continue in his role in a reduced capacity, in order to enable him to maintain his important advocacy, clinical and teaching work. Dr. Wood remains committed to Numinus over the long term and will continue as the Company's Chief Medical Officer through the integration of Novamind, though with reduced office hours.
Integration and Consolidation of Operations
As a result of the acquisition, Numinus now has 13 operating wellness clinics across North America, four clinical research sites and a dedicated psychedelics research laboratory. The Company intends to continue operating all of these locations and is reviewing previously announced organic clinic growth plans, considering the significantly expanded scale this acquisition has provided.
Clinics in Utah and Arizona will continue to operate under existing branding until later this year, at which point all locations will be rebranded to reflect the Numinus brand.
Securities Issuance
As approved by shareholders on June 8, 2022, Numinus has issued 43,474,659 common shares to the former shareholders and RSU holders of Novamind, as consideration for the acquisition – representing 0.84 of one (the "Exchange Ratio") Numinus common share per each Novamind share and Novamind restricted share unit (RSU). Given securities processing times, these Numinus shares should settle in Novamind investor accounts by June 16, 2022.
In connection with the Transaction, all 3,346,052 incentive stock options of Novamind were cancelled and replaced at the Exchange Ratio through the issuance of 2,810,684 incentive stock options of Numinus (the "Replacement Options") with each Replacement Option being exercisable to acquire one common share of Numinus (a "Common Share"), and of which (i) 2,453,684 Replacement Options are exercisable at a price of approximately $0.4762 per Common Share until December 11, 2025, (ii) 252,000 Replacement Options are exercisable at a price of approximately $1.1905 per Common Share until December 22, 2025, and (iii) 105,000 Replacement Options are exercisable at a price of approximately $0.4762 per Common Share until April 30, 2025.
In addition, all 19,044,831 outstanding warrants of Novamind have been adjusted in accordance with their respective contractual terms and will be exercisable at the Exchange Ratio to acquire 15,997,658 Common Shares.
In connection with the Transaction, the Company engaged Eight Capital ("Eight Capital") as exclusive financial advisor. In consideration of the services provided by Eight Capital, the Company agreed to pay a fee in the amount of $700,000 (the "Completion Fee"), of which $200,000 are to be paid in Common Shares valued at $0.45 per Common Share, being 444,444 Common Shares (the "Completion Fee Shares"), with the balance of the Completion Fee to be paid in cash. The issuance of the Completion Fee Shares is subject to approval from the Toronto Stock Exchange. The Completion Fee Shares will be subject to resale restrictions expiring four months and one day from the date of issuance in accordance with applicable securities laws.
Details of the Transaction are set out in Numinus' management information circular dated May 4, 2022, which is available under the Company's profile on SEDAR at www.sedar.com.
About Numinus
Numinus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.
Forward-Looking Statements
This news release includes certain "forward‐looking information" and "forward‐looking statements" (collectively "forward‐looking statements") within the meaning of applicable Canadian securities legislation, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. All statements in this news release that address events or developments that the Company expects to occur in the future are forward‐looking statements. Forward‐looking statements are statements that are not historical facts and are often identified by words such as "expect", "plan", "anticipate", "project", "target", "potential", "schedule", "forecast", "budget", "estimate", "intend" or "believe" and similar expressions or their negative connotations, or that events or conditions "will", "would", "may", "could", "should" or "might" occur, and include information regarding expectations regarding the potential benefits of the Transaction and the ability of the combined company to successfully achieve business objectives; and expectations for other economic, business, and/or competitive factors.
Forward‐looking statements necessarily involve assumptions, risks and uncertainties, certain of which are beyond the Company's control. These forward‐looking statements are qualified in their entirety by cautionary statements and risk factor disclosure contained in filings made by the Company with the Canadian securities regulators, including the Company's financial statements and related MD&A for the financial year ended August 31, 2021 and its interim financial statements and related MD&A for the three and six months ended February 28, 2022, all filed with the securities regulatory authorities in all provinces and territories of Canada, except Québec, and available under the Company's profile at www.sedar.com. The risk factors are not exhaustive of the factors that may affect the Company's forward‐looking statements. The Company's forward‐looking statements are based on the applicable assumptions and factors management considers reasonable as of the date hereof, based on the information available to management of the Company at such time. The Company does not assume any obligation to update forward‐looking statements if circumstances or management's beliefs, expectations or opinions should change other than as required by applicable securities laws. There can be no assurance that forward‐looking statements will prove to be accurate, and actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward‐looking statements. Accordingly, undue reliance should not be placed on forward‐looking statements.
View original content:
SOURCE Numinus Wellness Inc. | https://www.wibw.com/prnewswire/2022/06/10/numinus-completes-acquisition-novamind-announces-executive-appointments/ | 2022-06-11T00:52:35Z |
Red Wings Zamboni driver, a fan favorite, sues over firing
DETROIT (AP) — A popular Zamboni driver for the Detroit Red Wings says he was dismissed for urinating in a drain. Al Sobotka filed a discrimination lawsuit this week against Olympia Entertainment, two months after he was fired. Sobotka worked for the Red Wings for 51 years. His lawyer says the 68-year-old Sobotka has a health condition that causes him to frequently urinate. Sobotka couldn’t get to a restroom so he urinated in a drain that carries ice runoff from the Zamboni machines at Little Caesars Arena. Someone saw him and apparently reported it in February. Sobotka says he was “heartbroken” over his firing. There was no immediate comment from Olympia Entertainment. | https://localnews8.com/sports/ap-national-sports/2022/04/20/red-wings-zamboni-driver-a-fan-favorite-sues-over-firing/ | 2022-04-20T23:30:27Z |
(The Hill) – Florida Gov. Ron DeSantis (R) is escalating his feud with the White House over the COVID-19 response as he positions himself for a possible presidential campaign in 2024.
DeSantis has been taking heat for his decision not to pre-order from the federal government COVID-19 vaccines for infants and young kids.
The White House initially made 10 million vaccines for young children available for states to pre-order in anticipation that the shots will get the green light from federal regulators. Having a small stockpile of doses on hand will mean shots can start being administered shortly after the Centers for Disease Control and Prevention endorses their use.
But Florida was the only state that decided not to place an order.
During a press conference on Thursday, DeSantis argued that kids have “practically zero risk” of getting seriously ill from COVID, so the state will not be devoting any resources to getting them vaccinated.
“Doctors can get it. Hospitals can get it. But there’s not going to be any state programs that are going to be trying to get COVID jabs to infants and toddlers and newborns,” DeSantis said to applause from the crowd on hand. “That’s not where we’re gonna be utilizing our resources.”
White House officials accused DeSantis of taking away parents’ rights to choose whether to get their kids vaccinated.
“The state of Florida intentionally missed multiple deadlines to order vaccines to protect its youngest kids,” White House coronavirus response coordinator Ashish Jha told reporters Friday.
“Now, despite repeated efforts to reach out and engage officials in the state of Florida, elected officials deliberately chose to delay taking action to deny Florida parents the choice whether to vaccinate their children or not,” Jha said.
DeSantis has spent much of the pandemic attacking the Biden administration’s COVID-19 mitigation efforts.
The Sunshine State’s governor has made it a point of pride to question and challenge a range of federal guidance, repeatedly promoting the “freedom” of a state without policies like mask or vaccine mandates.
The Department of Health is led by Surgeon General Joseph Ladapo, a DeSantis appointee who has openly questioned the safety and benefit of the COVID-19 vaccines.
In March, Florida became the first state to recommend against vaccinating healthy kids and teenagers ages 5 to 17. The state issued guidance saying those kids “may not benefit from receiving the currently available COVID-19 vaccine.”
Even though federal agencies and national health groups recommend vaccinating young children, DeSantis suggested they have not been through enough testing to ensure they are safe for use in kids.
“Our Department of Health has been very clear, the risk outweighs the benefits and we recommend against it,” DeSantis said.
Still, he noted the state was not stopping any doctor or hospital from ordering what they may need.
Florida’s Department of Health said it was merely choosing not to participate in the “convoluted” federal vaccine distribution process, “especially when the federal government has a track record of developing inconsistent and unsustainable COVID-19 policies.”
The agency insisted there will be no delay in providers getting doses should they want any.
There was more finger pointing on Friday, after the White House implied DeSantis bowed to public pressure and reversed course by allowing pediatricians and other providers to order vaccines.
“Yesterday, pediatricians in every state in the country could order vaccines or had the opportunity to order vaccines for their offices, except for pediatricians of Florida. As of today, pediatricians in Florida now have that choice,” Jha said.
“Whether that’s a reversal or not, I will leave up to you to decide. But something clearly changed between yesterday and today in the state of Florida.”
But Florida health department spokesman Jeremy Redfern said nothing has changed, and the plan all along has been to let providers start ordering from the state’s online portal as soon as the Food and Drug Administration authorized the shots.
Redfern said Florida refuses to be the Biden administration’s warehouse for unused vaccines. Once a doctor’s office or hospital knows what their demand is, they’re free to put in an order with the state, he said.
Lisa Gwynn, president of the Florida Chapter of the American Academy of Pediatrics (FCAAP), accused the DeSantis administration of playing political games.
“Look at all the attention that this whole thing has brought to our governor,” she said.
Gwynn said it wasn’t clear that doctors would be allowed to order vaccines so quickly.
“The challenge right now that we’re most concerned about is because we’re the last ones to order, we’re going to be the last ones to receive it,” Gwynn said.
“We could have started vaccinating our kids this week. But now we have to wait until July. You know, I mean, kids can still get sick. Kids can bring it home and give it to family members.” | https://cw33.com/news/nexstar-media-wire/desantis-escalates-feud-with-white-house-amid-criticism-over-states-vaccine-plan/ | 2022-06-18T19:33:18Z |
Breaches of voting machine data raise worries for midterms
ATLANTA (AP) — Sensitive voting system passwords posted online. Copies of confidential voting software available for download. Ballot-counting machines inspected by people not supposed to have access.
The list of suspected security breaches at local election offices since the 2020 election keeps growing, with investigations underway in at least three states -- Colorado, Georgia and Michigan. The stakes appeared to rise this week when the existence of a federal probe came to light involving a prominent loyalist to former President Donald Trump who has been promoting voting machine conspiracy theories across the country.
While much remains unknown about the investigations, one of the most pressing questions is what it all could mean for security of voting machines with the midterm elections less than two months away.
Election security experts say the breaches by themselves have not necessarily increased threats to the November voting. Election officials already assume hostile foreign governments might have the sensitive data, and so they take precautions to protect their voting systems.
The more immediate concern is the possibility that rogue election workers, including those sympathetic to lies about the 2020 presidential election, might use their access to election equipment and the knowledge gained through the breaches to launch an attack from within. That could be intended to gain an advantage for their desired candidate or party, or to introduce system problems that would sow further distrust in the election results.
In some of the suspected security breaches, authorities are investigating whether local officials provided unauthorized access to people who copied software and hard drive data, and in several cases shared it publicly.
After the Georgia breach, a group of election security experts said the unauthorized copying and sharing of election data from rural Coffee County presented “serious threats” to the November election. They urged the state election board to replace the touchscreen devices used throughout the state and use only hand-marked paper ballots.
Harri Hursti, a leading expert in voting security, said he is concerned about another use of the breached data. Access to the voting equipment data or software can be used to develop a realistic looking video in which someone claims to have manipulated a voting system, he said.
Such a fake video posted online or to social media on or after Election Day could create chaos for an election office and cause voters to challenge the accuracy of the results.
“If you have those rogue images, now you can start manufacturing false, compelling evidence — false evidence of wrongdoing that never happened,” Hursti said. “You can start creating very compelling imaginary evidence.”
There has been no evidence that voting machines have been manipulated, either during the 2020 election or in this year’s primaries. But conspiracy theories widely promoted among some conservatives have led to calls for replacing the machines with hand-marked and hand-counted ballots and raised concerns that they could be targeted by people working inside election offices or at polling places.
The suspected breaches appear to be orchestrated or encouraged by people who falsely claim the 2020 election was stolen from Trump. In several of the cases, employees of local election offices or election boards gave access to voting systems to people who were not authorized to have it. The incidents emerged into public view after the voting system passwords for Mesa County, Colorado, were posted online, prompting a local investigation and a successful effort to replace the county clerk from overseeing elections.
MyPillow CEO Mike Lindell, who has organized or attended forums around the U.S. peddling conspiracy theories about voting machines, said this week that he had received a subpoena from a federal grand jury investigating the breach in Colorado and was ordered to hand over his cellphone to FBI agents who approached him at a fast-food restaurant in Minnesota.
“And they told me not to tell anybody,” Lindell said in a video afterward. “OK, I won’t. But I am.”
Lindell and others have been traveling the country over the past year, holding events where attendees are told that voting machines have been corrupted, that officials are “selected” rather than elected and that widespread fraud cost Trump the 2020 election.
In an interview with the Star Tribune of Minneapolis, Lindell said FBI agents questioned him about the Colorado breach and Dominion Voting Systems. The company provides voting equipment used in about 30 states and has had its machines targeted in the Colorado, Georgia and Michigan breaches.
When agents asked him why he flies between different states, Linden told them, “I’m going to attorney generals and politicians, and I’m trying to get them to get rid of these voting machines in our country.”
The Justice Department did not respond when asked for details about its investigation.
Dominion has sued Lindell and others, accusing them of defamation. In a statement this week, the company said it would not comment about ongoing investigations but said its systems are secure. It noted that no credible evidence has been provided to show that its machines “did anything other than count votes accurately and reliably in all states.”
The scope of the federal grand jury probe in Colorado isn’t known, but local authorities have charged Mesa County clerk Tina Peters in what they described as a “deceptive scheme which was designed to influence public servants, breach security protocols, exceed permissible access to voting equipment and set in motion the eventual distribution of confidential information to unauthorized people.”
Peters has pleaded not guilty and said she had the authority to investigate concerns that the voting equipment had been manipulated. She has appeared at numerous events with Lindell over the past year, including Lindell’s “cybersymposium” last August in which a digital copy of Mesa County’s election management system was distributed.
David Becker, a former U.S. Justice Department attorney who now leads the Center for Election Innovation & Research, notes the irony of those who raise alarms about voting equipment being involved in allegations of breaches of the same systems.
“The people who have been attacking the integrity of elections are destroying the actual integrity of elections,” he said.
___
Associated Press writer Michael Balsamo contributed to this report.
___
Follow the AP’s voting coverage at: https://apnews.com/hub/voting
Copyright 2022 The Associated Press. All rights reserved. | https://www.mysuncoast.com/2022/09/16/breaches-voting-machine-data-raise-worries-midterms/ | 2022-09-17T00:01:20Z |
More baby formula is expected on store shelves as soon as this weekend through a variety of government efforts.
On Wednesday, 60 tons of formula landed at Dulles International Airport in Washington from Ramstein Air Base in Germany, the second shipment from Europe as part of the Biden administration's Operation Fly Formula. That effort was started to address the nationwide shortage that was exacerbated by the closure of formula maker Abbott Nutrition's plant in February after several inspections by the US Food and Drug Administration found "insanitary conditions."
Chris Calamari, who leads Abbott's nutrition division, apologized for his company's role in the shortage Wednesday at a hearing before the House Energy and Commerce Subcommittee on Oversight and Investigation.
"On behalf of everyone at Abbott, I want to express our extraordinary disappointment about the shortage. We are deeply, deeply sorry," Calamari said.
Abbott said Tuesday that it plans to restart work at its Sturgis, Michigan, plant on June 4, with the first batches of new formula expected to be available to consumers on or around June 20. When the plant is up and running, it will be able to increase capacity by 40%, according to Calamari.
On Wednesday, Calamari outlined Abbott's additional plans to boost supply by bringing in more formula on nearly 50 flights a week to 12 airports across the country. Abbott has also converted some of its manufacturing facilities to make formula and is working with US Department of Agriculture WIC agencies to make sure program participants get formula for free, Calamari said.
"By the end of June, we expect we will be supplying more formula to Americans than we were in January, before the recall," he said.
More formula from companies made overseas is scheduled to arrive in the coming days, according to US Health and Human Services Secretary Xavier Becerra. First lady Jill Biden and US Surgeon General Dr. Vivek Murthy were on hand to greet Wednesday's shipment.
"I've been heartbroken to hear the stories of parents searching for formula. As a mom and a nana, it's impossible to hear stories of children suffering and not imagine your own children in the same position," Biden said. "There is more to do. We know that. Joe knows that."
The latest shipment contains hypoallergenic Nestle Gerber Good Start Extensive HA formula. The company said the formula will head to a Nestle distribution center in Pennsylvania and will immediately be sent to hospitals, WIC families and retailers nationwide.
For the past few months, Nestle said, it has stepped up production and accelerated how it gets product to market and to hospitals.
Gerber Vice President of Technical Production Scott Fitz testified at Wednesday's hearing that his company is also "working tirelessly to help parents and caregivers get the formula that they need."
"Our factories run 24/7 to produce formula as efficiently as possible while maintaining our high safety standards. We are prioritizing the manufacture of products that are most in-demand as well as specialty formulas that have been in critically short supply," he said.
Robert Cleveland, a senior vice president at the other big formula maker in the US, Mead Johnson Nutrition, a Reckitt subsidiary that makes Enfamil and Nutramigen, said that his company has increased the supply of infant formula by more than 30% compared with this time last year. The company also has trucks ready to load as soon as the products are complete and has reduced the types of products it makes to get the formula out faster.
"We're taking all of these measures while keeping a close eye on quality and safety to ensure that we always meet the near-pharmaceutical-grade safety requirements that apply to infant formula production. We will take no shortcuts," Cleveland said.
The USDA announced Wednesday that it will temporarily cover the costs of alternative brands, sizes and forms of formula for low-income families in states that have WIC contracts with manufacturers Reckitt or Gerber. Abbott is covering the cost difference in other states.
State agencies contract with one of the three main makers of baby formula to provide product to infants in the Special Supplemental Nutrition Program for Women, Infants and Children, also known as WIC. Typically, people who use WIC benefits can buy only the brand of formula made by the company that the state has contracted with for that purpose. There are also restrictions on the sizes they can buy.
About half of US states and territories have contracts with Abbott, according to the USDA, but because the company had to recall some of its products, it has created an increased demand for other brands, and families are having a hard time finding those, too.
"Just clarifying that the non-Abbott states can be adding new brands as well is a big piece, which is a position that neither the companies nor USDA had been in a place to say before," said Brian Dittmeier, senior director of public policy with the nonprofit National WIC Association. "That really makes a lot more options for those states."
He said those states aren't seeing the greatest need, necessarily, "but it is definitely an area that we need more support."
WIC is the largest purchaser of formula in the US, with more than half going to infants in the program.
The Access to Baby Formula Act, which Biden signed Saturday, gives the government this ability to be more flexible.
"We encourage states and their formula manufacturers to work together to maximize access to infant formula for WIC participants, and USDA will provide the funding to make that possible," Agriculture Secretary Tom Vilsack said in a news release Wednesday.
The FDA said Tuesday that it is doing "everything in our power" to make sure there is enough baby formula for parents and caregivers who need it, including discussions with other manufacturers and suppliers about bringing other formulas to the US.
The agency is allowing Kendal Nutricare, a company based in the UK, to import some of its baby formula to the US, and 2 million cans will be on US store shelves starting in June. The government is working with the company to fast-track its efforts to immediately send more than 40,000 cans that are now in stock.
Going forward, though, the country will need to take a closer look at why one plant can shut down and cause such shortages, Dittmeier said. The Abbott plant in Michigan, for example, is the only one of its facilities that produces specialty formulas like the ones given to infants who are allergic to milk.
"How do we spread this out a bit more?" Dittmeier asked.
"Frankly, a national security concern here has been exposed. This is is an essential product for the country," he said. "This has exposed a weakness in our essential supply line, and that needs to be remedied quickly."
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://www.albanyherald.com/features/health/more-baby-formula-is-heading-to-store-shelves-as-early-as-this-weekend/article_e8379b5c-27dd-5bb7-8f35-904b0786017c.html | 2022-05-25T23:40:13Z |
LOS ANGELES, Aug. 17, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Enochian Biosciences, Inc. ("Enochian" or the "Company") (NASDAQ: ENOB).
Class Period: January 17, 2018 – June 27, 2022
Lead Plaintiff Deadline: September 26, 2022
If you are a shareholder who suffered a loss, click here to participate.
The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors: (1) that co-founder and inventor Gumrukcu was engaged in a variety of frauds; (2) that Gumrukcu was not a licensed doctor anywhere in the world; (3) that, as a result of the foregoing, Gumrukcu's purported contributions to the Company lacked a reasonable basis; (4) that, as a result of the foregoing, the Company had overstated its commercial prospects; (5) that Gumrukcu had improperly diverted approximately $20 million from Enochian to entities he owned; and (6) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View original content:
SOURCE The Law Offices of Frank R. Cruz, Los Angeles | https://www.mysuncoast.com/prnewswire/2022/08/17/enob-investors-have-opportunity-lead-enochian-biosciences-inc-securities-fraud-lawsuit/ | 2022-08-17T16:49:38Z |
Area law enforcement to dispose of unused prescription meds this weekend
Published: Apr. 27, 2022 at 3:54 PM CDT|Updated: 1 hour ago
TOPEKA, Kan. (WIBW) - Saturday is National Prescription Drug Take Back Day.
Local law enforcement agencies will have drop sites set up across the state to accept and safely dispose of people’s unused prescription drugs.
Find a site near you: DEA Site Locator
Drop Sites:
- Brown County Sheriff’s Office (709 Utah Street; Hiawatha, KS)
- Soldier Township Fire Department (600 NW 46th St.; Topeka, KS)
- Mission Township Fire Department (3101 SW Urish Rd.; Topeka, KS)
- Law Enforcement Center (320 S Kansas Ave.; Topeka, KS)
- Concordia City Hall (701 Washington; Concordia, KS)
- Wabaunsee Co. Courthouse (215 Kansas Ave; Alma, KS)
- Maple Hill Senior Center (218 Main St.; Maple Hill, KS)
- CVS Pharmacy (1215 Merchant St.; Emporia, KS)
- Wal-Mart Pharmacy (2301 Industrial Rd.; Emporia, KS.)
- Dillons (618 W 6th St.; Junction City, KS)
Copyright 2022 WIBW. All rights reserved. | https://www.wibw.com/2022/04/27/area-law-enforcement-dispose-unused-prescription-meds-this-weekend/ | 2022-04-27T22:19:51Z |
WEST COLUMBIA, S.C., July 20, 2022 /PRNewswire/ -- Allied Air Enterprises, a Lennox International Inc. Company, has been recognized for excellence in product design in the 2022 Dealer Design Awards Program, sponsored by The ACHR NEWS (Air Conditioning, Heating & Refrigeration News) magazine. The company's LYNX™ 18 SEER Inverter Heat Pump under the Ducane™ brand was chosen as the Gold winner in the Residential High-Efficiency category. Selected from 132 entries by a panel of independent contractors, the winners of the 2022 Dealer Design Awards represent the outstanding product innovations serving the HVAC industry today. A distinguished publication among contractors and technicians, The ACHR News is the leading trade magazine in the heating, ventilating, air conditioning, and refrigeration industries.
ACHR News Publisher Sarah Harding stated, "These awards give us a unique opportunity to recognize the outstanding research and development efforts that go into many of the products serving the HVACR industry." As one DDA judge noted, "All contractors are struggling with access to equipment, finding many sizes of different pieces of equipment out of stock. This (LYNX 18) solves a very real problem in our industry."
"The Allied Air team is excited to have our LYNX 18 SEER Inverter Heat Pump named a Gold winner in the Residential High-Efficiency category of The ACHR News Dealer Design Awards," said Kim McGill, VP - Marketing, Allied Air Enterprises. "Designed as an intelligent replacement upgrade, LYNX 18 provides a balance of performance and value for any budget to generate new business opportunities for Allied's dealers and installers."
Powered by intelligent algorithms instead of expensive, proprietary thermostats, the versatile LYNX 18 works with a wide range of conventional 24v thermostats. The unit's proprietary QuickLink™ Inverter Technology provides superior comfort, with consistent dehumidification and temperature levels. The LYNX 18's five operating modes can dial in the perfect balance of comfort and increase energy savings by up to 22% annually compared to conventional 14 SEER single-stage heat pumps.
Winning entries in the Dealer Design Awards will be featured in the week of July 18, 2022 issue of The ACHR News, which is distributed nationally to over 27,000 HVACR contractors, wholesalers and distributors, and other industry professionals. See complete DDA Award coverage at www.achrnews.com.
For more information on the new LYNX™ 18 Inverter Heat Pump and Allied Air Enterprises' complete line of leading heating and cooling solutions please visit www.alliedair.com.
A division of Lennox International, Allied Air Enterprises™ serves residential and commercial marketplaces in the United States and Canada with the heating and cooling solutions of industry-leading brands like Armstrong Air®, AirEase™, Concord®, Ducane™, Allied™, Allied Commercial™ and MagicPak®. From concept to production, Allied Air HVAC systems are produced through the design, engineering, high-quality testing and manufacturing efforts employed at five Allied facilities based across North America. For more information, visit http://www.alliedair.com or call 1-800-448-5872.
View original content:
SOURCE Allied Air Enterprises | https://www.wibw.com/prnewswire/2022/07/20/allied-air-enterprises-named-gold-winner-achr-news-2022-dealer-design-awards/ | 2022-07-20T18:34:51Z |
The partnership will deliver lifesaving technology to school systems, transportation systems, and first responder environments using Artificial Intelligence active shooter identification, active shooter training, and ballistic hardening systems.
EXTON, Pa., July 21, 2022 /PRNewswire/ -- United Safety, a global manufacturer of safety and survivability solutions, announced the launch of a strategic partnership with Exigent effective July 21, 2022.
The partnership with Exigent, based in Huntsville, AL, will focus on gun detection leveraging Exigent's cutting-edge technology known as Exigent®-GR. The Exigent-GR gun detection capability is based on AI technology developed for use by the military. Exigent-GR combines state-of-the-art camera technology with sophisticated computer vision in either a single robust device that autonomously scans and processes images to identity guns or can also be integrated with existing facility camera system to autonomously identify guns.
Randy Riley, President and CEO of the manager of Exigent, explains "current security camera systems require a human to identify gun threats. Even dedicated security professionals using the best camera system cannot provide 100% real-time observation. An effective, pro-active solution is needed to identify guns before they enter an area where shots are fired and that is where the Exigent-GR technology comes into play." He continues stating "we are excited to partner with United Safety with deep expertise and knowledge of the various industries it serves and a proven track record in bringing innovative technologies to market."
United Safety continues to grow its portfolio of product offerings that include the most innovative and reliable safety and survivability solutions its customers can trust to protect life and property. Joseph Mirabile, CEO & President of United Safety states "the partnership between United Safety and Exigent is one that has special meaning to me. Anything that United Safety can do to help our customers navigate these complex challenges by bringing them access to lifesaving technology is at the very core of what we stand for as an organization. We believe the Exigent® - GR technology can help make a difference in the lives of the people we serve on an all too frequent basis."
United Safety and Survivability Corporation is committed to delivering the most innovative and reliable safety and survivability solutions that our customers can trust to protect life and property. As a global leader in the design and engineering of world-class safety, survivability, and technology solutions across a variety of industries and categories, our portfolio of products includes seating for commercial buses, fire trucks, ambulances, military vehicles, motor coaches, rail cars and locomotives. We design and build specialty soldier survivability systems for military vehicles and our revolutionary fire suppression systems are used in school buses, public transit, heavy machinery and more. Active Air Purification and AEGIS® Microbial Surface Treatment help to protect the public and operators by eliminating bacteria and viruses from air and surfaces. Further information about United Safety can be found at www.unitedsafetycorporation.com.
Exigent, LLC develops innovative solutions to solve the hardest problems to provide high rewards in high-risk environments. We compete on the same level as multinational corporations in delivering Artificial Intelligence-based solutions for our customers. We offer unparalleled capabilities in AI solutions and a superior advanced capability to identify and solve problems much faster than other competitive approaches. Further information about Exigent can be found at www.exigent-xr.com.
Media Contact: Marisa Rosenthal
Email: mrosenthal@usscgroup.com
Phone: 215.518.0492
View original content to download multimedia:
SOURCE United Safety & Survivability Corporation | https://www.mysuncoast.com/prnewswire/2022/07/21/united-safety-launches-strategic-partnership-with-exigent/ | 2022-07-21T18:48:12Z |
ATLANTA (AP) — Democrats in Georgia predict dire outcomes should Sen. Raphael Warnock lose to challenger Herschel Walker this fall and Republicans regain control of Capitol Hill.
“They’re going to take away our democratic rights one after another,” longtime state lawmaker Nan Orrock warned partisans at a birthday party for the senator, who turned 53 on July 23. “Failure,” she said, “is not an option.”
Warnock took a different tack.
“I work with anybody to get something good done for the people of Georgia,” he told the same crowd, highlighting a trio of Republican senators with whom he has made legislative deals. Warnock mentioned President Joe Biden’s name just once and referred several other times only to “the president of the United States,” trying to distinguish himself from Biden — and the rising inflation that has marked his term.
Running for his first full Senate term, Warnock is pitching himself as a senator willing to do whatever it takes to help his state. That’s a shift from his approach in what were nationally elevated twin runoff campaigns won by Warnock and fellow Georgia Democrat Jon Ossoff in January 2021, giving their party Senate control two months after Biden was elected president.
Now, with inflation up and Biden’s popularity down, Warnock requires a more nuanced argument, and he’s selling his work in Washington, especially on the economy, as something distinct from the White House and the Senate’s Democratic leadership.
Republicans sense an opportunity in a state they dominated for two decades before 2020. Walker, a first-time candidate like Warnock was two years ago, is making every effort to shape the contest as a referendum on what his campaign calls the “Biden-Warnock agenda.”
“This is still a national race,” said Gail Gitcho, a senior adviser to Walker. “The burden is on Raphael Warnock and the extremely close ties he has to Joe Biden in this environment. Herschel has put him on the defensive.”
Warnock’s strategy of playing up his “bipartisan” credentials and leaving other Democrats to attack Republicans and rally the party faithful could be the incumbent’s only shot to recreate his runoff coalition. In that election, Democrats were united and enthusiastic; Republicans were not, especially GOP-leaning moderates whom then-President Donald Trump alienated with his lies that Biden’s victory was fraudulent. Some of those voters helped Warnock to his 94,000-vote win a 2% margin. This time, Warnock cannot depend on Trump to push those key swing voters in his direction.
Attracting them again starts with not directly dignifying Republican attacks.
Asked about Walker’s broadsides, Warnock ignored specifics and bemoaned “demagogues trying to divide us.”
He pivoted again when asked about Biden’s performance. “I’m focused on the job I’m doing,” Warnock said. “When that means standing with this person or that person, it’s based on what it does for Georgia.”
Even on the president’s accomplishments, Warnock avoids partisan cheerleading. He hailed the American Rescue Plan, a coronavirus relief package passed without any Republican votes, for its tax cuts aimed at lower-income workers. He praised a long-sought infrastructure bill as a “bipartisan” success that included “the Cruz-Warnock amendment.”
“Hear me out, now,” Warnock said, laughing as some of his supporters jeered Sen. Ted Cruz, R-Texas. The two men, Warnock explained, wanted to make the eastward expansion of Interstate 14 — now just a short stretch in central Texas — a federal priority. Because a Senate committee hadn’t endorsed the idea, the unlikely partners had to work the full Senate.
The amendment passed unanimously.
“Guess what: The highway that runs through Texas also runs through Georgia,” Warnock said. “It goes past red districts and blue districts. … Everybody needs to be able to get to where they need to go.”
Warnock noted other efforts with Republican Sens. Tommy Tuberville of Alabama and Marco Rubio of Florida. With Tuberville, he led a measure that would open European markets to peanut farmers in their two states. With Rubio, he worked on legislation to improve maternal mortality rates in the United States.
Tuberville is a staunch Trump ally. Rubio came to Georgia to campaign against Warnock at the outset of the runoff campaign. Warnock didn’t mention those details.
As for the uneven economy, Warnock notably referred to “global inflation” while sidestepping Biden.
He noted his work on a jobs and technology measure, which cleared the Senate on Wednesday with 17 Republican votes. The bill, which aims to boost computer chip production in the United States, would strengthen supply chains and expand national technology production, among other investments, Warnock explained.
The senator emphasized his proposals to cap insulin costs for people with diabetes and allow Medicare to negotiate for lower drug prices from pharmaceutical companies. He reminded supporters that he called on Congress to suspend the federal gas tax in February, early in the 2022 energy price surge.
“Somebody must have been listening,” Warnock said, because Georgia’s Republican administration suspended the state gas tax in March and “the president of the United States is now on record saying we should suspend the gas tax” nationally.
Warnock reminded reporters that he came out swinging when Biden’s budget plans called for closing the Pentagon’s combat readiness center in Savannah. “I stood up against the administration” and “a terrible idea,” Warnock said, taking a position that aligns him with the Republicans in the state’s congressional delegation.
Additionally, he said he’s “pushing the president of the United States right now” on student loan cancellations for some borrowers. Biden’s Department of Education already has eased some rules on debt repayment, and the president is still considering a more blanket forgiveness up to a cap. The White House has said a decision on the amount could come in August.
In Walker’s camp, Gitcho relishes the thought of Warnock replicating scenes from the two-month runoff blitz, when Biden traveled twice to Georgia and shared stages with Warnock and Ossoff. “The best surrogate Warnock could have,” she said of the beleaguered president. “But we know that won’t happen.”
Warnock instead appears ready to brandish his party credentials carefully. In fundraising solicitations and online ads, Warnock says he’s “running to keep Georgia blue.” But the campaign targets those to reliable Democratic voters.
Standing over birthday cakes and candles, the senator fondly recalled his runoff victory and thanked Georgians who “gave us the narrowest majority.”
“Think about what would have happened had it gone the other way,” he allowed. But at his crescendo 15 minutes later, the Baptist minister went bigger — and perhaps toward a potentially decisive middle.
“We are one nation,” he said, voice rising. “We are one people. And come November, Georgia is going to do it one more time.”
___
Follow AP for full coverage of the midterms at https://apnews.com/hub/2022-midterm-elections and on Twitter, https://twitter.com/ap_politics | https://cw33.com/news/politics/ap-politics/sen-warnock-cites-bipartisanship-avoids-biden-in-georgia/ | 2022-07-31T16:07:18Z |
WARSAW, Poland (AP) — Poland on Friday summoned France’s ambassador over French President Emmanuel Macron’s reference to Poland’s prime minister as a “far-right anti-Semite” in a budding feud over Russia’s war on Ukraine.
It was not immediately clear exactly when Ambassador Frederic Billet would arrive at Poland’s Foreign Ministry. Officials in Poland blamed the harsh words on campaign fervor ahead of this weekend’s presidential election in France.
The bitter exchange between Macron and Poland’s Prime Minister Mateusz Morawiecki appears as an unwelcome crack in the European Union’s unity forged amid outrage over Russia’s aggression on Ukraine.
In an interview published online by the French Le Parisien newspaper Thursday, Macron called Morawiecki a “far-right anti-Semite who bans LGBT persons.” Macron, who is seeking a second term in Sunday’s vote, also claimed that Morawiecki has been trying to help French far-right presidential candidate Marine Le Pen.
Piotr Mueller, a spokesman for Poland’s right-wing government, said it was a “lie” to suggest that Morawiecki had anything to do with anti-Semitism and blamed Macron’s remarks on the emotions of a heated election campaign.
Poles are especially sensitive to accusations of anti-Semitism because of the Holocaust that Nazi Germany largely carried out in Poland. Most of Europe’s Jews lived in Poland before World War II and millions perished in death camps or ghettos run by German Nazi forces that occupied the country during the war.
Macron didn’t specify what he was referring to, but Morawiecki angered Israel and many Jews in 2018 when he said that there were also “Jewish perpetrators” of the Holocaust. Morawiecki’s government also introduced a law that penalizes apportioning blame to Poles for Holocaust crimes committed by the Germans. Another law Morawiecki’s team introduced effectively bars restitution of private property that had been owned by Holocaust victims and was later seized by the state.
The French leader’s remarks were in response to Morawiecki’s harsh criticism of his talks with Russia’s leader Vladimir Putin in a still futile effort to end the bloodshed in Ukraine. Morawiecki said Monday that no talks should be held with (war) criminals like Nazi Germany’s leader Adolf Hitler or the Soviet Union’s Joseph Stalin. | https://cw33.com/news/international/ap-international/poland-france-trade-barbs-over-russias-war-on-ukraine/ | 2022-04-09T14:07:11Z |
All Credit Union Branches Accepting Book Donations for San Diego Elementary School Students
SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- North Island Credit Union has launched a book drive to help ensure children in low-income households have access to books outside the classroom. The book drive is being conducted in partnership with the Scripps Howard Foundation and ABC 10News as part of its "If You Give a Child a Book . . ." childhood literacy campaign.
Through August 30th, North Island Credit Union encourages community members to drop off new books to any of its branch locations in San Diego County. A complete list of North Island Credit Union locations is available here. Donated books should be new and appropriate for kindergarten through elementary school students. All books will be given to students attending Title 1 schools in San Diego County.
"We invite everyone to join this effort to make books accessible and nurture a joy of reading for children in our underserved communities," said North Island Credit Union CEO Steve O'Connell. "This campaign will get books directly into the hands of children who need them most, helping address the literacy gap in our communities and providing the resources to support reading outside the classroom."
Drop Off locations include:
- 7968 El Cajon Blvd, La Mesa, CA
- 2550 Fifth Ave, San Diego, CA
- 9119 Clairemont Mesa Blvd, San Diego, CA
- 9420 Mira Mesa Blvd, San Diego, CA
- Naval Air Base, Saufley St Bldg. 318, San Diego, CA
- 10549 Scripps Poway Pkwy, San Diego, CA
- 45 N. Broadway, Chula Vista, CA
- 5898 Copley Dr, San Diego, CA
- 1101 Palm Ave, Imperial Beach, CA
- 884 Eastlake Pkwy, Chula Vista, CA
- 301 N. Magnolia Ave, El Cajon, CA
The annual "If You Give a Child a Book … " childhood literacy campaign is a partnership of the Scripps Howard Foundation, members of the Scripps family, employees of The E.W. Scripps Company, and the communities it serves. The campaign has distributed more than 500,000 books since its launch in 2016. Monetary donations are also accepted to purchase books for students in need here.
About North Island Credit Union, a division of California Credit Union
California Credit Union is a federally insured, state chartered credit union founded in 1933 that serves public or private school employees, community members and businesses across California. With more than 165,000 members and assets of over $4 billion, California Credit Union has 24 branches throughout Los Angeles, Orange and San Diego counties. The credit union operates in San Diego County as North Island Credit Union, a division of California Credit Union. California Credit Union offers a full suite of consumer, business and investment products and services, including comprehensive consumer checking and loan options, personalized financial planning, business banking, and leading-edge online and mobile banking. Please visit northisland.ccu.com for more information or follow the credit union on Instagram® or Facebook® @northislandcu.
View original content to download multimedia:
SOURCE North Island Credit Union | https://www.mysuncoast.com/prnewswire/2022/08/01/north-island-credit-union-launches-book-drive-benefit-local-title-1-schools/ | 2022-08-01T17:01:32Z |
DALLAS (KDAF) — Can you believe it’s already hump day? The National Weather Service center in Fort Worth has shared a look at the forecast for not only the end of the week but the weekend and early next week.
As the work week moves from Thursday to Friday rain chances will fall off and only be near Central Texas. North Texans should expect highs at or above the seasonal norm.
“By later this week, North and Central Texas will continue to see low chances for showers and thunderstorms across primarily Central Texas. Though widespread severe weather is not expected, Highs in the lower to mid 90s will and humid conditions will create plenty of instability for a few more robust storms with pea hail, very gusty outflow winds, and brief heavy downpours and minor flooding,” NWS Fort Worth said.
As the weekend arrives it will be dry and near seasonal temperatures before a cool front arrives on Sunday.
NWS Fort Worth said, “Next weekend into early next week is expected to be dry with a cool front bringing slightly cooler and less humid conditions behind a cold front Sunday through Tuesday. Highs remain in the lower to middle 90s on Saturday, with highs mid 80s to lower 90s with breezy north-northeast moving into Monday.” | https://cw33.com/news/local/looking-at-north-texas-forecast-for-end-of-work-week-weekend-early-next-week/ | 2022-09-07T16:15:06Z |
Tickets Are on Sale Now for This Sure-to-be-Historic Bout
DENVER, Aug. 16, 2022 /PRNewswire/ -- In a boxing rubber match for the ages, Saul Canelo Alvarez and Gennadiy "GGG" Golovkin, two of the Sweet Science's all-time pound-for-pound greats, will confront each other a for a third time on Saturday, September 17 at T-Mobile Arena in Las Vegas. And thanks to a partnership between DAZN and Fathom Events, fight fans nationwide will be able to experience all the DAZN PPV action and drama LIVE -- on the big screen in more than 700 movie theaters.
The live DAZN broadcast begins at 5 p.m. PT / 8 p.m. ET with a jam-packed undercard, with the main card ring walk expected sometime after 8 p.m. PT /11 p.m. ET. Tickets are on sale now at FathomEvents.com.
The four-weight-division world champion - but now seemingly fallible - Canelo enters the rematch on the heels of his close loss in May via unanimous decision to defending WBA light heavyweight champion Dmitry Bivol. While the Canelo vs. GGG series stands at 1-0-1 in his favor, Canelo will be placing his WBA, WBC, IBF, WBO and The Ring super-middleweight titles on the line when he once again faces an opponent against whom he previously earned a controversial draw and then a close majority decision.
A complete list of theater locations and showtimes is available on the Fathom Events website (theater participants are subject to change).
About Fathom Events
Fathom is a recognized leader in the entertainment industry as one of the top distributors of content to movie theaters in North America. Owned by AMC Entertainment Inc. (NYSE: AMC); Cinemark Holdings, Inc. (NYSE: CNK); and Regal, a subsidiary of the Cineworld Group (LSE: CINE.L), Fathom operates the largest cinema distribution network, delivering a wide variety of programming and experiences to cinema audiences in all of the top U.S. markets and to more than 45 countries. For more information, visit www.FathomEvents.com.
ABOUT DAZN
DAZN is the world's leading sports entertainment platform. The only global digital sports broadcaster, DAZN is live in over 200 countries and is reimagining the way people enjoy sport. With a single, frictionless platform, sports fans can watch, bet, play, share, socialise, and buy tickets, NFTs and merchandise. Live and on-demand sports content, anywhere, in any language, on any device – only on DAZN. DAZN is a global, privately-owned company with employees in over 25 countries. For more information on DAZN, our products, people, and performance, visit www.dazngroup.com.
View original content to download multimedia:
SOURCE Fathom Events | https://www.mysuncoast.com/prnewswire/2022/08/16/third-times-charm-dazn-fathom-events-bring-canelo-vs-ggg-iii-theater-near-you-live-september-17/ | 2022-08-16T15:09:38Z |
DUBLIN, Ireland, June 13, 2022 /PRNewswire/ -- ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor's office, today announced the commencement of the ProVIDE pivotal clinical trial to evaluate the safety and effectiveness of the ProVee System, a nitinol expander designed to gently re-shape the enlarged prostate and alleviate the symptoms caused by BPH. The first procedure was successfully performed by Sijo Parekattil, M.D., Principle Investigator at Avant Concierge Urology, Winter Garden, Florida.
According to Dr Parekattil, "The ProVee procedure is straightforward and comfortably performed in a doctor's office." He continued, "I see many patients whose quality of life are adversely impacted by the symptoms associated with an enlarged prostate and the ProVee System represents an exciting new alternative for BPH treatment."
Steve Kaplan, M.D., Professor of Urology at the Icahn School of Medicine at Mount Sinai in New York is the Global Lead Investigator for the ProVIDE study. "The ProVee System has the potential to be an effective treatment for BPH that can be safely and reliably performed in the office setting" said Dr. Kaplan. "This international, multi-center clinical study will thoroughly evaluate the safety, efficacy and long-term durability of the ProVee device and I look forward to presenting the data from this large controlled clinical trial."
About the ProVIDE Study
The ProVIDE clinical trial is a prospective, multi-center, double-blind controlled study to evaluate the safety, performance, and effectiveness of the ProVee System in patients with lower urinary tract symptoms secondary to BPH. 225 subjects, enrolled across 18 investigational sites in the US and 4 International sites, will be randomized to either receive
the ProVee System or undergo a sham procedure. After three months, patients will be unblinded and participants who underwent the sham procedure and meet the study inclusion criteria will be eligible to receive treatment with ProVee. Primary effectiveness will be evaluated using the International Prostate Symptom Score (IPSS) and based on the change from the subject's baseline measurement to those at three and twelve months.
About ProVerum Limited
ProVerum Limited is an innovative Dublin based SME, founded in 2016 and focused on the development of novel minimally invasive technologies to treat BPH. The ProVee System is an investigational device and is not approved for commercial sale. For more information, please visit www.proverummedical.com
View original content:
SOURCE ProVerum | https://www.wibw.com/prnewswire/2022/06/13/proverum-first-enrolment-provide-clinical-study-bph-treatment/ | 2022-06-13T11:16:00Z |
Families of mass shooting victims knock on lawmakers’ doors to call for an assault weapons ban
Families from shootings in Texas, Florida, Connecticut, and Colorado came together as they call on lawmakers to do more to reform gun laws.
WASHINGTON (Gray DC) - Inside the halls of Congress, a group of people gather.
The group likely would have never met, if it were not for the gun violence that rocked their lives and killed their family members.
“I said before I don’t want to be sharing her story. I want her here to create her own story,” said Kimberly Rubio, who is here in the offices of Senators to advocate for 10-year-old Lexi Rubio who died in the Uvalde school shooting.
Beside her stands the families of other victims from Parkland, Florida, Aurora, Colorado, and Newtown, Connecticut.
“I want to see to see their reaction face-to-face and unfortunately yesterday, we saw one of the faces. It’s a telling story on what he thinks about it all,” said Felix Rubio as Kimberly Rubio chimed in “it’s Ted Cruz.”
Cruz is calling for the passage of a Secure Our Schools Act that would use leftover COVID funds to put more police officers and mental health counselors in schools.
But the Rubio’s don’t think it’s enough. They want to see an assault weapons ban passed.
“That’s not enough,” said Kimberly Rubio about Cruz’s call to action. “That did nothing for students and the two teachers of Uvalde and even at that why do you want our schools to look like prisons? You know that’s not how our children should be growing up. And, that’s a reactive approach and we’re looking at a proactive stance which is the federal ban of assault weapons.”
Also joining the families of mass shooting victims is Connecticut mother Kristin Song, whose name has become well known on Capitol Hill. For years she has been advocating for a national safe storage law after her son Ethan was killed in an accidental shooting with an unsecured gun in 2018. Ethan’s Law has passed the House but remains stalled in the Senate.
“We are lobbying the senators to try to get onboard with Ethan’s Law. Also, we are discussing the assault weapons freeze,” said Song, who later added, “76% of all school shooters get their guns from home or a relatives home and those guns are unsecured.”
It’s a message that puts her mission, side-by-side with families like Felix and Kimberly Rubio.
President Joe Biden said he supports an assault weapons ban. Meanwhile Congress passed bipartisan gun reform earlier this year which expanded things like background checks.
Song said that action has helped lawmakers become more interested in considering proposals like hers for safe storage reform.
“They’re much more interested. From the time I started lobbying four years ago to the time now, there’s a lot more interest,” said Song.
The group also visited lawmaker such as Senators Tammy Duckworth and Joe Manchin.
The families hope to see more gun reform legislation move forward next year.
Copyright 2022 Gray DC. All rights reserved. | https://www.mysuncoast.com/2022/09/15/families-mass-shooting-victims-knock-lawmakers-doors-call-an-assault-weapons-ban/ | 2022-09-15T23:35:21Z |
ELMAU, Germany (AP) — President Joe Biden on Sunday praised the continued unity of the global alliance confronting Russia, as he and other heads of the Group of Seven leading economies strategized on sustaining the pressure in their effort to isolate Moscow over its months-long invasion of Ukraine.
Biden and his counterparts were meeting to discuss how to secure energy supplies and tackle inflation, aiming to keep fallout from the war from splintering the global coalition working to punish Moscow. They were set to announce new bans on imports of Russian gold, the latest in a series of sanctions the club of democracies hopes will further isolate Russia economically over its invasion of Ukraine.
Leaders also were coming together in a new global infrastructure partnership meant to provide an alternative to Russian and Chinese investment in the developing world.
“We’ve got to make sure we have us all staying together,” Biden said during a pre-summit sit-down with German Chancellor Olaf Scholz, who holds the G-7′s rotating presidency and is hosting the gathering. “You know, we’re gonna continue working on economic challenges that we face but I think we get through all this.”
Scholz replied that the “good message” is that “we all made it to stay united, which Putin never expected,” a reference to Russian President Vladimir Putin, who sent his military across the border into Ukraine in late February.
“We have to stay together, because Putin has been counting on, from the beginning, that somehow NATO and the G-7 would splinter, but we haven’t and we’re not going to,” Biden replied, as he and Scholz sat on a terrace that overlooked the picturesque Bavarian Alps.
“We can’t let this aggression take the form it has and get away with it,” added Biden.
Hours before the summit formally opened, Russia launched missile strikes against the Ukrainian capital Sunday, striking at least two residential buildings, Kyiv Mayor Vitali Klitschko said. They were the first such strikes by Russia in three weeks.
Biden condemned Russia’s actions as “more of their barbarism.”
Other leaders echoed Biden’s praise of coalition unity.
The head of the European Union’s council of governments said the 27-member block maintains “unwavering unity” in backing Ukraine against Russia’s invasion with money and political support, but that “Ukraine needs more and we are committed to providing more.”
European Council President Charles Michel said EU governments were ready to supply “more military support, more financial means, and more political support” to enable Ukraine to defend itself and “curb Russia’s ability to wage war.”
The EU has imposed six rounds of sanctions against Russia, the latest one being a ban on 90% of Russian crude oil imports by the end of the year. The measure is aimed at a pillar of the Kremlin’s finances, its oil and gas revenues.
Biden and the leaders of Britain, Canada, France, Germany, Italy and Japan, plus the EU, were spending Sunday in both formal and informal settings, including working sessions on the war’s effects on the global economy, including inflation, and on infrastructure.
Biden, who arrived in Germany early Sunday, said G-7 nations, including the United States, will ban imports of gold from Russia. A formal announcement was expected Tuesday as the leaders hold their annual summit.
Senior Biden administration officials said gold is Moscow’s second biggest export after energy, and that banning such imports would make it more difficult for Russia to participate in global markets. The officials spoke on condition of anonymity to discuss details before the announcement.
British Prime Minister Boris Johnson said the ban will “directly hit Russian oligarchs and strike at the heart of Putin’s war machine.”
“Putin is squandering his dwindling resources on this pointless and barbaric war. He is bankrolling his ego at the expense of both the Ukrainian and Russian people,” Johnson said. “We need to starve the Putin regime of its funding.”
Gold, in recent years, has been the top Russian export after energy — reaching almost $19 billion or about 5% of global gold exports, in 2020, according to the White House.
Of Russian gold exports, 90% was consigned to G-7 countries. More than 90% of those exports, or nearly $17 billion, was exported to the UK. The United States imported less than $200 million in gold from Russia in 2019, and under $1 million in 2020 and 2021.
Among the issues to be discussed are price caps on energy, which are meant to limit Russian oil and gas profits that Moscow can pump into its war effort. The idea has been championed by U.S. Treasury Secretary Janet Yellen.
Michel said price caps on Russian oil imports were under discussion. But he said “we want to go into the details, we want to fine-tune … to make sure we have a clear understanding of what are the direct effects” if such a step were to be taken by the group.
Leaders were also set to discuss how to maintain commitments addressing climate change while also solving critical energy supply needs brought on by the war.
“There’s no watering down of climate commitments,” John Kirby, a spokesman for Biden’s National Security Council, said Saturday as the president flew to Germany.
Biden is also set to formally launch a global infrastructure partnership designed to counter China’s influence in the developing world. He had named it “Build Back Better World” and introduced the program at last year’s G-7 summit.
Biden and other leaders will announce the first projects to benefit from what the U.S. sees as an “alternative to infrastructure models that sell debt traps to low- and middle-income partner countries,” Kirby said. The projects are also supposed to help advance U.S. economic competitiveness and our national security,” he said.
After the G-7 summit concludes on Tuesday, Biden will travel to Madrid for a summit of the leaders of the 30 members of NATO to align strategy on the war in Ukraine.
___
Superville reported from Telfs, Austria. Associated Press writers Jill Lawless in London and Geir Moulson in Elmau, Germany, contributed to this report. | https://cw33.com/business/ap-business/biden-g-7-leaders-huddle-on-energy-inflation-ukraine-war/ | 2022-06-26T12:23:22Z |
VANCOUVER, BC, June 14, 2022 /PRNewswire/ - Kootenay Silver (TSXV: KTN) is pleased to announce JV operator Aztec Minerals Corp. (TSXV: AZT) has reported the final gold and multi-element results for the Cervantes Project 2021-2022 Reverse Circulation (RC) Phase 2 drill program in Sonora, Mexico. The program involved 26 RC drill holes with a combined total of 5,249 meters that tested four targets (California, California North, Jasper, and Purisima East).
The Cervantes project is a 65/35 joint venture with Kootenay holding a 35% participating interest.
Highlights from final drill results
- Results for Hole CAL22-018—a deep probe to test the large IP chargeability anomaly of the California zone, reached a total depth of 264.48 meters before caving.
- The multi-element ICP results show good relationships between Au, Cu, Bi, Ag and As, with prospective grades and widths of Cu and Ag supporting a potential porphyry deposit at depth.
- Continued intercepts of anomalous gold mineralization in the California zone
- Multi-Element ICP results received for Cervantes drill holes
Results form the California target continue to return anomalous gold mineralization.
View drill section here: California Drill Section CAL22-018
Reported lengths are apparent widths, not true widths, and the observed gold mineralization appears to be widely distributed in disseminations, fractures and veinlets within quartz-feldspar porphyry, feldspar porphyry stocks, quartzites and related hydrothermal breccias.
Click to view: California Longitudinal Section and California 2022 Drill Plan Map
Holes CAL22-018, 019, 020, and 021 intersected anomalous gold mineralization, extending the known mineralized zone at depth, and to the north, east and south of the California zone. The now completed RC Phase 2 drilling program covers an area measuring approximately 900 meters long by 250 to 500 meters wide, with demonstrated, continuous anomalous mineralization up to 265 meters depth vertically. The porphyry gold-copper mineralization is open in all directions.
Table 1. Select Multi-Element Results of Cervantes Phase 2 Drill Program
The Aztec-Kootenay JV has now completed its Phase 2 RC program of 26 holes, totaling 5,249 meters at the Cervantes Property. Drilling commenced in December 2021. The primary objectives of the 2021 – 2022 phase 2 exploration program was to better define the open pit, heap leach gold potential of the porphyry oxide cap at California, evaluate the potential for deeper copper-gold porphyry sulfide mineralization underlying the oxide cap, test for north and west extensions of the California mineralization at California North and Jasper, and assess the breccia potential of Purisima East.
Drill samples cuttings are collected every 5 feet (1.52m) from all drill holes. The samples are analyzed by Bureau Veritas for gold with a 30-gram sample size using the method FA430 followed by MA300. Over limits, when present, are analyzed by AR404 or FA550. All holes contain certified blanks, standards, and duplicates as part of the quality control program. The QA/QC review for all drilling has been completed with excellent results showing good data integrity. The samples are shipped to and received by Bureau Veritas Minerals laboratory for the gold and multielement geochemical analysis and additional gold results will be received and reported in the next several weeks. Final multielement ICP results are expected to follow the release of the preliminary gold assays and are expected to be received during the second quarter 2022.
Aztec has recently completed drill hole collar surveying, field work for Drone Photogrammetry survey created a detailed ortho-topographic base map, and Terraspec readings on the RC drill chips. Aztec is now carrying out channel sampling and geologic mapping of the new drill roads at California, California Norte and Jasper, relogged the 2017-2018 core, expand surface sampling and mapping on the property in general to continue the 2021 phase 1 surface program, and generate Leapfrog modeling of the geology, geochemistry and geophysics.
Qualified Persons
The Kootenay technical information in this news release has been prepared in accordance with the Canadian regulatory requirements set out in National Instrument 43-101 (Standards of Disclosure for Mineral Projects) and reviewed and approved on behalf of Kootenay by James McDonald, P.Geo, President, CEO & Director for Kootenay, a Qualified Person.
About Kootenay Silver Inc.
Kootenay Silver Inc. is an exploration company actively engaged in the discovery and development of mineral projects in the Sierra Madre Region of Mexico and in British Columbia, Canada. Supported by one of the largest junior portfolios of silver assets in Mexico, Kootenay continues to provide its shareholders with significant leverage to silver prices. The Company remains focused on the expansion of its current silver resources, new discoveries and the near-term economic development of its priority silver projects located in prolific mining districts in Sonora, State and Chihuahua, State, Mexico, respectively.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:
The information in this news release has been prepared as at June 14, 2022. Certain statements in this news release, referred to herein as "forward-looking statements", constitute "forward-looking statements" under the provisions of Canadian provincial securities laws. These statements can be identified by the use of words such as "expected", "may", "will" or similar terms.
Forward-looking statements are necessarily based upon a number of factors and assumptions that, while considered reasonable by Kootenay as of the date of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Many factors, known and unknown, could cause actual results to be materially different from those expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as otherwise required by law, Kootenay expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Kootenay's expectations or any change in events, conditions or circumstances on which any such statement is based.
Cautionary Note to US Investors: This news release may contain information about adjacent properties on which we have no right to explore or mine. We advise U.S. investors that the SEC's mining guidelines strictly prohibit information of this type in documents filed with the SEC. U.S. investors are cautioned that mineral deposits on adjacent properties are not indicative of mineral deposits on our properties. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.
2022 number 13
View original content to download multimedia:
SOURCE Kootenay Silver Inc. | https://www.wibw.com/prnewswire/2022/06/14/kootenay-silver-announces-aztec-kootenay-jv-final-gold-results-2021-2022-drill-program-cervantes-property-sonora/ | 2022-06-14T17:52:42Z |
HOUSTON, July 19, 2022 /PRNewswire/ -- Lexitas, a leading provider of technology-enabled litigation services and a portfolio company of funds advised by Apax, announced its acquisition of Phipps Reporting. Headquartered in West Palm Beach with sixteen additional offices, Phipps Reporting is one of the largest and most successful firms in the state of Florida.
"We are thrilled to welcome Christine Phipps and Phipps Reporting to our organization. The company has experienced dynamic growth over the past 10 years making the Inc. 5000 eight consecutive times, fueled by its best-in-class employees and reporters, acquisition strategy and unflagging dedication to providing outstanding services. This acquisition will significantly expand the depth and quality of Lexitas' service offerings in the Florida, Midwest and Southeast markets," said Gary Buckland, Chief Executive Officer at Lexitas.
Christine Phipps, CEO of Phipps Reporting, said "Lexitas is the only firm I would have ever considered for the Phipps Reporting team and clients. In my wildest dreams, I never imagined the success that Phipps would achieve, and the time has come for us to take the next step so that we can continue our growth and take Phipps to the next level. By joining the Lexitas family, we will be able to offer an expanded range of services, while continuing to provide the warm, personalized service that our clients expect and which we are known for. The synergy of our two companies will create an unparalleled client experience."
Founded in 1987, Lexitas is a leading national provider of legal support services to law firms, corporations, and insurance companies. Services include record retrieval, court reporting, process service, registered agent, legal staffing, document review and commercial contracts outsourcing. For more information visit https://lexitaslegal.com and https://www.phippsreporting.com/.
View original content to download multimedia:
SOURCE Lexitas | https://www.wibw.com/prnewswire/2022/07/19/lexitas-announces-acquisition-phipps-reporting/ | 2022-07-19T12:09:28Z |
What are the best Mizuno golf shoes?
Your golf swing depends on a solid foundation. The best technique and clubs can’t deliver if your feet are slipping and shifting at impact. High-quality golf shoes are critical to your success and comfort. They keep your feet firmly planted and cushion your feet for a long day on the course.
Japanese manufacturer Mizuno is a leader in sports equipment. Mizuno golf clubs have long been recognized for their quality and precision. Mizuno golf shoes deliver the quality construction and comfort golfers have come to expect. For its versatility and comfort, the best Mizuno golf shoes are the Mizuno Wave Hazard Boa Golf Shoes.
What to know before you buy Mizuno golf shoes
Do you really need golf shoes?
Some golfers try to navigate the course in tennis shoes or other flat-bottomed sneakers. These shoes are not designed to grip the turf and easily slip and slide. If you slip while swinging a golf club, you risk making poor contact with the ball and even losing control of the club. You also could injure yourself if centrifugal force pulls your arms through without making clean contact with the ball.
Golf shoes are designed to hold the feet in place and also waterproof for early morning dew and rainy conditions.
Are spiked or spikeless golf shoes better?
Golf shoes with spikes and without them have their distinct advantages. Mizuno offers both kinds of soles.
Spiked golf shoes hold to the grass more firmly. There are also replaceable spikes that allow you to swap out worn spikes and put fresh spikes in their place.
Spikeless shoes are popular because they are lighter and still provide a medium level of traction. Spikeless shoes can also be worn off the course.
What style are Mizuno golf shoes?
Mizuno uses a modern, athletic design to its golf shoes. They have slightly wider soles for traction and are designed to hold the cushioned midsole. The G-style line has a sneaker look to it that can be worn with most outfits and in most settings.
What to look for in Mizuno golf shoes
Boa Fit lacing system
The Boa Fit system eliminates tangled laces and ensures a custom fit for each golfer. It was designed for snowboard boots but was introduced on golf shoes over 15 years ago. It uses a dial, lace and guide system. The dial is turned to tighten the lace through the guide system. When the proper level of comfort and tightness is felt, the dial holds the tension in place, and then easily releases when turned the opposite direction.
Midsole
Mizuno golf shoes feature Mizuno’s Enerzy midsole. It is a high rebound material that increases the golfer’s energy return ratio for the highest rebound performance.
Outsole
The rubber X10 outsole is designed with a tread that grips all terrains. It provides excellent grip and increases a golfer’s confidence when swinging.
Waterproofing
Mizuno golf shoes have a one-year warranty for waterproofing. The waterproofing formula was created in Japan and is applied to all Mizuno golf shoes.
How much you can expect to spend on Mizuno golf shoes
Mizuno has a limited line of golf shoes that range from $100-$150. The G-style golf shoes are priced between $100-$110, depending on gender and size. The Nexlite model is priced between $110-$125, depending on the size and design year. The Wave Hazard and Wave Cadence shoes are priced between $125-$150 and feature the most innovations and more leather than synthetic material.
Mizuno golf shoes FAQ
Are waterproof shoes worth the investment?
A. If you play in the early morning dew or a rainy climate, waterproof shoes are valuable. Anyone who has played with wet socks and feet will tell you how uncomfortable and distracting it is. Dry feet are as important as warm hands are in the winter.
Does Mizuno make metal spikes for golf shoes?
A. All of Mizuno’s golf shoes are spikeless or have rubber spikes. Most golf courses no longer allow metal spikes, so there is a very limited market for them.
What are the best Mizuno golf shoes to buy?
Top Mizuno golf shoes
Mizuno Wave Hazard Boa Golf Shoes
What you need to know: This golf shoe is versatile and comfortable, and it firmly grips all course terrains.
What you’ll love: Featuring the Mizuno Enerzy midsole, the shoe is bouncy and envelops your feet. The Boa lacing system allows the golfer to tighten the shoes to an exact fit. They come in two color patterns and have a one-year waterproofing warranty.
What you should consider: The mesh above the toe section easily scuffs around the natural crease.
Where to buy: Sold by Amazon
Top Mizuno golf shoes
Mizuno G-Style Soft Touch Golf Shoes
What you need to know: These spikeless golf shoes have a simple style and excellent comfort, and the sneaker design can be worn on and off the course.
What you’ll love: Featuring a soft-touch waterproof upper and spineless sole, these spikeless golf shoes deliver optimal comfort with a modern look. They come in blue and white. The sizes accommodate golfers with wide feet.
What you should consider: The front of the shoes show a crease after several rounds.
Where to buy: Sold by Amazon
Worth checking out
Mizuno Nexlite 006 Boa Golf Shoes
What you need to know: Spikeless and stylish, these are some of the lightest golf shoes around, weighing only 8 ounces per shoe.
What you’ll love: The soft synthetic upper feels soft to the touch, and the Boa lacing system provides a snug fit. The shoes feature a silicone toe wrap and a one-year waterproofing warranty. The sole and tread are designed for the firmest grip.
What you should consider: These shoes are offered in a limited number of sizes.
Where to buy: Sold by Amazon
Want to shop the best products at the best prices? Check out Daily Deals from BestReviews.
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Steve Ganger writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved. | https://cw33.com/reviews/br/sports-fitness-br/golf-br/best-mizuno-golf-shoes/ | 2022-08-05T20:28:09Z |
LAKEWOOD, Colo., June 9, 2022 /PRNewswire/ -- In celebration of Pride Month, Natural Grocers® will be donating $5,000 to the Human Rights Campaign to support the organization's efforts to end discrimination against the LGBTQ+ community and their work towards equality for all.
Celebrated through the month of June, Pride Month is when the world's LGBTQ+ communities (and their allies) come together and celebrate the freedom to be themselves and the impact they've had in the world.
"We're pleased to make this donation to the Human Rights Campaign. Commitment to our Community and commitment to our Crew are two of our Five Founding Principles. At the heart of this commitment is the belief that all people should be empowered to experience health and wellbeing. We cannot be true to this conviction without cultivating inclusion throughout every aspect of our organization. Celebrating inclusivity refreshes, expands, and shapes our perspective, energizing our mission of equitable access to health and wellness for all," states Heather Isely, Executive Vice President of Natural Grocers.
- For more information related to the Human Rights Campaign, click here.
ABOUT NATURAL GROCERS BY VITAMIN COTTAGE
Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is an expanding specialty retailer of natural and organic groceries, body care products, and dietary supplements. The products sold by Natural Grocers must meet strict quality guidelines and may not contain artificial colors, flavors, preservatives or sweeteners, or partially hydrogenated or hydrogenated oils. The Company sells only USDA-certified organic produce and exclusively pasture-raised, non-confinement dairy products, and free-range eggs. Natural Grocers' flexible smaller-store format allows it to offer affordable prices in a shopper-friendly, clean, and convenient retail environment. The Company also provides extensive free science-based Nutrition Education programs to help customers make informed health and nutrition choices. The Company, founded in 1955, has 162 stores in 20 states. Visit www.NaturalGrocers.com for more information and store locations.
View original content to download multimedia:
SOURCE Natural Grocers by Vitamin Cottage, Inc. | https://www.kxii.com/prnewswire/2022/06/09/natural-grocers-celebrates-supports-pride-month/ | 2022-06-09T10:57:25Z |
WASHINGTON (AP) — The Justice Department has declined to charge former White House chief of staff Mark Meadows and another aide to former President Donald Trump, Dan Scavino, for contempt of Congress for their defiance of subpoenas in the Jan. 6 congressional investigation.
That’s according to a person familiar with a letter sent by the Justice Department to a lawyer for the House of Representatives on Friday. The person was not authorized to discuss the matter publicly and was granted anonymity.
The action came the same day as the Justice Department said a grand jury had indicted Peter Navarro, a trade adviser in the Trump White House, for his refusal to cooperate with the committee’s investigation.
The New York Times first reported the decision not to prosecute.
THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below.
WASHINGTON (AP) — Former Trump White House official Peter Navarro was indicted Friday on contempt charges after defying a subpoena from the House panel investigating the Jan. 6 attack on the U.S. Capitol.
Navarro is former President Donald Trump’s second aide to be charged with contempt of Congress for refusing to cooperate with the Jan. 6, 2021, investigation. His arrest comes months after the indictment of former White House adviser Steve Bannon.
Navarro, 72, was charged with one contempt count for failing to appear for a deposition before the House committee and a second charge for failing to produce documents the committee requested.
During an initial court appearance on Friday, Navarro alleged that the Justice Department had committed “prosecutorial misconduct” and said that he was told he could not contact anyone after was approached by an FBI agent at the airport on Friday and put in handcuffs. He said he was arrested while trying to board a flight to Nashville, Tennessee, for a television appearance.
“Who are these people? This is not America,” Navarro said. “I was a distinguished public servant for four years!”
During the hearing, he said the House committee was a “sham committee” and that prosecutors were “playing hardball” and were “despicable.” If convicted, each charge carries a minimum sentence of a month in jail and a maximum of a year behind bars.
The indictment underscores that the Justice Department is continuing to pursue criminal charges against Trump associates who have attempted to impede or stonewall the work of congressional investigators examining the most significant attack on U.S. democracy in decades.
The Justice Department and Attorney General Merrick Garland have faced pressure to move more quickly to decide whether to prosecute other Trump aides who have similarly defied subpoenas from the House panel.
The indictment alleges that Navarro, when summoned to appear before the committee for a deposition, refused to do so and instead told the panel that because Trump had invoked executive privilege, “my hands are tied.”
After committee staff told him they believed there were topics he could discuss without raising any executive privilege concerns, Navarro again refused, directing the committee to negotiate directly with lawyers for Trump, according to the indictment. The committee went ahead with its scheduled deposition on March 2, but Navarro did not attend.
The indictment came days after Navarro revealed in a court filing that he also had been subpoenaed to appear before a grand jury this week as part of the Justice Department’s sprawling probe into the deadly insurrection at the U.S. Capitol.
“This was a preemtive strike by the prosecution against that lawsuit,” Navarro told Magistrate Judge Zia Faruqui during his court appearance. “It simply flies in the face of good faith and due process.”
Navarro, who was a trade adviser to Trump, said he was served the subpoena by the FBI at his Washington, D.C., home last week. The subpoena was the first known instance of prosecutors seeking testimony from someone who worked in the Trump White House as they investigate the attack. Prosecutors said the indictment was handed down Thursday night.
Navarro made the case in his lawsuit Tuesday that the House select committee investigating the attack is unlawful and therefore a subpoena it issued to him in February is unenforceable under law.
He filed the suit against members of the committee, Speaker Nancy Pelosi, D-Calif., and the U.S. attorney in Washington, Matthew M. Graves, whose office is now handling the criminal case against him.
In an interview with The Associated Press this week, Navarro said the goal of his lawsuit is much broader than the subpoenas themselves, part of an effort to have “the Supreme Court address a number of issues that have come with the weaponization of Congress’ investigatory powers” since Trump entered office.
Members of the select committee sought testimony from Navarro about his public efforts to help Trump overturn the 2020 presidential election, including a call trying to persuade state legislators to join their efforts.
The former economics professor was one of the White House staffers who promoted Trump’s baseless claims of mass voter fraud. Trump, in turn, promoted a lengthy report Navarro released in December 2020, which Navarro falsely claimed contained evidence of the alleged misconduct and election fraud “more than sufficient” to swing victory to his former boss.
Navarro has refused to cooperate with the committee, and he and fellow Trump adviser Dan Scavino were found in contempt of Congress in April.
Members of the committee made their case at the time that Scavino and Navarro were among just a handful of people who had rebuffed the committee’s requests and subpoenas for information. The Justice Department has not yet moved forward with charges against Scavino or Meadows, who initially cooperated with the committee, turning over more than 2,000 text messages sent and received in the days leading up to and of the attack. But in December, Meadows ceased cooperation. Federal prosecutors have not yet indicated whether he too will be charged.
Despite the opposition from several Trump allies, the Jan. 6 panel, comprised of seven Democrats and two Republicans, has managed to interview more than 1,000 witnesses about the insurrection in the past 11 months and is now preparing for a series of public hearings to begin next week. Lawmakers on the panel hope the half-dozen hearings will be a high-profile airing of the causes and consequences of the domestic attack on the U.S. government. | https://cw33.com/news/politics/ap-politics/navarro-indicted-on-contempt-charges-for-defying-1-6-panel/ | 2022-06-04T13:36:20Z |
LAS VEGAS, May 19, 2022 /PRNewswire/ -- 1791 Management ("1791") filed a Securities Fraud and Market Manipulation Lawsuit against Energy Vault Inc (NRGV). The action charges Energy Vault with intentional violations of securities laws and fraud, including deliberate fraudulent misrepresentations and omissions relating to the company's business, operations, and prospects.
American Financial Markets must reflect the unimpeded collective judgment of buyers and sellers. Otherwise, investors may stay out of markets if perceived to be unfair or subject to manipulation. Capital formation supporting U.S. domestic growth is vital. Confidence in our system should never be undermined.
CONTACTS:
1791 Management
https://www.1791management.com/
Phone: 702-850-9905
Email: info@1791management.com
View original content:
SOURCE 1791 Management | https://www.kxii.com/prnewswire/2022/05/19/lawsuit-filed-against-energy-vault-nyse-nrgv-1791-management-files-securities-fraud-market-manipulation-lawsuit-against-energy-vault-inc/ | 2022-05-19T18:43:48Z |
LEADING OFF: MLB celebrates Robinson 75 years after debut
By The Associated Press
Players across the majors will don Jackie Robinson’s No. 42 — and all of them in Dodger blue this year — for the 75th anniversary of Robinson’s big league debut. The Dodgers, of course, will be at home in Los Angeles, facing the Cincinnati Reds. Meanwhile in New York, Commissioner Rob Manfred will host an event for youth baseball players from the city in Times Square with special guests Ken Griffey Jr., Mariano Rivera, CC Sabathia, Joe Torre, Willie Randolph and Butch Huskey. Also, the Guardians are set to reintroduce themselves to the city of Cleveland with their home opener against the San Francisco Giants. | https://localnews8.com/news/2022/04/14/leading-off-mlb-celebrates-robinson-75-years-after-debut/ | 2022-04-15T02:03:28Z |
Man thought he won $600 in lottery but really won a lot more
Published: Sep. 7, 2022 at 10:50 AM CDT|Updated: moments ago
ANNANDALE, Va. (Gray News) – A man in Virginia was excited as he was redeeming what he thought was a $600 winning lottery ticket.
But when lottery staffers looked at the ticket, they quickly discovered it was worth a lot more.
As it turned out, Jose Flores Velasquez had really won $1 million.
According to the Virginia Lottery, Velasquez bought a 20X the Money ticket at a gas station after work.
He is the second top prize winner in the latest version of the scratch-off game.
He chose to take the one-time cash option of $759,878 instead of the $1 million prize over 30 years.
Velasquez plans to use his winnings to take care of his family and possibly start his own business.
Copyright 2022 Gray Media Group, Inc. All rights reserved. | https://www.kxii.com/2022/09/07/man-thought-he-won-600-lottery-really-won-lot-more/ | 2022-09-07T15:56:05Z |
America's employers extended a streak of robust hiring in March, adding 431,000 jobs in a sign of the economy's resilience in the face of a still-destructive pandemic and the highest inflation in 40 years.
The Labor Department's report Friday showed that last month's job growth helped reduce the unemployment rate to 3.6%, the lowest level since the pandemic erupted two years ago.
Despite the inflation surge, persistent supply bottlenecks, the damaging effects of COVID-19 and now a war in Europe, employers have added at least 400,000 jobs for 11 straight months.
Inflation may be starting to weaken consumer spending, the main driver of the economy. Americans increased their spending by just 0.2% in February, down from a much larger gain in January.
Still, the job market has continued to rebound with unexpected speed from the coronavirus recession. Job openings are at a near-record level, and applications for unemployment benefits have dropped to near their lowest point since 1969.
The still-solid U.S. job market reflects a robust rebound from the brief but devastating coronavirus recession, which wiped out 22 million jobs in March and April 2020 as businesses shut down or cut hours and Americans stayed home to avoid infection.
But the recovery has been swift. Fueled by generous federal aid, savings amassed during the pandemic and ultra-low borrowing rates engineered by the Federal Reserve, U.S. consumers have spent so fast that many factories, warehouses, shipping companies and ports have failed to keep pace with their customer demand. Supply chains have snarled, forcing up prices.
As the pandemic has eased, consumers have been broadening their spending beyond goods to services, such as health care, travel and entertainment, which they had long avoided during the worst of the pandemic. The result: Chronically high inflation is causing hardships for many lower-income households that face sharp price increases for such necessities as food, gasoline and rent.
It's unclear whether the economy can maintain its momentum of the past year. The government relief checks are gone. The Fed raised its benchmark short-term interest rate two weeks ago and will likely keep raising it well into next year. Those rate hikes will result in more expensive loans for many consumers and businesses.
Inflation has also eroded consumers' spending power: Hourly pay, adjusted for higher consumer prices, fell 2.6% in February from a year earlier — the 11th straight month in which inflation has outpaced year-over-year wage growth. According to AAA, average gasoline prices, at $4.23 a gallon, are up a dizzying 47% from a year ago.
Squeezed by inflation, some consumers are paring their spending. The Commerce Department reported Thursday that consumer spending rose just 0.2%% in February — and fell 0.4% when adjusted for inflation — down from a 2.7% increase in January.
Still, the job market has kept hurtling ahead. Employers posted a near-record 11.3 million positions in February. Nearly 4.4 million Americans quit their jobs, a sign of confidence that they could find something better.
Even so, so many jobs were lost in 2020 that the economy still remains more than 2 million shy of the number it had just before the pandemic struck. Over the past year, employers have added an average of 556,000 jobs a month. At that pace — no guarantee to continue — the nation would recover all the jobs lost to the pandemic by June. (That still wouldn't include all the additional hiring that would have been done over the past two years under normal circumstances.)
Brighter job prospects are beginning to draw back into the labor force people who had remained on the sidelines because of health concerns, difficulty finding or affording daycare, generous unemployment benefits that have now expired or other reasons.
Over the past year, 3.6 million people have joined the U.S. labor force, meaning they now either have a job or are looking for one. But their ranks are still nearly 600,000 short of where they stood in February 2020, just before the pandemic slammed into the economy. | https://www.tdtnews.com/news/article_c18d7218-b1b8-11ec-81c7-e7b104a82e81.html | 2022-04-01T14:02:08Z |
OROS Insulation Tech will Allow Human Cells to Remain at Desired Temperatures Longer
PORTLAND, Ore., Aug. 30, 2022 /PRNewswire/ -- OROS, a leading next-gen thermal materials business, has provided Blue Origin superior insulation technology that will support vital science being carried on the aerospace company's latest mission, scheduled to launch August 31. Batteries used to keep human cells at viable livable temperatures aboard the Blue Origin NS-23 will be insulated with OROS' technology to vastly prolong operable life.
Once the Blue Origin NS-23 rocket leaves earth's atmosphere it will operate in temperatures at or below -450F. As part of the rocket's payload, human cells will be exposed to the effects of space. To prevent cells from freezing, batteries aboard the Blue Origin capsule will be used to maintain an optimal thermal environment for these cells. OROS' insulation technology will be applied to prolong the life of these mission-critical batteries.
The fundamental research aboard the Blue Origin NS-23 is the first step to better understand how humans could colonize the Moon, Mars—and beyond. However, without OROS' groundbreaking insulation, the experiment would be impossible to conduct. "By lowering energy requirements, we can eventually sustain long-term life in space," explains OROS Co-Founder and CEO, Michael Markesbery.
The foundation of OROS' material innovation is aerogel, a substance pioneered by NASA to insulate spacecraft and touted as the lowest thermally conductive material known to mankind. By devising novel, flexible and durable aerogel solutions, OROS produces game-changing materials that unlock a broad spectrum of applications transcending spaceflight.
"We're only getting started," continues Markesbery. "From aerospace, to cold-chain packaging [vaccines, drugs, etc.], to structural insulation and apparel, our applications are vast, and we're honored to be moving the science forward in collaboration with our partners at Blue Origin."
OROS is a materials technology company that develops the most scientifically innovative thermal solutions on the planet. Their vision is to create technology that empowers humanity to reach our full potential. For more information, visit www.orosapparel.com.
View original content:
SOURCE OROS | https://www.kxii.com/prnewswire/2022/08/31/blue-origin-taps-oros-advanced-thermal-materials-space/ | 2022-08-31T15:13:25Z |
LOS ANGELES, Sept. 13, 2022 /PRNewswire/ -- Cal State LA's College of Ethnic Studies is presenting a multicultural children's book fair this month. "I Read to See Me: A Celebration of Multicultural Children's Books" will be held Saturday, Sept. 24, from 11 a.m. to 2 p.m. at Cal State LA in the courtyard of King Hall.
The event is free and open to the public.
"When we foster a child's love of reading, we're fostering that child's ability to thrive in their studies, to discover who they are and to later realize their potential as an adult," said Julianne Malveaux, dean of the College of Ethnic Studies and a nationally renowned educator and economist. "This is why this event is so important and needed."
The college is co-hosting the event with the African American Children's Book Project, a national literacy organization that promotes and preserves books by and about Black Americans. The organization promotes reading as a part of a healthy lifestyle and emphasizes how books empower, enrich and enlighten children's lives.
The book fair will include panels that feature award-winning authors and illustrators who will discuss their literary journey and the importance of having diverse books in schools and home libraries. A series of panels featuring educators and publishing professionals will focus on the importance of diverse books, what they are, and how to find them. A highlight of the afternoon will be the Cal State LA Reading Circle, with dynamic presenters who will deliver presentations about and read from their books.
Book fair attendees will be able to take part in book signings, visit with exhibitors and participate in promotional giveaways. The first 200 youth attendees will receive a free copy of a book by one of the featured authors or illustrators. The event will also offer a wide selection of affordable diverse books for purchase.
The fun-filled afternoon is a chance to connect with dynamic literary creators and an opportunity to gain knowledge about the world of children's publishing.
Award-winning author Andrea J. Loney will debut her new book, Curve & Flow: The Elegant Vision of L.A. Architect Paul R. Williams, illustrated by Keith Mallett. The book celebrates trailblazing Black architect Paul R. Williams, who defied the odds and broke down racial barriers in his field to become a world-renowned architect.
"My work is driven by the belief that all children deserve to see themselves honestly and lovingly depicted in the pages of a book," Loney said. "I also believe that all kids should get the opportunity to explore the world in all its richness and diversity through books."
Monica Mancillas, author, musician and self-described unapologetic dreamer, will also debut her new book at the event. A first-generation immigrant, her own story closely mirrors that of her new picture book, Mariana and Her Familia, a heartwarming tale of a young girl on her first trip to Mexico, who learns there is no language barrier when it comes to love.
"In a climate in which books featuring marginalized voices are being banned, we must fight harder than ever for children to see themselves represented in stories," Mancillas said.
Celebrated illustrator and author Benson Shum, who wrote the picture book, Anzu the Great Kaiju, will also be featured at the book fair.
"Diverse books are so important because to be seen and heard is what everyone needs," Shum said. "To read stories of all cultures makes for a better world for everyone." Shum is also a Disney animator and has worked on films such as Encanto, Moana, Raya and the Last Dragon, Frozen, and Frozen 2.
Vanesse Lloyd-Sgambati, founder of the African American Children's Book Project and a consultant for the event, noted the importance of multicultural book events.
"Studies show that children who engage in reading activities outside of their normal school coursework do better in school," Lloyd-Sgambati said. "It is also essential that you give children of all ages access and choice. That reluctant reader may not have been given a book of their interest. Finding out what a child likes to read and giving them books that reflect their image plays an important role in building lifelong readers."
The College of Ethnic Studies is the newest college at Cal State LA and one of only two colleges of Ethnic Studies in the state. The college centers the histories, traditions, cultures, experiences, struggles and accomplishments of diasporic communities of color, making connections between the local and transnational.
"Storytelling is one of our oldest forms of artistic expression, and books hold our stories," said Malveaux, who is a syndicated columnist and author. "Books can help build cultural respect and understanding—at a time when our nation needs both."
Media contacts: Margie Low, Cal State LA Public Affairs, margiey@calstatela.edu; Jocelyn Stewart, Cal State LA Communications & Public Affairs, jocelyn.stewart@calstatela.edu
View original content to download multimedia:
SOURCE Cal State LA | https://www.wibw.com/prnewswire/2022/09/13/cal-state-la-college-ethnic-studies-present-i-read-see-me-celebration-multicultural-childrens-books/ | 2022-09-13T17:36:58Z |
Highly Detailed Bratz® Minis and Real-Working Bratz® Mini Cosmetics Are the First to Join MGA's Miniverse™
CHATSWORTH, Calif., June 16, 2022 /PRNewswire/ -- The girls with a passion for fashion are at it again! MGA Entertainment (MGA), the largest and fastest growing privately held toy and entertainment company in the U.S., announced today the biggest news since the launch of its Bratz® fashion doll sensation that took the world by storm more than 20 years ago – Bratz® Minis and Bratz® Mini Cosmetics. Featuring a total of 40 different minis to collect in the first series, the new line will bring these pop culture favorites to your pocket as meticulously detailed, real working collectible minis.
"As Bratz celebrates 21 years since hitting shelves, we are so excited to launch the next big thing, Bratz Minis and Bratz Mini Cosmetics, featuring the same bold fashions, attitudes, and details but in a shrunk-down, highly detailed, collectible size," said Isaac Larian, Founder and CEO of MGA Entertainment. "The real-working features are unlike anything the industry or collectors have seen before, so get them before they sell out!"
Each Bratz Minis mystery pack includes two nearly 2-inch tall Bratz dolls in mini replica packaging, mirroring the full-sized dolls iconic classic packaging. The trapezoid-shaped package becomes the display stand for each miniature doll and fans can collect 24 different Bratz Minis in this first series.
The Bratz Mini Cosmetics includes two real working, mini cosmetics, including eye shadow, lipstick, and mascara, in a mini replica makeup bag, all inside a mystery trapezoid package that doubles as a display stand, too. There are 16 different Bratz Mini Cosmetics to collect.
Bratz® Minis and Bratz® Mini Cosmetics will be available beginning in July 2022 at U.S. retailers including Amazon, Walmart, and Target at MSRP $9.99 and globally in major markets. Follow along on Tik Tok, Instagram, and YouTube at @officialminiverse and #miniverse for news and announcements of new minis, categories, and exclusives.
Bratz Minis and Bratz Minis Cosmetics kick-off the launch of MGA's Miniverse™, the new collectible line of miniatures that brings everyone's favorite brands into the burgeoning mini collectible category. The miniature craze, which appeals to both adult collectors and kid's collectibles, has picked up steam, with more than 75 million unique videos found in a recent search featuring minis of toys and other everyday objects in all shapes, styles, and categories. MGA's Miniverse™ will continue to expand with other MGA popular toy brands, like Little Tikes®, L.O.L. Surprise!™ and Rainbow High™, and into new mini categories to satisfy the desires of collectors and kids at heart.
MGA Entertainment is the fastest growing and largest privately held toy and entertainment company in the U.S. Headquartered in Chatsworth, Calif. and with offices globally, the company creates innovative, proprietary, and licensed consumer products and entertainment, including toys, games, dolls, apparel, consumer electronics, home décor, stationery, sporting goods, movies, and television series. The MGA family includes award-winning brands such as L.O.L. Surprise!™, Little Tikes®, Rainbow High™, Shadow High™, Bratz®, MGA's Miniverse™, Na! Na! Na! Surprise™, Mermaze Mermaidz™ Color Change, Baby Born® Surprise and Zapf Creations®. For more information, please visit us at www.mgae.com or check us out at LinkedIn.
View original content to download multimedia:
SOURCE MGA Entertainment | https://www.mysuncoast.com/prnewswire/2022/06/16/next-big-surprise-mga-entertainment-are-mini-sized-bratz-minis-are-here/ | 2022-06-16T12:47:47Z |
DALLAS (STACKER) — Oil prices fell this week as the United States and international partners took steps to meet global oil demand.
Stacker compiled statistics on gas prices in Dallas, TX metro area using data from AAA. Gas prices are current as of March 31. State gas tax data is from World Population Review. Three states—Connecticut, Georgia, and Maryland—temporarily suspended gas taxes to defray costs for consumers while prices are up.
The Biden administration announced March 31 that it will order the release of an unprecedented 1 million barrels of oil each day for six months from the country’s strategic petroleum supply to lower gas prices.
In an effort to incentivize domestic oil companies to increase production, the White House called on Congress to approve “use-it-or-lose-it” fees. Companies on leased wells or public land that haven’t been used for production in years will be forced to pay fees under the proposed policy.
The Organization of the Petroleum Exporting Countries and its allies met March 31 and confirmed a 432,000-barrels-per-day increase in oil production beginning in May.
Dallas by the numbers
– Current price: $3.77
— Texas average: $3.85
— Texas gas tax: $0.20 per gallon (#42 highest among all states)
– Week change: -$0.05 (-1.4%)
– Year change: +$1.22 (+48.0%)
– Historical expensive gas price: $4.07 (3/10/22)
Metros with the most expensive gas
#1. San Luis Obispo-Atascadero-Paso Robles, CA: $6.06
#2. Los Angeles-Long Beach, CA: $6.04
#3. Ventura, CA: $6.02
Metros with the least expensive gas
#1. Amarillo, TX: $3.56
#2. Joplin, MO: $3.61
#3. Lawton, OK: $3.62
States with the highest gas tax per gallon
#1. Pennsylvania: $0.59
#2. California: $0.53
#3. Washington: $0.52
States with the lowest gas tax per gallon
#1. Alaska: $0.0895
#2. Hawaii: $0.16
#3. Virginia: $0.162
You may also like: Where people in Dallas are moving to most | https://cw33.com/news/local/how-gas-prices-have-changed-in-dallas-in-the-last-week-2/ | 2022-04-01T16:19:37Z |
The best sweatpants for women
Sweatpants are a must-have for any wardrobe. They are the go-to for traveling, long study sessions, romping around the house or simply a comfortable alternative to jeans or pants. If you’re looking for new sweatpants, you’ll need to consider a few things before choosing a pair, such as the activity you need them for and how you would like them to fit.
What to consider before buying a pair of sweatpants
Activity
Ask yourself what will you primarily use these sweatpants for. If you’re an athlete looking for a pair of sweatpants to use after or before games or during training, you may want pants that wick moisture or are jogger-style. If you’re looking for a pair to just throw on in a flash and wear for total comfort, a pair with soft lining and loose-fitting style may suit you more.
Style
Are you wearing your sweatpants to achieve a certain style or just for the sake of lounging? The athletic-leisure — or “athleisure” — look is popular, and you may want sweatpants that are tailored and could pass for traditional pants. Or a loose-fitting pair of sweatpants could give you a relaxed, casual streetwear look.
Maintenance
The care your sweatpants need to prolong their life depends on their material. Basic cotton-blend sweatpants are low-maintenance and probably only have to be washed with like colors in cold water, but sweatpants with special technology for moisture control may need to be hand-washed or line dried. Consider this when shopping and determine the time and resources you have to care for them properly.
Sweatpants FAQ
Should I size up for sweatpants?
A. This is up to you. If you prefer your sweatpants to hug certain features, keep the size you normally would wear. To have extreme comfort and range of motion, you can size up. Ultimately, brands’ size charts vary and you’ll have to assess your numerical measurements to make the decision.
How should sweatpants normally fit?
A. The traditional pair of sweatpants should fit based on the way the pockets lay. They should be relaxed and drape against your leg, not poking out and laying high on your hip.
The best sweatpants to buy
Top sweatpants for working out
Under Armour Women’s Rival Fleece Joggers
With athletes in mind, these sweatpants joggers have fitted, ribbed ankle cuffs to prevent tripping on fabric during exercises. They offer coziness while you work out by using a mid-weight cotton-blend fleece with elastane to ensure flexibility and softness. Their interior is lined for warmth and the waistband falls at the hips, with a drawstring cord to adjust the fit. Sold by Amazon
The Gym People Women’s Jogger Pants with Pockets
Available in 12 colors, these sweatpants are designed for active people, and their low-friction material keeps you from chafing and irritation. Tailored with a slim fit for performing high-intensity workouts, they are high-waisted with a wide elastic waistband to smooth your shape and grip your torso. Sold by Amazon
Libin Women’s Athletic Sweatpants
Made with comfort in mind, these joggers are stretchy and lightweight to simulate a second skin. The drawstring makes for an adjustable waist and the waistband is foldable for extra support. It features two deep side pockets for convenience on the go. Sold by Amazon
Top sweatpants for lounging
Amazon Essentials Women’s Relaxed Fit Fleece Jogger Sweatpants
In 31 colors, these are tapered at the ankle that offers a more fitted appearance. The French terry material is a soft and cozy blend with a drawstring closure at the waist. The sizes range from XS to 6XL. Sold by Amazon
Amazon Essentials Women’s Lightweight Lounge Terry Jogger Pajama Pant
Available in 23 colors, these basic sweatpants are made of French terry cotton. Spandex in the blend offers a bit of flexibility. Sold by Amazon
Women’s Cinch Bottom High Waist Jogger
With an elasticized waistband, these cotton sweatpants have a baggy fit. They’re high-waisted for a comfortable above-the-hip fit. Sold by Amazon
Top sweatpants for yoga
Dibaolong Women’s Yoga Sweatpants
In 24 colors, these offer an easy slip-on waistband with no drawstring or closure necessary. The waist is fitted with extra-soft material that conforms to your shape, keeping your pants from slipping and dropping down. They are high-waisted to smooth your shape and are a polyester/spandex blend, making them lightweight and flexible. Sold by Amazon
Sarin Matthews Women’s Yoga Sweatpants
With a wide-leg fit, these give you freedom to practice yoga without any constricting material around your ankles. Available in 43 designs and patterns, these sweatpants have a drawstring to adjust the fit and are not too tight, with a no-pinch design. Sold by Amazon
Built for yoga practice, these wide-leg sweatpants use buttery material to ensure comfort while performing. Made with large side pockets, they have a straight-leg fit and do not constrict any movement from the waist down. The material is not transparent — it prevents any lines from being seen. Sold by Amazon
Top cropped sweatpants
With wide-leg openings, these pants fall in the middle of the calf, achieving a cropped look. They can be styled for everyday use and are made from a lush, soft fabric. Sold by Amazon
Special Magic Women’s Sweatpants Cropped Jogger
These are highlighted by a tailored elastic hem around the middle of the calf. They are tight enough to perform during workouts but loose enough to prevent constriction and discomfort. Sold by Amazon
Leggings Depot Women’s Cropped Capri Sweatpants
With a thin, flexible waistband, these cropped joggers use material that stretches and bends without discomfort and offers a full range of motion. The hem is fitted with an elastic cuff to narrow the shape of the pants. Opaque so they don’t show undergarment lines or skin, they come in dozens of colors and designs and have a mid-rise fit at the waist. Sold by Amazon
Want to shop the best products at the best prices? Check out Daily Deals from BestReviews.
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Isabella Acitelli writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved. | https://cw33.com/reviews/br/apparel-br/bottoms-br/12-best-sweatpants-for-women/ | 2022-09-01T03:52:27Z |
KETTERING, Ohio (AP) — Bryson DeChambeau says he had surgery on his left wrist Thursday for a fracture hamate that has been bothering him for the last two months and likely will keep him out of the PGA Championship.
DeChambeau said on Instagram the surgery at The Kettering Medical Center was for the fractured hook of the hamate.
The former U.S. Open champion says he slipped on a marble floor in Saudi Arabia while playing table tennis and landed on his hip and hand. He withdrew after the first round of the Saudi International and did not return for seven weeks until the Match Play. He played three rounds at Match Play, missed the cut at the Texas Open and said at the Masters he was at 80%. He shot 80 the second round at Augusta National and missed the cut.
“I made attempts to play through this injury at three recent events, including the Masters, but this is typically an injury that requires surgical treatment,” DeChambeau said. “Through continued discomfort from the fracture, it has caused me to alter my grip and swing, resulting in my inability to compete at golf’s highest level. This has not been easy physically and mentally for me.”
DeChambeau said he would take appropriate time off to rest and recover and he looked forward “to competing at the highest level within the next two months.”
The PGA Championship starts in five weeks, May 19-22, at Southern Hills in Tulsa. The U.S. Open is a month later at The Country Club outside Boston. | https://cw33.com/sports/ap-sports/dechambeau-has-surgery-on-left-wrist-like-to-miss-pga/ | 2022-04-15T07:43:46Z |
WIMBLEDON, England (AP) — Wimbledon quarterfinalist Nick Kyrgios is due in court back home in Australia next month, and a lawyer representing him said Tuesday the “precise nature of” the allegations “is neither certain at this moment nor confirmed by either the prosecution or” the 27-year-old professional tennis player.
Kyrgios practiced at the All England Club on Tuesday, and the All England Club confirmed he is scheduled to play his match against Cristian Garin of Chile on Wednesday.
“While Mr. Kyrgios is committed to addressing any and all allegations once clear, taking the matter seriously does not warrant any misreading of the process Mr. Kyrgios is required to follow,” attorney Pierre Johannessen wrote in a statement emailed to the media.
Johannessen wrote that “the allegations are not considered as fact” by the court, and Kyrgios is not “considered charged” with an offense until a first appearance in court.
Wednesday’s match against Garin is the third Grand Slam quarterfinal of the Australian’s career — he is 0-2 in the others — and first in 7 1/2 years.
“We have been made aware of legal proceedings involving Nick Kyrgios in Australia, and as they are ongoing, we are not in a position to offer a comment,” an All England Club spokesperson said Tuesday. “We are in touch with Nick’s team and he remains scheduled to play his quarterfinal match tomorrow.”
The Canberra Times reported that Kyrgios is supposed to appear in court on Aug. 2. The newspaper cited local police as saying that a 27-year-old Australian man is involved in a case about “common assault following an incident in December 2021.”
Canberra police did not immediately respond to an after-hours request for comment emailed by The Associated Press.
A spokesperson for the ATP men’s tennis tour wrote in an email: “The ATP is aware of the Australian case involving Nick Kyrgios but as legal proceedings are ongoing it would be inappropriate to comment further at this time.”
___
More AP Wimbledon coverage: https://apnews.com/hub/wimbledon and https://apnews.com/hub/tennis and https://twitter.com/AP_Sports | https://cw33.com/sports/ap-sports/wimbledon-quarterfinalist-kyrgios-due-in-court-in-australia/ | 2022-07-06T10:42:45Z |
Former President Donald Trump’s crusade for vengeance suffered two devastating blows after Georgia Gov. Brian Kemp and Secretary of State Brad Raffensperger won their primaries Tuesday despite rejecting Trump’s entreaties to reverse his 2020 election loss.
It’s a huge warning sign for the way Republican voters view the former president’s crusade to punish those who were not willing to overturn the will of the voters in 2020.
Voters also demonstrated an openness to embracing scandal-plagued candidates — depending on the candidate, and the scandal.
Here are some takeaways from Tuesday’s primary elections in Georgia, Alabama, Arkansas, Texas and Minnesota:
TRUMP’S BIGGEST PRIMARY DEFEAT
Trump had hoped to turn Georgia Gov. Brian Kemp into an example of the danger in defying him. Instead, Kemp on Tuesday became an example of how Republican incumbents might not have as much to fear from Trump as the former president would like.
Kemp cruised past former U.S. Sen. David Perdue in the Republican primary. The victory came a year and a half after Kemp rejected Trump’s demands to help overturn the presidential election by declaring Trump the winner in Georgia instead of Joe Biden, who actually won.
Perdue’s campaign fixated on Trump’s lie that the 2020 presidential election was stolen from him, but Kemp won by flexing the power of his office. To rally the base, he signed laws allowing most Georgians to carry guns without a permit and banning most abortions after a fetal heartbeat is detected. He also announced an investment by Hyundai in a new plant in the state to make batteries for electric vehicles.
Now Kemp will face Democrat Stacey Abrams in a rematch of their 2018 gubernatorial clash. Unlike Trump in 2020, Perdue accepted his defeat Tuesday night, even seeming to brush aside some supporters who took up a chant suggesting there was fraud.
“I’m sorry, but what we’re going to do right now is make sure Stacey Abrams is not governor of this state,” Perdue said.
DANGER OF ELECTION DENIAL
The Georgia governor’s race wasn’t the only Trump grudge match that backfired on the former president. Secretary of State Brad Raffensperger, who personally rejected Trump’s call to “find” enough votes to declare him the winner in Georgia, defeated his Trump-backed primary challenger as well.
Trump recruited U.S. Rep. Jody Hice from a safe congressional seat to face Raffensperger in the Republican primary, but Hice lost. Trump endorsed primary challengers to the insurance commissioner and attorney general, and they, too, lost.
It’s clear the former president’s harping on 2020 simply did not speak to Republican voters in Georgia, the country’s newest battleground state.
“Georgia underscores one of Trump’s big problems if/when he runs again,” Brendan Buck, a former spokesperson for onetime House Speaker Paul Ryan, tweeted Tuesday. “He, of course, won’t be able to let go of the 2020 nonsense, and nobody wants to hear his whining about it anymore.”
Trump has scored some primary victories with election deniers — most significantly last week in Pennsylvania, when Republican voters there chose his preferred gubernatorial candidate Doug Mastriano, who said he wouldn’t have certified Biden’s 2020 win of the state.
But multiple Republicans have made clear they’re eyeing 2024 presidential bids, including Pence and Florida Gov. Ron DeSantis. And they have distanced themselves in ways large and small from Trump’s election allegations. Elections are usually about the future, and by the time the 2024 GOP primary rolls around, November 2020 will be ancient history.
DECLINING POWER OF SCANDAL
Trump did notch some wins Tuesday. They came with baggage, but that didn’t seem to stop them.
Former football great Herschel Walker, Trump’s pick for U.S. Senate in Georgia, dominated his Republican challengers. Party leaders had first shied away from him because of his checkered history.
Walker, in his autobiography, admits struggling with mental illness. His ex-wife said that during their marriage he held a gun to her head and threatened to kill her. He claimed to have founded a chicken processing company employing hundreds but reported only eight workers when applying for a loan during the coronavirus pandemic. He lied about founding a charity to help veterans get aid with mental health.
But eventually even Republican Senate leader Mitch McConnell ended up embracing Walker as the party’s best chance to oust Democratic U.S. Sen. Raphael Warnock. The bet is that voters won’t care as much about scandals in post-Trump America.
That theory certainly got a boost Tuesday in Texas. Republican Attorney General Ken Paxton was indicted in 2015 on securities fraud charges and is still awaiting trial. He’s under investigation for corruption by the FBI and by the state bar of Texas for his role in trying to overturn the 2020 presidential election. Yet he easily won his primary against Land Commissioner George P. Bush, powered by his ability to use his office to cater to conservative causes by, for example, investigating the parents of transgender children.
Back in Georgia, firebrand Rep. Marjorie Taylor Greene won her Republican primary, shrugging off challengers who complained Greene was giving the party a bad name by engaging in Holocaust denial and other headline-grabbing, bombastic behavior.
Trump set the model in 2016, and his followers are perfecting it — never let a scandal get in the way of winning an election.
___
A GAME OF INCHES
The marquee Democratic matchup of the night — in Texas’ 28th Congressional District, between progressive Jessica Cisneros and centrist Rep. Henry Cuellar, one of the last abortion rights opponents in the Democratic caucus — was too early to call Wednesday.
The two candidates were separated by the thinnest margin of votes in a rematch two months after they were forced into a runoff. It drove home two realities: Elections are a game of inches, and even a victory won’t resolve the great left versus center divide in the Democratic Party.
After the collapse of much of Biden’s agenda in Congress, progressives have gotten a boost in recent primaries. Their candidate, Summer Lee, narrowly won the primary in Pennsylvania’s 12th Congressional District last week. In Oregon’s 5th Congressional District, centrist Rep. Kurt Schrader was trailing a progressive challenger after their primary last week; the results were delayed by ballot counting problems.
Also Tuesday, Rep. Lucy McBath handily defeated Rep. Carolyn Bourdeaux in the Democratic primary in Georgia’s 7th Congressional District in the Atlanta suburbs. While neither has embraced the left wing of the party, Bourdeaux was better known as a moderate than McBath.
Still, the left lost a key congressional primary in the Cleveland area just a few weeks ago. They had an awful track record in 2020. And some Democrats worry — and Republicans hope — that leftist wins in places like Oregon’s 5th or Texas’ 28th will make it harder for the party to hold those relatively moderate districts, especially in what’s looking like a dismal fall for Democrats.
Sometimes, though, races are so close that there’s eventually a winner but no resolution to the political debate they embody. Progressives can note Cisneros improved her margin after losing to Cuellar in 2020. Centrists can point to how the incumbent kept it close even amid the party’s fury about a possible end to the right to abortion.
After Texas, the struggle between the Democrats’ left and centrist wings seems poised to go on.
___
Follow AP for full coverage of the midterms at https://apnews.com/hub/2022-midterm-elections and on Twitter, https://twitter.com/ap_politics. | https://cw33.com/news/politics/ap-politics/takeaways-trumps-big-primary-defeat-scandals-for-the-win/ | 2022-05-25T08:06:13Z |
ST. CHARLES, Mo., June 23, 2022 /PRNewswire/ -- Eurofins Discovery, the leading brand with over 35 years of success providing a complete solution of products and services for drug discovery, announces a client publication advancing cognitive health research through use of the company's BioMAP® Human Phenotypic Profiling and Screening Platform and enzyme assays for neurotransmitter degradation.
Published in BMC Complementary Medicine and Therapies, the work of scientists from The Institute for Biomedical and Bioscience Research, University of Buckingham; the European Genomic Institute for Diabetes, Hospital Claude Huriez; and Sibelius Ltd., identifies changes in biomarkers of inflammation and tissue remodeling that result from the use of sage extract on in vitro, human primary cell translational disease models.
The work documents applicability of the BioMAP Platform beyond standard biopharmaceutical applications and demonstrates the portfolio breadth of Eurofins Discovery in providing testing for life enzyme assays and biomarker screening and profiling services in the neuro-inflammatory and neurodegenerative therapeutic space.
One of the challenges to evaluating potential nutritional interventions for neurodegeneration and other therapeutic areas is assessment of relevant biomarkers in standardized clinically validated in vitro disease models sensitive enough to detect changes in mixtures as well as purified drug candidates. The BioMAP Diversity PLUS® Panel can provide this key assessment while covering a broad range of tissue and disease biology. The panel reports on biomarkers common across many diseases that involve inflammation, is validated with clinically approved drugs, and provides results based on advanced data analytics powered by a comprehensive Reference Database.
Additional neurotransmitter metabolism enzyme assays from Eurofins Discovery helped identify specific effects of sage extract, with implications for cognitive performance. Learn more about the Phenotypic Center of Excellence at www.eurofinsdiscoveryservices.com/services/phenotypic-assays.
For further information
eurofinsdiscoveryservices.com
Eurofins Discovery is recognized as the industry leader for providing drug discovery researchers the largest and most diverse portfolio of standard and custom in vitro safety & pharmacology assays and panels for drug screening and profiling. In addition to in vitro safety pharmacology strengths, we also offer a broad portfolio of over 3,500 drug discovery services and 1,800 products. These include in vitro assays, cell-based phenotypic assays, safety pharmacology and efficacy, ADME toxicology, medicinal chemistry design, synthetic chemistry, and custom proteins and assay development capabilities. We support a variety of drug discovery targets such as GPCRs, Kinases, Ion Channels, Nuclear Hormone Receptors and other proteins & enzymes. The Eurofins Discovery capabilities, expertise, knowledge and skill sets enable the company to provide clients the benefit of being able to work with a single outsourcing provider (CRO) for all their drug discovery programs.
Eurofins is Testing for Life. With 58,000 staff across a network of 900 laboratories in 54 countries, Eurofins' companies offer a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
View original content to download multimedia:
SOURCE Eurofins Discovery | https://www.wibw.com/prnewswire/2022/06/23/use-biomap-platform-assess-nutraceuticals-published-biomed-central/ | 2022-06-23T17:57:07Z |
Becker gets 2 1/2 years in prison for bankruptcy offenses
LONDON (AP) — Tennis great Boris Becker was sentenced to 2 1/2 years in prison on Friday for illicitly transferring large amounts of money and hiding assets after he was declared bankrupt.
The three-time Wimbledon champion was convicted earlier this month on four charges under the Insolvency Act and had faced a maximum sentence of seven years in prison.
Judge Deborah Taylor announced the sentence after hearing arguments from both the prosecutor and Becker’s attorney. She told the former top-ranked player that he’s shown no remorse.
“While I accept your humiliation as part of the proceedings, there has been no humility,” Taylor said.
Becker will have to serve at least 15 months before being eligible for release.
The 54-year-old German was found to have transferred hundreds of thousands of pounds (dollars) after his June 2017 bankruptcy from his business account to other accounts, including those of his ex-wife Barbara and estranged wife Sharlely “Lilly” Becker.
Becker was also convicted of failing to declare a property in Germany and hiding an 825,000 euro ($871,000) bank loan and shares in a tech firm.
The jury at Southwark Crown Court in London acquitted him on 20 other counts, including charges that he failed to hand over his many awards, including two Wimbledon trophies and an Olympic gold medal.
Becker, wearing a striped tie in Wimbledon’s purple and green colors, walked into the courthouse hand in hand with girlfriend Lilian de Carvalho Monteiro.
The six-time Grand Slam champion has denied all the charges, saying he had cooperated with trustees tasked with securing his assets — even offering up his wedding ring — and had acted on expert advice.
At Friday’s sentencing hearing, prosecutor Rebecca Chalkley said Becker had acted “deliberately and dishonestly” and that he was “still seeking to blame others.”
Defense attorney Jonathan Laidlaw argued for leniency, saying his client hadn’t spent money on a “lavish lifestyle” but rather on child support, rent and legal and business expenses. Becker, he told the court, has experienced “public humiliation” and has no future earnings potential.
The judge said Becker’s two-year suspended sentence for tax evasion and attempted tax evasion in Germany in 2002 was “a significant aggravating factor” in her decision Friday. She said he “did not heed the warning” and opportunity of that suspended sentence.
Becker’s bankruptcy stemmed from a 4.6 million euro ($5 million) loan from a private bank in 2013, as well as about $1.6 million borrowed from a British businessman the year after, according to testimony at the trial.
During the trial Becker, said his $50 million career earnings had been swallowed up by payments for an “expensive divorce” and debts when he lost large chunks of his income after retirement.
Becker rose to stardom in 1985 at the age of 17 when he became the first unseeded player to win the Wimbledon singles title and later rose to the No. 1 ranking. He has lived in Britain since 2012.
___
More AP Tennis: https://apnews.com/hub/tennis and https://twitter.com/AP_Sports | https://localnews8.com/news/ap-national-business/2022/04/29/becker-gets-2-1-2-years-in-prison-for-bankruptcy-offenses-2/ | 2022-04-29T16:40:15Z |
TORONTO, Aug. 2, 2022 /PRNewswire/ - SoftwareReviews, a leading source for insights on the software provider landscape, has published its 2022 Project Portfolio Management Emotional Footprint, naming six providers in the Enterprise and Midmarket spaces as Champions.
Project portfolio management (PPM) software helps to optimize an organization's project portfolios, collecting and consolidating data across multiple projects to assist in managing risks, resources, and timelines. In 2022, organizations are seeking adaptive portfolio management models highly focused on the product versus the project delivery method. This adaptive PPM model allows businesses to change directions per business needs to gain the most business value.
"Portfolio managers and project management offices (PMO) often lack the resources required to operate a commercial grade PPM tool," says Long Dam, principal research director at Info-Tech Research Group and PPM category analyst. "The complexity of the software is compounded when the IT department does not have adequate PPM subject matter knowledge."
For a seamless, agile delivery process, managers are also seeking software integrations that provide an efficient, easy-to-use, comprehensive solution, such as being able to access Jira, Microsoft Excel, Gantt charts, and email all in one place.
"PPM solutions that are intuitively simple to use and maintain will typically fare better with users," adds Dam. "Organizations are now seeking more simplistic solutions to avoid the additional overhead burden along with reducing the inherent risks of highly complex solutions."
To support organizations searching for the right project portfolio management software for their unique needs, SoftwareReviews has identified the top PPM software providers for the year based on verified survey data collected from 874 end-user reviews. These providers have received high scores on SoftwareReviews' Emotional Footprint.
The Net Emotional Footprint (NEF) of each software provider is a result of aggregated emotional response ratings across the areas of service, negotiation, product impact, conflict resolution, strategy, and innovation. The NEF is a powerful indicator of overall user sentiment toward the provider and its product from the software user's point of view.
The 2022 Enterprise Project Portfolio Management Software Champions are as follows:
- Planisware Enterprise, 98 NEF, ranked high for being respectful.
- TeamDynamix PPM, 95 NEF, ranked high for being reliable.
- Planview PPM Suite, 93 NEF, ranked high for saving time.
The 2022 Midmarket Project Portfolio Management Software Champions are as follows:
- Accelo PPM, 99 NEF, ranked high for putting clients' interests first.
- Scoro, 100 NEF, ranked high for over-delivering.
- LiquidPlanner, 99 NEF, ranked high for being efficient.
SoftwareReviews' comprehensive software reviews provide the most accurate and detailed view of a complicated and ever-changing market. The data comes from real end users who use the software day in and day out and IT professionals who have worked with it intimately through procurement, implementation, and maintenance.
To compare and evaluate Portfolio Project Management software providers using the most in-depth and unbiased analyst reports available, visit SoftwareReviews' Project Portfolio Management dedicated category page.
For more information about SoftwareReviews, the Data Quadrant, or the Emotional Footprint, or to access resources to support the software selection process, visit softwarereviews.com and connect via LinkedIn, Twitter, and Facebook.
About SoftwareReviews
SoftwareReviews is the most in-depth source of buyer data and insights for the enterprise software market. By collecting customer experience data from business and IT professionals, the SoftwareReviews methodology produces detailed and authentic insights into the experience of evaluating and purchasing enterprise software.
View original content to download multimedia:
SOURCE SoftwareReviews | https://www.mysuncoast.com/prnewswire/2022/08/02/deliver-adaptive-project-portfolio-management-with-these-intuitive-ppm-software-champions-according-softwarereviews-users/ | 2022-08-02T18:51:58Z |
HIGHLAND PARK, Ill. (AP) — One week after a shooting at a Fourth of July parade that left seven dead, the Chicago suburb of Highland Park held a moment of silence Monday morning to mark the exact time police say the first shot was fired.
More than 100 people gathered and hugged each other in a downtown plaza for a tribute that began at 10:14 a.m. and lasted longer than the planned two minutes. Churches in the community along Lake Michigan north of Chicago tolled their bells seven times.
The event was held not far from the building where a gunman fired dozens of shots from the roof along the parade route. A huge memorial of flowers along with chairs holding photographs of the seven victims is now there.
The tribute came a day after restaurants and small shops in the business district where the shooting occurred and had been blocked off with crime scene tape since the shooting reopened.
Robert E. Crimo III, 21, has been charged with seven counts of first-degree murder and, according to prosecutors, will face several counts of attempted murder and other charges. More than 30 people were wounded in the attack. Authorities have said that Crimo, of neighboring Highwood, legally purchased five weapons and planned the attack for weeks. | https://cw33.com/news/u-s-news/ap-us-headlines/week-after-july-4-parade-shooting-a-moment-of-silence/ | 2022-07-12T14:24:10Z |
NASHVILLE, Tenn. (WKRN) — An Arkansas-based establishment is recalling more than 100,000 pounds of frozen beef products, according to a release.
A release states 119,581 pounds of frozen beef products sold by Conagra Brands Inc. were labeled as beef and broccoli but contained orange chicken bits inside. The frozen beef products were produced on May 26 and May 27.
The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced the major recall on Saturday stating that the product also contained egg, which is not an ingredient declared on the product label.
The product was shipped to retail locations nationwide and impacts the P.F. Chang’s Home Menu Beef and Broccoli frozen beef that is not sold at P.F. Chang’s restaurants.
FSIS says the product containing the recalled beef is inside a 22-ounce plastic bag with lot code “5006 2146 2012” and has a best-by date of May 21, 2023.
According to Conagra Brands Inc., there have been no reported adverse reactions to those who have consumed the product so far.
Consumers who purchased the products are urged to throw them away, not consume them or return them to the place of purchase.
For more information on the recall click here. | https://cw33.com/news/nexstar-media-wire/over-100k-pounds-of-frozen-beef-recalled-due-to-misbranding-allergy-risks/ | 2022-07-30T19:06:50Z |
WAIMEA, Hawai'i, Aug. 10, 2022 /PRNewswire/ -- The Beneficiaries of the Parker Ranch Foundation Trust (PRFT) announced today that Toby Taniguchi has been appointed as a Trustee of PRFT, effective January 1, 2023. The Beneficiaries of PRFT are Queen's North Hawaii Community Hospital, Hawaii Community Foundation, Hawaii Preparatory Academy, and Parker School.
Taniguchi is Chief Executive Officer of KTA Super Stores, a multi-generational family grocery business on Hawaii Island. KTA is well-known by Big Island residents for its long-standing support and advocacy for local food through its Mountain Apple brand. Taniguchi has served on the Board of Directors of Parker Ranch, Inc. since 2018.
Taniguchi became President and Chief Operating Officer of KTA in 2021. He has worked for KTA since 1996 and has held various positions at all levels within the organization. He is actively involved in numerous public service and nonprofit organizations, and currently serves as chairman of Community First, a 501(c)3 formed to serve as a catalyst for solutions to improving health and lowering medical costs on Hawaii Island. Additionally, Taniguchi also serves on the Board of Directors for the Hawaiian Electric Company, Employers' Protective Insurance Company, Public Schools of Hawaii Foundation and the Lyman House Museum. He is a Pacific Century Fellow (Class of 2003) and was recognized by Pacific Business News in its "40 Under 40" listing and by Hawaii Business Magazine in its "20 for the Next 20" listing. He received a Bachelor of Science from the University of Portland, and an Executive Food Management Certificate from the University of Southern California.
Taniguchi joins the three current Trustees of PRFT, Mike Fujimoto, Mike Gibson and Tim Johns.
"Several years ago, the Beneficiaries established a structured process for Trustee selection. We followed those procedures and undertook a very extensive search and vetting process, and we are pleased Toby will be joining the organization as a Trustee," said Saundra Gulley, Chair of the PRFT's Distribution Committee and Beneficiary Representative from Parker School. "Toby is uniquely qualified to assist PRFT in its mission to support the Beneficiaries, given his business experience, the various roles he has held in the governance of complex organizations, and his knowledge and understanding of our culture and doing business in Hawaii. We are grateful for his willingness to serve."
"Toby has made significant contributions as a Director of Parker Ranch, Inc. for four years and to our Waimea and Big Island communities through his various experiences serving in leadership roles, both in business and the non-profit sector," said Tim Johns, Lead Trustee of the Parker Ranch Foundation Trust. "We are fortunate to have someone of Toby's professionalism, executive presence and impeccable reputation to serve with us as a Trustee."
Parker Ranch is one of the largest and oldest cattle ranches in the United States. Parker Ranch Inc. is wholly-owned by Parker Ranch Foundation Trust whose beneficiaries are four non-profits: Queen's North Hawai'i Community Hospital, Hawai'i Preparatory Academy, Parker School, and Hawai'i Community Foundation. To learn more, please visit www.parkerranch.com or www.prft.org.
View original content to download multimedia:
SOURCE Parker Ranch | https://www.mysuncoast.com/prnewswire/2022/08/11/beneficiaries-parker-ranch-foundation-trust-appoint-toby-taniguchi-trustee/ | 2022-08-11T03:36:43Z |
DALLAS (KDAF) — It may not be the massive $790 million Mega Millions jackpot, but it’s a jackpot win nonetheless and we don’t think this North Texas resident will be complaining one bit about their big win.
The Texas Lottery reports a resident of Arlington has recently claimed a $7.25 million jackpot from the game Lotto Texas. When this top-prize-winning ticket was bought, the purchaser chose the cash value option and the winner will receive exactly $4,632,166.56 before taxes.
The claimant of this over $4.6 million prize chose to remain anonymous. The Arlington resident’s ticket matched all six of the numbers drawn 7, 10, 23, 34, 46 and 47. That ticket was purchased at Circle K on Valley View Lane in the city of Irving.
The lottery says, “Lotto Texas is played by picking six numbers from one to 54 and offers multimillion-dollar jackpots. Drawings are held every Monday, Wednesday and Saturday at 10:12 p.m. CT. For $1 more per Play, a player can select the Extra! add-on feature and win up to $10,000 more on non-jackpot prizes.” | https://cw33.com/news/texas/arlington-resident-claims-7-25-million-jackpot-texas-lottery-prize/ | 2022-07-25T19:31:13Z |
Florida Keys Sheriff’s ‘Farm’ Benefits Animals, Inmates And The Public
By Web staff
Click here for updates on this story
KEY WEST, Florida (WFOR) — A one-of-a-kind refuge managed by the Monroe County Sheriff’s Office in the Florida Keys benefits the animals, inmates, and the public.
The Children’s Animal Farm, on the grounds of the sheriff’s office detention center near Key West, houses about 150 domestic and exotic animals from 45 species.
Last Sunday, the farm was open to the public for their annual Easter party complete with the “Easter Bunny,” as well as inmate trusties who introduced visiting families to resident animals.
“This is an animal sanctuary and we take in animals that have been abandoned, abused, confiscated, or donated,” said animal farm supervisor Jeanne Selander. “They come to us because they need a home, and we give them a forever home.”
Nicknamed “Farmer Jeanne,” Selander oversees a crew of selected trusties who help look after the animals. All are screened and classified as being safe to work outside the detention center and interact with the public.
“The inmates working on the farm benefit the farm because we have a workforce that can actually help care for the animals,” said Selandar. “And it’s beneficial to the inmates because they get to be outside, they get to work with the animals, they get to feel like they’re making a difference.”
Trusties feed, water, and care for animals that range from pigs and miniature horses to Kramer the emu, Cricket the armadillo, an alligator, kinkajous, a pair of lemurs, and a 70-year-old African spurred tortoise dubbed Albert. They also build habitats, paint, and repair fences.
“It’s calming, very calming,” said trusty Michael Hernandez. “Keeps you out of trouble, keeps your mind focused. You know you’re in the outside world.”
The unique facility is usually open to the public on the second and fourth Sundays of each month.
The only indications of the farm’s jail setting are the barbed wire atop its tall surrounding fences and the orange detention jumpsuits worn by the inmates.
Hernandez, who described himself as an “animal person,” believes he will continue to spend time at the farm even after his jail term ends.
“As a matter of fact, when I get out, I’m hoping to visit the farm to do some more work on the farm, paint some more, play with the animals some more — you know, so they won’t forget me,” he said.
Please note: This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform. | https://localnews8.com/cnn-regional/2022/04/15/florida-keys-sheriffs-farm-benefits-animals-inmates-and-the-public/ | 2022-04-15T20:37:38Z |
NEW YORK, Sept. 12, 2022 /PRNewswire/ -- Future FinTech Group Inc. (NASDAQ: FTFT) ("hereinafter referred to as "Future FinTech", "FTFT" or "the Company"), a blockchain application technology developer and fintech service provider, announced that Future FinTech Labs ("FTFT Labs"), a wholly subsidiary of the Company, has teamed up with Currency Cloud Inc. ("Currencycloud"), a subsidiary of Visa and a global payment platform that is registered with FinCen and is licensed for money transmission in various states in the US, to launch the remittance app Tempo to offer US-based immigrants and others a streamlined, secure and cost-effective way to send money from the US to North America (Canada and Mexico), Europe (Austria, Belgium, Czech Republic, France, Germany, Hungary, Italy, Poland, Portugal, Spain, Sweden and the United Kingdom), Australia, India and the Philippines.
By working with Currencycloud and other service providers, FTFT Labs can provide its customers with a multicurrency digital wallet that makes sending money to the aforementioned countries easier and more cost-effective than many other remittance services who charge high fees per transfer. Most importantly for FTFT Labs, the Tempo app is a remittance service that its users can trust, with features that make moving money seamless and with in-app customer support at their fingertips. Tempo's conversion tool means users can remit payment to foreign accounts following currency conversion and hold foreign currencies for users' convenience; Tempo's Funds Feature allows users to easily add funds to the digital wallet.
By continuously adding new features to the app, FTFT Labs aims to bring the most innovative, easy-to-use remittance services to the fingertips of an often overlooked market: US immigrants. To learn more about the Tempo app, please visit http://ftfttempo.com.
Mr. Sean Liu, CEO of FTFT Labs, said of the launch, "Tempo represents an easy, fast and secure way to transfer money cross-border. Working with Currencycloud and using the breadth of its services, it allows us to offer our customers a seamless product from start to finish. We are confident we are making remittance a seamless process for our end users."
Lewis Nurcombe, Vice President Sales, Currencycloud commented, "Migrants in the US should be able to send money cross-border without friction and without prohibitive costs. A fintech company like Future FinTech Labs understands the needs of working people wanting to send money to family and friends, and as such is successfully re-imagining how money flows for this huge market."
The Tempo app is available for download from the Apple App Store and Google Play.
About Future FinTech Group Inc.
Future FinTech Group Inc. is a blockchain application technology developer and fintech service provider incorporated in Florida. The Company's operations include a blockchain-based online shopping mall platform, Chain Cloud Mall ("CCM"), supply chain financing services, assets management, and cryptocurrency market data services. The Company is also engaged in the development of blockchain based e-Commerce technology and cryptocurrency mining, cryptocurrency investment management as well as financial service technology businesses. For more information, please visit http:/www.ftft.com/.
About Currencycloud
Banks, Fintechs and businesses everywhere can make bigger, better, bolder leaps with Currencycloud, a Visa solution. Currencycloud gives businesses the capability to move money across borders, and transact globally in multiple currencies, fast. Experts at what they do, their technology makes it easy for clients to embrace digital wallets, and to embed finance into the core of their business - no matter what industry they're in.
Since 2012, Currencycloud has processed more than $100bn to over 180 countries, working with banks, financial institutions and Fintechs around the world, including Starling Bank, Revolut, Penta and Lunar. Based in London with offices in New York, Amsterdam, Cardiff, and Singapore, Currencycloud works with partners including Visa, Dwolla, GPS and Mambu to deliver simple, clear cross-border infrastructure solutions for clients. They are regulated in the UK, Canada, US, the EU and Australia.
Safe Harbor Statement
Certain of the statements made in this press release are "forward-looking statements" within the meaning and protections of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause the actual results, performance, capital, ownership or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as "may," "will," "anticipate," "assume," "should," "indicate," "would," "believe," "contemplate," "expect," "estimate," "continue," "plan," "point to," "project," "could," "intend," "target" and other similar words and expressions of the future.
All written or oral forward-looking statements attributable to the Company are expressly qualified in their entirety by this cautionary notice, including, without limitation, those risks and uncertainties described in our annual report on Form 10-K for the year ended December 31, 2021 and other reports and filings of the Company with SEC. Such reports are available upon request from the Company, or from the Securities and Exchange Commission, including through the SEC's Internet website at http://www.sec.gov. We have no obligation and do not undertake to update, revise or correct any of the forward-looking statements after the date hereof, or after the respective dates on which any such statements otherwise are made.
View original content to download multimedia:
SOURCE Future FinTech Group Inc. | https://www.mysuncoast.com/prnewswire/2022/09/12/ftfts-future-fintech-labs-partners-with-currencycloud-launch-low-cost-remittance-app-tempo/ | 2022-09-12T13:38:35Z |
DENVER, June 16, 2022 /PRNewswire/ - SSR Mining Inc. (NASDAQ: SSRM) (TSX: SSRM) (ASX: SSR) ("SSR Mining" or the "Company") is pleased to announce that it has filed with and received acceptance from the Toronto Stock Exchange ("TSX") for a Notice of Intention to make a Normal Course Issuer Bid ("NCIB") under the requirements of the TSX permitting SSR Mining to purchase for cancellation up to 10,600,000 common shares of the Company ("Common Shares"), representing approximately 5.0% of SSR Mining's total issued and outstanding Common Shares. As of June 6, 2022 SSR Mining had 212,638,432 issued and outstanding Common Shares.
Rod Antal, President and CEO said, "Building on last year's peer leading capital returns which exceeded US$190 million, our strong free cash flow outlook for 2022 and balance sheet will enable us to continue our robust capital returns program this year. We kicked-off 2022 with a 40% increase to our quarterly dividend to US$0.07/share, or approximately US$60 million annually. As per our capital allocation framework for returning excess capital to shareholders, we plan on supplementing this quarterly dividend with the recently approved NCIB program."
SSR Mining believes that the market price of its Common Shares does not always reflect its underlying fundamental value and future growth prospects. SSR Mining's purchase of its Common Shares under the NCIB will supplement the existing base dividend and is part of its capital allocation framework for returning excess cash to shareholders. Under SSR Mining's previous Normal Course Issuer Bid, which commenced on April 21, 2021 and terminated on April 20, 2022, the Company was authorized the purchase of up to 10,000,000 Common Shares. SSR Mining purchased and cancelled 8,800,700 Common Shares via open market purchases through the facilities of the TSX and the Nasdaq at a weighted average price paid per Common Share of US$16.82 for US$148.1 million.
SSR Mining may purchase Common Shares under the NCIB over the next twelve-month period beginning June 20, 2022 and ending June 19, 2023. The exact timing and amount of any purchases will depend on market conditions and other factors. SSR Mining is not obligated to acquire any Common Shares and may suspend or discontinue purchases under the NCIB at any time. Any purchases made under the NCIB will be effected through the facilities of the TSX, Nasdaq and/or alternative Canadian and United States trading systems. Any purchases made pursuant to the NCIB will be made in accordance with the rules of the TSX, applicable U.S. securities laws and will be made at market price at the time of purchase. Under the NCIB, other than purchases made under block purchase exemptions, the Company may purchase up to 116,057 Common Shares on the TSX during any trading day, such number being 25% of 464,230 Common Shares, which is the average daily trading volume on the TSX for the most recently completed six calendar months prior to the TSX's acceptance of the notice of the NCIB.
In connection with the NCIB, the Company has entered into an automatic share purchase plan with a designated broker (the "ASPP") which sets certain price thresholds for purchases of Common Shares. The ASPP is intended to allow for the purchase of Common Shares under the NCIB at times when it would ordinarily not be permitted to purchase shares due to regulatory restrictions and customary self-imposed blackout periods. The ASPP is also intended to meet the requirements of a Rule 10b5-1 trading plan under the U.S. Securities Exchange Act of 1934, and transactions under the ASPP, and under the NCIB generally, will be conducted in accordance with Rule 10b-18 under the U.S. Securities Exchange Act of 1934.
About SSR Mining
SSR Mining Inc. is a leading, free cash flow focused gold company with four producing assets located in the USA, Turkey, Canada, and Argentina, combined with a global pipeline of high-quality development and exploration assets. In 2021, the four operating assets produced approximately 794,000 gold-equivalent ounces. SSR Mining is listed under the ticker symbol SSRM on the NASDAQ and the TSX, and SSR on the ASX.
SSR Mining Contacts:
F. Edward Farid, Executive Vice President, Chief Corporate Development Officer
Alex Hunchak, Director, Corporate Development and Investor Relations
SSR Mining Inc.
E-Mail: invest@ssrmining.com
Phone: +1 (416) 306-5789
To receive SSR Mining's news releases by e-mail, please register using the SSR Mining website at www.ssrmining.com.
Cautionary Note Regarding Forward-Looking Information and Statements:
Except for statements of historical fact relating to us, certain statements contained in this news release constitute forward-looking information, future oriented financial information, or financial outlooks (collectively "forward-looking information") within the meaning of applicable securities laws. Forward-looking information may be contained in this document and our other public filings. Forward-looking information relates to statements concerning our outlook and anticipated events or results and, in some cases, can be identified by terminology such as "may", "will", "could", "should", "expect", "plan", "anticipate", "believe", "intend", "estimate", "projects", "predict", "potential", "continue" or other similar expressions concerning matters that are not historical facts.
Forward-looking information and statements in this news release are based on certain key expectations and assumptions made by us. Although we believe that the expectations and assumptions on which such forward-looking information and statements are based are reasonable, undue reliance should not be placed on the forward-looking information and statements because we can give no assurance that they will prove to be correct. Forward-looking information and statements are subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include, but are not limited to: local and global political and economic conditions; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy, government ownership requirements, changes in environmental, tax and other laws or regulations and the interpretation thereof; the unpredictability and fluctuation in the trading price of the Company's common shares; developments with respect to the COVID-19 pandemic, including the duration, severity and scope of the pandemic and potential impacts on mining operations; and other risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission on EDGAR and the Canadian securities regulatory authorities on SEDAR.
Forward-looking information and statements in this news release include any statements concerning, among other things: future purchases of the Company's Common Shares; and any and all other timing, exploration, development, operational, financial, budgetary, economic, legal, social, environmental, regulatory, and political matters that may influence or be influenced by future events or conditions.
Such forward-looking information and statements are based on a number of material factors and assumptions, including, but not limited in any manner to, those disclosed in any other of our filings on EDGAR and SEDAR. While we consider these factors and assumptions to be reasonable based on information currently available to us, they may prove to be incorrect.
The above list is not exhaustive of the factors that may affect any of the Company's forward-looking information. You should not place undue reliance on forward-looking information and statements. Forward-looking information and statements are only predictions based on our current expectations and our projections about future events. Actual results may vary from such forward-looking information for a variety of reasons including, but not limited to, risks and uncertainties disclosed in our filings on our website at www.ssrmining.com, on SEDAR at www.sedar.com, on EDGAR at www.sec.gov and on the ASX at www.asx.com.au and other unforeseen events or circumstances. Other than as required by law, we do not intend, and undertake no obligation to update any forward-looking information to reflect, among other things, new information or future events. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.
View original content:
SOURCE SSR Mining Inc. | https://www.wibw.com/prnewswire/2022/06/16/ssr-mining-announces-normal-course-issuer-bid/ | 2022-06-16T12:52:23Z |
Transformative New All-Digital Media Network Unveiled as Part of LaGuardia's Reimagined Terminal C; Award-Winning Digital Media Program Completed at Terminal B
Cutting Edge Digital Infrastructure Coming to International Airports at JFK and Newark Liberty
Thousands of Square Feet of Digital Displays Strategically Placed to Lift Brand Campaigns to New Altitudes as Business, Leisure Travel Soar
NEW YORK, Aug. 11, 2022 /PRNewswire/ -- Today, the Port Authority of New York and New Jersey and Clear Channel Airports (CCA), the Americas-based airports business of Clear Channel Outdoor Holdings, Inc., (NYSE: CCO) announced new, world-class digital media infrastructure at the region's airports, including the unveiling of a transformative, new all-digital media network as part of LaGuardia's reimagined Terminal C.
The Port Authority and Clear Channel signed a 12-year contract in November 2020 for the advertising franchise at all Port Authority airports. Under the contract, Clear Channel committed to upgrade the airports' digital displays. Clear Channel is now in the process of completing that contract and modernizing the entire advertising program across Newark Liberty International, John F. Kennedy International, New York Stewart International and LaGuardia airports, with over 95 percent of the overall investment going into highly impactful digital displays. An award-winning digital media program was completed at LaGuardia Airport's Terminal B earlier this year, with cutting-edge digital displays now coming to EWR and JFK later this year.
Specifically, the new all-digital displays in Terminal C feature:
- Two unique 50+ foot-wide head-on, 90-degree corner LED soffits, a first and the largest digital asset CCA has ever installed in an airport;
- An iconic 43-foot-wide video wall at eye-level, one of the largest of its kind;
- Six large LED displays positioned within key gate-hold areas;
- A network of 98-inch ultra-high-definition displays on the way to and from piers;
- Two head-on large format video walls as you descend into baggage claim; and
- A network of 75-inch portrait ultra-high-definition displays across the arrivals floor.
The recovery in air travel this spring and summer -- with some days exceeding pre-COVID 19 levels -- signals that business and leisure travelers are once again headed to conferences, meetings and tourist destinations. The growing number of travelers is creating an advertising environment for brands to reconnect with this valuable audience at LGA, JFK and EWR. Importantly, air travel returning to pre-pandemic levels is now driving a resurgence in airport advertising that opens the door for marketers to help shape the consumer experience and journey in major airports.
"It takes state-of-the-art technology to create a world-class airport, and that's exactly what Clear Channel has provided with its investment in cutting edge digital technology throughout our facilities," said Port Authority Executive Director Rick Cotton. "Spacious interiors, floor-to-ceiling windows, inspiring public art, iconic restaurants and shops and Clear Channel's extraordinary digital displays all combine to meet the Port Authority of New York and New Jersey's new standard in airports: award-winning, best-in-class facilities worthy of the region."
"The new digital media infrastructure being rolled out at our facilities matches the agency's transformative redevelopment efforts across the region," said Port Authority Chairman Kevin O'Toole. "Modernizing our advertising platforms is just another step in the Port Authority's broader efforts to provide a world-class, 21st century travel experience for our customers."
"The quality of the media Clear Channel is designing and integrating into Port Authority airports is more than world-class and will play a vital role in transforming the passenger and advertiser experience as well as redefining airport media," said John Moyer, SVP, Development, CCA. "The new state of the art LaGuardia Terminal C digital media network is elegantly incorporated into the spectacular terminal design and positioned and sized for maximum impact. Unique new 90-degree digital corner locations are also perfect to showcase anamorphic content as well as being among the best media in the region."
Overall, the new media network in LaGuardia Terminal C alone amounts to nearly 2,000 square feet of digital signage, most of it head-on or in high dwell areas with more to come as other concourses are opened.
As LaGuardia is a point of welcome and farewell for passengers in the NY/NJ region, Clear Channel is uniquely poised to help brands connect with these key airport arrival and departure audiences throughout the area in a 360-degree experience by reaching them on its myriad displays at the airport and throughout the city and region wherever they drive, walk or fly.
The Port Authority of New York and New Jersey is a bi-state agency that builds, operates, and maintains many of the most important transportation and trade infrastructure assets in the country. For over a century, the agency's network of major airports; critical bridges, tunnels and bus terminals; a commuter rail line; and the busiest seaport on the East Coast has been among the most vital in the country – transporting hundreds of millions of people and moving essential goods into and out of the region. The Port Authority also owns and manages the 16-acre World Trade Center campus, which today welcomes tens of thousands of office workers and millions of annual visitors. The agency's historic $37 billion 10-year capital plan includes unprecedented transformation of the region's three major airports – LaGuardia, Newark Liberty and JFK – as well as an array of other new and upgraded assets, including the $2 billion renovation of the 90-year-old George Washington Bridge. The Port Authority's annual budget of $8 billion includes no tax revenue from either the states of New York or New Jersey or from the City of New York. The agency raises the necessary funds for the improvement, construction or acquisition of its facilities primarily on its own credit. For more information, visit www.panynj.gov or check out the Now Arriving blog.
About Clear Channel Outdoor Holdings, Inc.
Clear Channel Outdoor Holdings, Inc. ("CCOH") (NYSE: CCO) is at the forefront of driving innovation in the out-of-home advertising industry. Our dynamic advertising platform is broadening the pool of advertisers using our medium through the expansion of digital billboards and displays and the integration of data analytics and programmatic capabilities that deliver measurable campaigns that are simpler to buy. By leveraging the scale, reach and flexibility of our diverse portfolio of assets, we connect advertisers with millions of consumers every month across more than 500,000 print and digital displays in 26 countries.
View original content to download multimedia:
SOURCE Clear Channel Airports | https://www.mysuncoast.com/prnewswire/2022/08/11/port-authority-clear-channel-bring-new-all-digital-media-program-airports/ | 2022-08-11T18:54:26Z |
Puerto Rico governor rejects budget in new clash with board
By DÁNICA COTO
Associated Press
SAN JUAN, Puerto Rico (AP) — Puerto Rico’s governor says he is rejecting a proposed $12.4 billion budget filed by a federal control board overseeing the island’s finances and would submit his own version as the U.S. territory emerges from bankruptcy. Thursday’s announcement is the latest clash between the board and Gov. Pedro Pierluisi, who criticized it for insisting on reducing government costs by nearly $100 million. Pierluisis said estimated future collections are high enough to offset government costs and that he would submit a separate budget on Friday. | https://localnews8.com/news/2022/05/12/puerto-rico-governor-rejects-budget-in-new-clash-with-board/ | 2022-05-12T23:05:01Z |
WASHINGTON, June 8, 2022 /PRNewswire/ -- NASA and the Federal Emergency Management Agency (FEMA) have released a guide which provides resources for adapting to and mitigating impacts of climate change. The guide, Building Alliances for Climate Action, includes various perspectives, stories, insights, and resources about climate change to help individuals and organizations make informed decisions.
"NASA's Earth observation and research supports the Biden-Harris Administration's climate agenda, which outlines putting the climate crisis at the center of our nation's foreign policy and national security," said NASA Administrator Bill Nelson. "NASA is working hand in hand with FEMA to ensure communities across the U.S. and around the world have the resources they need to adapt in the face of extreme weather – which is increasing due to climate change."
The guide is a result of the Alliances for Climate Action, which NASA and FEMA co-hosted last year, a virtual series aimed at addressing rising demand for accurate, timely, and actionable information at a time of rapid global climate change. During the series, speakers shared their perspectives and paths to bolstering collective climate action.
"To meet this moment, we need to invest in initiatives to break the cycles of disaster, damage and reconstruction," said FEMA Administrator Deanne Criswell. "Our actions now will directly impact the future. In the past, FEMA was criticized for insufficient action on climate change. This will not be our future."
NASA also partners with FEMA in other ways related to climate and Earth science. Before, during and after disasters occur, NASA's Disasters Program coordinates with FEMA and other response agencies, decision-makers, and local governments to provide Earth-observing data and applied research results. NASA data informs choices, supports decisions, and guides actions to build resilient communities. NASA's Disasters Mapping Portal provides near-real time data on current events.
To improve access to key information, Nelson announced a concept for NASA's Earth Information Center, which is an opportunity for the agency to leverage its data and modeling capabilities to work with trusted government and community partners with longstanding engagement in communities most affected by climate change.
Supporting this effort are the Earth-observing missions we are flying today and building for the future. The center will complement the next generation of Earth observation satellites – NASA's Earth System Observatory -- to be launched by the end of this decade. As the next generation of missions to observe our planet, NASA's observatory will provide a 3D, holistic view of Earth to help us better understand what our planet's changes mean for humanity.
For more information about NASA's Earth science programs, visit:
View original content to download multimedia:
SOURCE NASA | https://www.wibw.com/prnewswire/2022/06/08/nasa-fema-release-comprehensive-climate-action-guide/ | 2022-06-08T19:15:20Z |
4-time Olympian survives plane crash with family and their puppy: ‘It is a miracle’
DETROIT (WXYZ) - A four-time Olympian survived a plane crash with her family in Michigan over the weekend.
From the wreckage, it’s hard to believe anyone survived when the single-engine Beechcraft A36 crashed just after takeoff.
Olympian Chirine Njeim, her husband Ronny Kamal and their 17-year-old niece Siena Kamal were on the plane.
Siena Kamal’s mother said the 17-year-old is in good spirits, but her left hand is covered in burns, with her forearm also burned.
“It is a miracle that all three people survived,” Ray Township Fire Department Chief Mark Hoskin said.
Officials say the couple’s puppy, Charlie, initially couldn’t be found in the wreckage. However, the following day a newspaper delivery driver, Penny Faulk, spotted the dog, who was later reunited with the family.
“I thought I saw a deer walk in front of me. I slowed down and I looked, and it was a puppy. I opened my door and called the dog over,” Faulk said.
Currently, the only person hospitalized from the crash is Ronny Kamal. The 44-year-old from Chicago underwent surgery. Officials say his piloting skills may have been what saved their lives.
“He [Ronny Kamal] had some piloting skills because the plane could have easily nosedived, and it could have been a totally different story,” Hoskin said.
Njeim has represented Lebanon in the Olympic sports of long-distance running and Alpine skiing.
Copyright 2022 WXYZ via CNN Newsource. All rights reserved. | https://www.mysuncoast.com/2022/07/26/4-time-olympian-survives-plane-crash-with-family-their-puppy-it-is-miracle/ | 2022-07-26T20:06:19Z |
DALLAS, May 3, 2022 /PRNewswire/ -- Match Group's Board of Directors (NASDAQ: MTCH) today announced that after 16 years in various roles across the organization, Shar Dubey will be resigning as an officer of Match Group, and Bernard Kim, the current President of Zynga, has been named Chief Executive Officer of the Company, effective May 31. Kim will assume day-to-day responsibilities for the organization and will be joining Match Group's Board of Directors. Dubey will continue to serve as a Director on Match Group's Board, and will serve as an advisor to the company, allowing her to focus on product strategy while playing an integral role in the transition.
Kim has served as President of Zynga from 2016, overseeing various functions including global marketing, user acquisition, revenue, consumer insights, data science, product management, mergers and acquisitions, and communications. Kim was instrumental in Zynga's explosive growth and was pivotal in the company's expansion to new markets such as blockchain and hyper-casual gaming, as well as new platforms like the Nintendo Switch, Snapchat, and smart home devices. This led to Zynga's record annual performance in 2021. Between 2016 and 2022, Kim helped quadruple Zynga's market cap, leading to its pending $12.7 billion acquisition by Take-Two, which was announced in January 2022. Prior to joining Zynga, Bernard spent nearly 10 years at Electronic Arts Inc. as the company's Senior Vice President of Mobile Publishing.
"Creative, dynamic executives that are able to lead an organization and promote a culture that produces innovative products, embraces new technologies, and attracts and retains the very best people are hard to find. We had it with Shar and it became apparent to us that Bernard's clear track record of success demonstrates the same unwavering commitment to people, products, and shareholder value," said Tom McInerney, Chairman of Match Group. "The Board is very grateful to Shar for her 16 years of outstanding service and accomplishments, and is at the same time fully energized by Bernard joining our very talented Match Group team and looks forward to continued future success."
"I'm honored to join Match Group's talented team at such a pivotal time, as the company continues to see powerful momentum, strong user engagement, and passionate employees who are driven to bring joy to millions of users from all walks of life," said Bernard Kim. "I have tremendous admiration for Shar Dubey's leadership and for Match Group's powerful mission to create meaningful connections for every single person worldwide today and in the future."
"I feel privileged that I am able to step down from a day-to-day operating role and have the time and headspace to focus on what is hopefully the 'give back' chapter of my life," said Shar Dubey. "As a Director and an advisor, I will have the flexibility to stay close to aspects of the business I love – product and strategy. I leave the company in great hands. With Bernard's energy, fresh thinking, and extensive mobile technology and consumer business experience, combined with the over 70 years of institutional knowledge and category experience of our brand CEOs and leaders at Match Group, I am ever so excited about this next phase of the company and the category."
The Board engaged a leading global search firm and conducted a robust and extensive search of a diverse slate of candidates for this process.
About Bernard Kim
As of May 31, 2022, Bernard Kim will be the Chief Executive Officer of Match Group. With over 20 years of leadership in the mobile, entertainment, and gaming industry, Bernard most recently served as Zynga's President.
At Zynga, Bernard oversaw how the company connected the world through games. He built and led a global team that was responsible for Zynga's global marketing, user acquisition, ad monetization, revenue, communications, consumer insights, data science, product management, business development, partnerships, mergers & acquisitions, and player network.
Bernard was instrumental in Zynga's turnaround and helped drive the company's player engagement and monetization strategies, which is the pinnacle of live services in mobile technology today. Bernard helped quadruple Zynga's market cap, navigating unprecedented market conditions while expanding to new platforms, markets, and audiences. Bernard led Zynga's groundbreaking acquisitions and was pivotal in the company's expansion to new markets such as blockchain gaming and hyper-casual, as well as new platforms like the Nintendo Switch, Snapchat and smart home devices. In 2020, he was honored as a 'Mobile Legend' at Pocket Gamer's Mobile Games Awards.
Prior to joining Zynga, Bernard spent nearly 10 years at Electronic Arts Inc. as the company's Senior Vice President of Mobile Publishing. In that role, he oversaw EA's mobile distribution, strategy, product management, analytics, network engagement, marketing, revenue demand planning, business development, third-party publishing, and mergers & acquisitions. During his tenure at EA, Bernard also led EA's games division in Asia and helped bring EA franchises to billions of players.
Before joining EA, Bernard served as Director of Sales and Channel Strategy at The Walt Disney Company, where he led sales and retail for Disney Mobile.
Bernard holds Bachelor of Arts degrees in both Economics and Communications from Boston College.
About Match Group
Match Group (NASDAQ: MTCH), through its portfolio companies, is a leading provider of digital technologies designed to help people make meaningful connections. Our global portfolio of brands includes Tinder®, Match®, Hinge®, Meetic®, OkCupid®, Pairs™, PlentyOfFish®, OurTime®, Azar®, Hakuna™ Live, and more, each built to increase our users' likelihood of connecting with others. Through our trusted brands, we provide tailored services to meet the varying preferences of our users. Our services are available in over 40 languages to our users all over the world.
Important Additional Information
This supplemental disclosure may be deemed to be solicitation material in respect of the solicitation of proxies from stockholders for the Match Group, Inc. 2022 Annual Meeting (the "2022 Annual Meeting"). Match Group has filed with the Securities and Exchange Commission (the "SEC") and made available to Match Group's stockholders of record on April 11, 2022 a Definitive Proxy Statement on Schedule 14A dated April 29, 2022 (the "Definitive Proxy Statement") containing important information about the matters to be considered by the Match Group's stockholders at its 2022 Annual Meeting. BEFORE MAKING ANY VOTING DECISION, MATCH GROUP, INC. STOCKHOLDERS ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS AND SUPPLEMENTS THERETO) CAREFULLY AND IN ITS ENTIRETY, BECAUSE IT CONTAINS IMPORTANT INFORMATION ABOUT THE PROPOSALS REGARDING THE MATTERS TO BE CONSIDERED AT THE 2022 ANNUAL MEETING. Investors and stockholders can obtain a copy of the documents filed by Match Group with the SEC, including the Definitive Proxy Statement (and any amendments and supplements thereto), free of charge from the SEC's website, http://www.sec.gov or by directing a request by mail to Match Group at or from Match Group's investor relations website at http://ir.mtch.com.
Participants in the Solicitation
Match Group and its directors, nominees and executive officers may be deemed to be participants in the solicitation of proxies from Match Group's stockholders with respect to the matters to be considered at the 2022 Annual Meeting. Information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, are described in the Definitive Proxy Statement filed with the SEC on April 29, 2022 and other relevant materials to be filed with the SEC.
View original content to download multimedia:
SOURCE Match Group | https://www.mysuncoast.com/prnewswire/2022/05/03/match-group-board-directors-names-bernard-kim-chief-executive-officer-shar-dubey-remain-director-advisor/ | 2022-05-03T20:45:43Z |
The 2022 RealTrends 500 Core Services rankings names Realogy Brokerage Group as top brokerage for volume of core services transactions including mortgage, title, home warranty, escrow, and property and casualty insurance
MADISON, N.J., April 11, 2022 /PRNewswire/ -- Realogy Brokerage Group – part of Realogy Holdings Corp. (NYSE: RLGY), the largest full-service residential real estate services company in the U.S. – leads the real estate industry in number of core services transactions, according to the 2022 RealTrends 500 Core Services list.
Brokerages included on the 2022 RealTrends 500 Core Services list are ranked by the total number of transactions across five categories of services including mortgage, title, home warranty, escrow, and property and casualty insurance. Realogy tops the list with 294,757 core services transactions, notably outperforming its peers in the title transactions category, with approximately 31% more title transactions than the number two spot.
"We remain laser focused on creating the best real estate transaction experience for our affiliated agents, that ultimately benefits our consumers," said M. Ryan Gorman, CEO of Coldwell Banker Real Estate, LLC and president and CEO of Realogy Brokerage Group. We are proud of the relationships with our best-in-class service providers, such as Realogy Title Group and Guaranteed Rate Affinity, and our investments in technology, which have made the transaction process much more efficient and enjoyable for all involved."
Realogy Brokerage Group's successful implementation of its core services reflects the company's broader strategy to offer a simplified home transaction process that addresses the comprehensive needs of a buyer or seller. With a unique business model encompassing franchise, brokerage, relocation, and title and settlement businesses, as well as a mortgage joint venture, Realogy puts brokers and agents in a position to deliver value throughout a property's lifecycle as the company continues to simplify and integrate the real estate transaction for consumers.
"We understand that consumers value an easy, frictionless experience, and service is key to a real estate professional's success," said Don Casey, President and CEO of Realogy Title Group. "We're thrilled to work with our Realogy Brokerage Group partners to deliver a quality, fully integrated transaction."
For more information about Realogy and its leadership role shaping the future of the real estate industry, visit www.realogy.com or follow @Realogy on Twitter, Facebook, and LinkedIn.
About Realogy Brokerage Group
Realogy Brokerage Group, a leading residential real estate brokerage company operates a full-service real estate brokerage business with approximately 675 owned and operated brokerage offices with approximately 56,000 independent sales agents principally under the Coldwell Banker®, Corcoran®, and Sotheby's International Realty® brand names in many of the largest metropolitan areas in the U.S. Realogy Brokerage Group is a subsidiary of Realogy Holdings Corp. (NYSE: RLGY).
About Realogy Holdings Corp.
Realogy (NYSE: RLGY) is moving the real estate industry to what's next. As the leading and most integrated provider of U.S. residential real estate services encompassing franchise, brokerage, relocation, and title and settlement businesses as well as a mortgage joint venture, Realogy supported approximately 1.5 million home transactions in 2021. The company's diverse brand portfolio includes some of the most recognized names in real estate: Better Homes and Gardens® Real Estate, CENTURY 21®, Coldwell Banker®, Coldwell Banker Commercial®, Corcoran®, ERA®, and Sotheby's International Realty®. Using innovative technology, data and marketing products, high-quality lead generation programs, and best-in-class learning and support services, Realogy fuels the productivity of its approximately 196,700 independent sales agents in the U.S. and approximately 136,700 independent sales agents in 118 other countries and territories, helping them build stronger businesses and best serve today's consumers. Recognized for 11 consecutive years as one of the World's Most Ethical Companies, Realogy has also been designated a Great Place to Work four years in a row, named one of LinkedIn's Top Companies in the U.S. the past two years, and honored on the Forbes list of World's Best Employers 2021.
Media Contacts:
Brianna Patrizio
(973) 407-5077
brianna.patrizio@realogy.com
View original content to download multimedia:
SOURCE Realogy Holdings Corp. | https://www.wibw.com/prnewswire/2022/04/11/realogy-brokerage-group-leads-industry-with-core-services-offerings/ | 2022-04-11T18:39:52Z |
HOUSTON, July 11, 2022 /PRNewswire/ -- Salient Midstream & MLP Fund (the "Fund") (NYSE: SMM) provided today a summary of unaudited statement of assets and liabilities and announced Net Asset Value (NAV) as of June 30, 2022.
On June 30, 2022, the Fund's total assets were $199.7 million and the NAV per share was $7.94. On June 30, 2022 the closing share price of the Fund was $7.57, which was trading at a 4.7% discount to the NAV.1 The Fund's NAV and market price total returns for the month of June were -18.3% and -10.9%, respectively, compared to -13.2% for the Alerian Midstream Energy Select Total Return Index (AMEIX).2 The Fund's NAV and market price total returns year-to-date (YTD) were 8.5% and 14.8%, respectively, compared to 10.0% for the AMEIX.2
On June 28, 2022, after consideration of a variety of factors and alternatives, the Board of Trustees determined that it would be in the best interest of shareholders to reorganize SMM into Salient MLP & Energy Infrastructure Fund ("SMLPX") (the reorganization of SMM into SMLPX is the "Reorganization"). The proposal to reorganize SMM into SMLPX will require the approval of SMM shareholders. This press release is not intended to, and does not constitute an offer to purchase or sell shares of SMM or SMLPX (together, the "Funds") nor is this press release intended to solicit a proxy from any shareholder of the Funds. The solicitation of the purchase or sale of securities or of proxy to effect the Reorganization will only be made by a definitive Proxy Statement/Prospectus. The Proxy Statement/Prospectus has yet to be filed with the U.S. Securities and Exchange Commission (the "SEC"). After the Proxy Statement/Prospectus is filed with the SEC, it may be amended or withdrawn. The Proxy Statement/Prospectus will not be distributed to shareholders of SMM unless and until a Registration Statement comprising of the Proxy Statement/Prospectus becomes effective with the SEC.
Over the last 12 months, SMM has increased its distribution by 46% and management plans to review the distribution rate every six months with expectations to continue passing through distribution increases as the Fund's portfolio has distribution increases.
Since the Fund's inception, the portfolio management team has focused on generating top-tier total returns rather than focusing on the distribution rate and the Fund's performance over multiple time period's versus its peers is provided in the table below along with a ranking of SMM vs. peers.
Since inception in 2012 SMM is the second best performing closed-end fund on market price and the third best on NAV in the peer group of eleven funds.
SMM's inception to date (ITD) annualized total return (based on market price) of -2.3% has outperformed the RIC Average of -5.9% and the with the C-Corp average of -4.9%. Likewise, on a NAV basis, SMM's ITD return of -1.9% compares favorably to the -4.0% return for the peer group of RIC Funds and -3.3% for C-Corp Funds.
June Market Commentary
June was a difficult month for energy infrastructure equities which were down 13.2% as measured by the Alerian Midstream Energy Select Index (AMEIX).2 We believe the proximate cause for the June correction was a market fear that a recession had started or will begin soon. In the past two recessions, oil demand has declined and we think investors have priced in some of those expectations today. Looking at past recessions, demand doesn't always decline – in both the 2001 and 1991 recessions global oil demand actually continued to grow.3 We will look to additional data points in coming months to determine whether demand is being impacted. Based on data in hand it still appears that demand continues to outstrip supply and that global inventories are continuing to decline at this time.3 For the remainder of 2022, we remain positive on the industry as 1) free cash flow after dividends is growing at a healthy pace, 2) hydrocarbon volumes are growing as drilling activity improves and 3) capital allocation remains mostly focused on returning excess cash to investors through buybacks and potential dividend increases.4
Crude oil as measured by the West Texas Intermediate (WTI) benchmark was down 7.8% for the month of June but is now up 40.6% for the year.5 Crude oil prices have moved sharply higher due to the war in Ukraine. Russia produces ~10 million barrels per day (mmbbls/d) of crude oil, or about 10% of global supply and is the second largest crude oil exporter after Saudi Arabia.6 Markets are worried that crude oil supplies may be disrupted which could lead to a spike in prices well above current levels. Europe's move towards sanctioning Russia's energy exports could lead to a further spike in global crude oil and natural gas prices. Longer term, we view crude oil prices in the $70-$80 per barrel range as being positive for investment in the American energy industry. While the Ukrainian war will have an as yet unknown effect on crude oil supply, fundamentals remain robust as energy consumption continues to rise post COVID.7 Commodity analysts continue to see a tight supply environment for both crude oil and natural gas in 2022 and potentially into 2023. We believe that current prices are sufficient to lead to U.S. volume growth in 2022. The promise of these incremental volumes should be supportive of midstream companies.
The Fund's Top 10 holdings as of June 30, 2022 are shown below:8
The Fund's unaudited balance sheet as of June 30, 2022 is shown below:
Salient Midstream & MLP Fund is a Delaware statutory trust registered as a non-diversified, closed-end management investment company under the Investment Company Act of 1940, as amended. The Fund's investment objective is to provide a high level of total return with an emphasis on making quarterly cash distributions to its common shareholders. The Fund seeks to achieve that objective by investing at least 80% of its total assets in securities of MLPs and midstream companies. There can be no assurance that the Fund will achieve its investment objective.
This press release contains "forward-looking statements" as defined under the U.S. federal securities laws. Generally, the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will," and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties that could cause actual future results to differ significantly from the Fund's present expectations or projections indicated in any forward-looking statements. These risks include, but are not limited to, changes in economic and political conditions; regulatory and legal changes; leverage risk; valuation risk; interest rate risk; tax risk; the volume of sales and purchase of shares; the continuation of investment advisory, administration and other service arrangements; and other risks discussed in the Fund's filings with the Securities and Exchange Commission. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. The Fund undertakes no obligation to publicly update or revise any forward-looking statements made herein. There is no assurance that the Fund's investment objective will be attained.
About Salient
Salient Partners, L.P. ("Salient") is a real asset and alternative investment firm that offers a suite of strategies focused on energy and infrastructure, real estate and tactical alternative investments. Institutions and investment advisors turn to Salient to build smarter, more efficient portfolios. Strategies are offered in the form of open- and closed-end funds and separately managed accounts. Salient was founded in 2002 and has offices in Houston and San Francisco. Learn more about Salient at www.salientpartners.com.
SMLPX seeks to maximize total return (capital appreciation and income). SMLPX seeks to achieve its investment objective by investing at least 80% of its net assets in securities of MLPs and energy infrastructure companies. Investing involves risk including the potential loss of principal. SMLPX may engage in other investment practices that may involve additional risks and you should review the prospectus for a complete description.
You should consider the investment objective, risks, charges and expenses of SMLPX carefully before investing. The prospectus and summary prospectus contain this and other information about SMLPX and are available, along with information for SMM, by calling 866-667-9228. They should be read carefully before investing.
Advisory services offered by Salient Capital Advisors, LLC (the "advisor"), a wholly owned subsidiary of Salient Partners, L.P. Salient is the trade name for Salient Partners, L.P., which together with its subsidiaries provides asset management and advisory services. Salient MLP & Energy Infrastructure Fund is distributed by Foreside Fund Services, LLC.
1 Past performance is not indicative of future results. Current performance may be higher or lower than the data shown. The data shown are unaudited. Returns do not reflect the deduction of taxes that shareholders may have to pay on Fund distributions or upon the sale of Fund shares.
2 Source: Salient Capital Advisors, LLC and Alerian, June 30, 2022. "Alerian Midstream Energy Select Index," "Alerian Midstream Energy Select Total Return Index," "AMEI" and "AMEIX" are trademarks of Alerian and their use is granted under a license from Alerian. Past performance is not indicative of how the index will perform in the future. The index reflects the reinvestment of dividends and income and does not reflect deductions for fees, expenses or taxes. The index is unmanaged and is not available for direct investment. Alerian Midstream Energy Select Total Return Index (AMEIX) is a total return composite of North American midstream energy infrastructure companies that are engaged in activities involving energy commodities. The capped, float-adjusted, capitalization-weighted index is disseminated in real time on a price-return basis. Inception date of the AMEIX is April 1, 2013.
3 Source: International Energy Agency (IEA), July 2002.
4 Free cash flow after distributions represents the cash a company generates after accounting for cash outflows to support operations and maintain its capital assets Hydrocarbon a compound of hydrogen and carbon, such as any of those which are the chief components of petroleum and natural gas. Share buybacks are when a company buys its own outstanding shares to reduce the number of shares available on the open market.
5 Source: Bloomberg, June 30, 2022.
6 Source: Energy Information Administration (EIA), June 30, 2022.
7 Source: Goldman Sachs, June 30, 2022.
8 Fund shares do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency. Data are based on total market value of Fund investments unless otherwise indicated. The data provided are for informational purposes only and are not intended for trading purposes.
View original content to download multimedia:
SOURCE Salient Partners, L.P. | https://www.wibw.com/prnewswire/2022/07/11/salient-midstream-amp-mlp-fund-announces-unaudited-net-asset-value-june-30-2022/ | 2022-07-11T20:44:04Z |
NEW YORK, Aug. 30, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of LifeStance Health Group, Inc. (NASDAQ: LFST) alleging that the Company violated federal securities laws.
This lawsuit is on behalf of all purchasers of LifeStance common stock pursuant and/or traceable to the documents issued in connection with LifeStance's June 10, 2021 initial public stock offering.
Lead Plaintiff Deadline: October 11, 2022
No obligation or cost to you.
Learn more about your recoverable losses in LFST:
https://www.kleinstocklaw.com/pslra-1/lifestance-health-loss-submission-form?id=31231&from=4
LifeStance Health Group, Inc. NEWS - LFST NEWS
CLASS ACTION CASE DETAILS: The filed complaint alleges that LifeStance Health Group, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the number of virtual visits clients were undertaking utilizing LifeStance Health was decreasing as the COVID-19 lockdowns were being lifted, thereby flatlining LifeStance Health's out-patient/virtual revenue growth; (ii) the percentage of in-person visits clients were undertaking utilizing LifeStance Health was increasing as the COVID-19 lockdowns were being lifted, thereby causing LifeStance Health's operating expenses to increase substantially; (iii) LifeStance Health had lost a large number of physicians due to burn-out and, as a result, its physician retention rate had fallen significantly below the 87% highlighted in the initial public offering's registration statement, and LifeStance Health had been expending additional costs to onboard new physicians who were less productive than the outgoing physicians they were replacing; and (iv) as a result, LifeStance Health's business metrics and financial prospects were not as strong as the initial public offering's registration statement represented.
WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in LifeStance you have until October 11, 2022 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you purchased LifeStance securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.
HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the LFST lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link: https://www.kleinstocklaw.com/pslra-1/lifestance-health-loss-submission-form?id=31231&from=4.
ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
www.kleinstocklaw.com
View original content:
SOURCE The Klein Law Firm | https://www.wibw.com/prnewswire/2022/08/30/lfst-alert-klein-law-firm-announces-lead-plaintiff-deadline-october-11-2022-class-action-filed-behalf-lifestance-health-group-inc-shareholders/ | 2022-08-30T11:20:22Z |
Moves to Drive Continued Success and Seize New Opportunities
PITTSBURGH, June 1, 2022 /PRNewswire/ -- CNX Resources Corporation (NYSE: CNX) ("CNX" or "the company") today announced executive leadership promotions. Donald W. Rush, Chief Financial Officer, will assume the role of Chief Strategy Officer (CSO), and Alan K. Shepard, Vice President and Chief Accounting Officer, will be promoted to the role of Chief Financial Officer. Both moves are effective immediately.
"Today's announcement further illustrates the deep bench filled with local talent within our organization. These leaders represent proven strategic forward-thinking, strong execution capabilities, and a dedicated commitment to CNX's value proposition and to the future of our region," said President and CEO Nick DeIuliis. Mr. DeIuliis continued, "While Alan will oversee the continued steady execution of our free cash flow per share growth plan, Don will focus on the future and its exciting upside opportunities incremental to our base business."
In his new role, Mr. Rush will continue to report to President and CEO Nick DeIuliis and help drive the company's strategy, growth avenues, value recognition, and branding. He will work closely with the executive team and the Board of Directors.
"Don successfully navigated CNX through a series of transformative transactions that evolved the company into the low cost and low CO2e intensive manufacturer of natural gas in the Appalachian Basin. He is particularly well suited to further position the company as a leader and differentiator in the ESG space and increase our intrinsic value per share," said Mr. DeIuliis.
Mr. Shepard will now report to President and CEO DeIuliis and be responsible for overseeing the company's finance organization. Mr. Shepard has served in numerous finance leadership capacities across his 20-year career, most recently as CNX's Chief Accounting Officer. Prior to rejoining CNX in 2020, he served as the Chief Financial Officer of EdgeMarc Energy.
Mr. DeIuliis commented further, "Alan's deep knowledge of our business, extensive financial expertise, steady guidance of our returns-focused strategy, and strong relationship with our Board of Directors and executive management team will serve CNX well as he leads our finance organization. We are excited for what is to come as he seizes the opportunities of this new role."
CNX Resources Corporation (NYSE: CNX) is unique. We are a premier natural gas development, production, midstream, and technology company centered in Appalachia, one of the most energy abundant regions in the world. With the benefit of a 158-year regional legacy, substantial asset base, leading core operational competencies, technology development and innovation, and astute capital allocation methodologies, we responsibly develop our resources and deploy free cash flow to create long-term per share value for our shareholders, employees, and the communities where we operate. As of December 31, 2021, CNX had 9.63 trillion cubic feet equivalent of proved natural gas reserves. The company is a member of the Standard & Poor's Midcap 400 Index. Additional information is available at www.cnx.com.
We are including the following cautionary statement in this press release to make applicable and take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 for any forward-looking statements made by, or on behalf of us. With the exception of historical matters, the matters discussed in this press release are forward-looking statements (as defined in 21E of the Securities Exchange Act of 1934 (the "Exchange Act")) that involve risks and uncertainties that could cause actual results to differ materially from projected results. Accordingly, investors should not place undue reliance on forward-looking statements as a prediction of actual results. These forward-looking statements may include projections and estimates concerning the timing and success of specific projects and our future production, revenues, income, and capital spending. When we use the words "believe," "intend," "expect," "may," "should," "anticipate," "could," "estimate," "plan," "predict," "project," "will," or their negatives, or other similar expressions, the statements which include those words are usually forward-looking statements. When we describe a strategy that involves risks or uncertainties, we are making forward-looking statements. The forward-looking statements in this press release speak only as of the date of this press release; we disclaim any obligation to update these statements. We have based these forward-looking statements on our current expectations and assumptions about future events. While our management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies, and uncertainties, most of which are difficult to predict and many of which are beyond our control. Specific factors that could cause future actual results to differ materially from the forward-looking statements are described in detail under the captions "Forward-Looking Statements" and "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission (SEC) and any subsequent reports filed with the SEC. Those risk factors discuss, among other matters, pricing volatility or pricing decline for natural gas and NGLs; local, regional and national economic conditions and the impact they may have on our customers; the impact of events beyond our control, including a global or domestic health crisis; dependence on gathering, processing and transportation facilities and other midstream facilities owned by others; conditions in the oil and gas industry; our current long-term debt obligations, and the terms of the agreements that govern that debt; strategic determinations, including the allocation of capital and other resources to strategic opportunities; cyber-incidents targeting our systems, oil and natural gas industry systems and infrastructure, or the systems of our third-party service providers; and changes in safety, health, environmental and other regulations.
View original content to download multimedia:
SOURCE CNX Resources Corporation | https://www.wibw.com/prnewswire/2022/06/01/cnx-announces-executive-leadership-changes/ | 2022-06-01T11:15:31Z |
AKRON, Ohio, April 27, 2022 /PRNewswire/ -- Sequoia Financial Group, LLC (Sequoia), an SEC-registered adviser providing financial planning, family wealth and asset management services, today announced the appointments of John Wiler as senior director, M&A project manager, and David Dellosa as director of marketing.
Before joining Sequoia, Wiler was marketing director at wealth manager MAI Capital Management in Cleveland. He has more than 25 years of strategic planning, organizational development and marketing experience, having also worked for the Legal Aid Society of Cleveland and for IMG and a predecessor firm. Wiler received a master of arts degree from Kent State University and a bachelor of arts degree from Allegheny College.
A veteran business development leader, Dellosa leads a team of five marketers at Sequoia. Previously, Dellosa served as senior manager, marketing at MAI Capital Management. Earlier, he was director, business development for golf clients at global marketing agency IMG and owner of Dellosa Creative, a marketing firm. He received a bachelor of fine arts degree from The University of Akron.
"Sequoia Financial is growing, both organically and through acquisitions, and we're delighted to attract experienced and talented professionals of the caliber of David and John to our expanding team," said Al Kantra, executive vice president and chief operating officer.
In 2021, Sequoia Financial Group acquired Mayfield Heights, Ohio-based NCA Financial Planners and Columbus, Ohio-based WEALTHSTONE ADVISORS, creating a firm with approximately $10 billion in assets under management and advisement.
Sequoia was recently recognized by Barron's as one of the top 100 RIA firms in the U.S. for 2021.
About Sequoia Financial Group
Sequoia Financial Group, LLC, founded in 1991, takes a client-centered approach to providing comprehensive financial planning and wealth management services, including asset management, estate and retirement planning, fiduciary consulting and family wealth. Sequoia builds and maintains strong relationships that emphasize long-term planning to help clients reach their financial and life goals. Sequoia was named one of America's Top RIAs by Barron's in 2021 and 2020 and received the Schwab Advisor Services 2019 Best-In-Business IMPACT Award. For more information, please visit https://www.sequoia-financial.com/.
View original content to download multimedia:
SOURCE Sequoia Financial Group | https://www.kxii.com/prnewswire/2022/04/27/sequoia-financial-group-announces-mampa-integration-marketing-appointments/ | 2022-04-27T19:30:49Z |
JPMAM's first ETF to invest primarily in the equity securities of large cap companies listed on The Nasdaq Stock Market®
NEW YORK, May 4, 2022 /PRNewswire/ -- J.P. Morgan Asset Management today announced the launch of JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), the firm's first ETF to list on The Nasdaq Stock Market®. The active equity ETF seeks to deliver an attractive distributable yield while also delivering a significant portion of the returns associated with the fund's primary benchmark, the Nasdaq-100 Index®, with less volatility.
JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) will be comprised of a portfolio of equity securities of large cap companies included in the Nasdaq-100 Index® and will incorporate an options strategy to generate income while lowering the volatility of the overall portfolio. This management style aims to deliver returns, offer incremental income and better manage risk within portfolios as investors navigate today's rising rate and inflationary environment.
The fund will be managed by 35-year industry veteran Hamilton Reiner as the lead portfolio manager alongside portfolio managers Eric Moreau and Andrew Stern.
"Investors are looking for yield, which is proving particularly challenging given the current economic backdrop. JEPQ is an innovative income solution which employs our differentiated options overlay strategy," said Hamilton Reiner, Portfolio Manager and Head of U.S. Equity Derivatives at J.P. Morgan Asset Management. "Leveraging our differentiated alpha engine, JEPQ is an active solution for investors looking to drive portfolio allocations while maximizing risk-adjusted expected returns."
"JEPQ was built for investors that are seeking income while also owning companies that provide exposure to Nasdaq's innovative marketplace. This strategy benefits from the intentionality of an active manager while being delivered through the ETF technology," said Bryon Lake, Global Head of ETF Solutions at J.P. Morgan Asset Management. "We're excited to expand our suite of active ETF capabilities and meet client needs with a tested investment strategy that balances income and equity exposure essential to portfolio construction."
The addition of JEPQ brings J.P. Morgan Asset Management's full U.S. suite of ETFs to 41 products with more than $75 Billion in assets under management. J.P. Morgan Asset Management ranks as a top ten ETF issuer in the U.S. with respect to AUM1, and number one in net active flows across active ETFs in the U.S. for 20212.
About J.P. Morgan Asset Management
J.P. Morgan Asset Management, with assets under management of USD 2.6 trillion (as of March 31, 2022), is a global leader in investment management. J.P. Morgan Asset Management's clients include institutions, retail investors and high net worth individuals in every major market throughout the world. J.P. Morgan Asset Management offers global investment management in equities, fixed income, real estate, hedge funds, private equity and liquidity. For more information: www.jpmorganassetmanagement.com.
J.P. Morgan Asset Management is the marketing name for the asset management businesses of JPMorgan Chase & Co. and its affiliates worldwide.
JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorgan Chase had $4.0 trillion in assets and $285.9 billion in stockholders' equity as of March 31, 2022. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S., and many of the world's most prominent corporate, institutional and government clients globally. Information about JPMorgan Chase & Co. is available at www.jpmorganchase.com.
J.P. Morgan ETFs are distributed by JPMorgan Distribution Services, Inc., which is an affiliate of JPMorgan Chase & Co. Affiliates of JPMorgan Chase & Co. receive fees for providing various services to the funds. JPMorgan Distribution Services, Inc. is a member of FINRA. More information is available at https://am.jpmorgan.com/us/en/asset-management/gim/adv/products/etfs.
Investors should carefully consider the investment objectives and risks as well as charges and expenses of an ETF before investing. The summary and full prospectuses contain this and other information about the ETF and should be read carefully before investing. To obtain a prospectus: Call 1-844-4JPM-ETF.
NOT FDIC INSURED | NO BANK GUARANTEE | MAY LOSE VALUE
Related Links: http://www.jpmorganchase.com
Nasdaq®, Nasdaq-100 Index®, Nasdaq 100® and NDX® are registered trademarks of Nasdaq, Inc. (which with its affiliates is referred to as the "Corporations") and are licensed for use by J.P. Morgan Asset Management. The ETF has not been passed on by the Corporations as to its legality or suitability. The ETF is not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO THE ETF.
1 Data according to ETFdb.com as of 4/29/2022.
2 Data according to Bloomberg as of 4/29/2022.
View original content to download multimedia:
SOURCE J.P. Morgan Asset Management | https://www.wibw.com/prnewswire/2022/05/04/jp-morgan-asset-management-expands-etf-lineup-jpmorgan-nasdaq-equity-premium-income-etf-jepq/ | 2022-05-04T14:12:34Z |
The No. 1 price generating software company helps business owners simplify sales process and increase cashflow
DALTON, Ga., Aug. 2, 2022 /PRNewswire/ -- The New Flat Rate, the No. 1 price generating software for home service contractors, has announced a partnership with OPTIMUS Financing by EGIA, the all-in-one financing and leasing platform for the home service industry, that will empower contractors with the ability to offer multiple financing options to their customers.
As part of the dealer-financing program, the program will enable participating dealers to select from multiple financing options that best align with their organizational structure and sales process.
"Funding projects can be burdensome for both the contractor and the customers, and it shouldn't be" said Danielle Putnam, president of The New Flat Rate. "For the contractors helping their customers, it can be time consuming. For the customers, finding the money to complete the project can be stressful. With this partnership with OPTIMUS Financing, we are helping contractors by offering them a tool that will give them the ability to finance their customers right on the spot."
The New Flat Rate's software provides a variety of menus that instantly give prices for repairs and supplies the customer with multiple options to choose from. These menus help decrease the stress of selling services while also increasing profits for the contractor.
OPTIMUS Financing is the comfort industry's most comprehensive dealer-driven financing program, facilitating financing of over $750 million per year. Dedicated to matching the right finance program for a diverse customer base, OPTIMUS uses soft pull technology to quickly help a customer find the right lending or leasing options.
"OPTIMUS Financing provides pathways that cover a wide range of credit profiles through a single platform," said Matthew Bratsis, vice president of contractor services for EGIA and creator of the OPTIMUS Financing Program. "Through this partnership, EGIA is gaining access to a plethora of contractors who can utilize our program to help their customers with funding for future projects. We share a common goal with The New Flat Rate, and together we can make the lives of the contractors easier by providing their customers with an easier path toward financial options that best suit them."
For more information about The New Flat Rate, please visit https://thenewflatrate.com/.
For more information about the OPTIMUS Financing program, please visit https://optimusfinancing.com/.
About The New Flat Rate
The New Flat Rate, Inc. pioneered the first menu pricing system for in-home service providers which has doubled and tripled the average service ticket for contractors across the United States and Canada. Targeting HVAC, Plumbing, and Electrical Service and Repair contractors, each market-specific edition is designed to do the bundling and upselling for technicians by providing hundreds of service, repair and equipment replacement "menus," each with up to five straightforward options consumers can choose. Voted No. 1 retail pricing generator during the 2021 HARDI conference, The New Flat Rate develops processes to eliminate objections and lower sales resistance for service technicians. For more information, visit http://thenewflatrate.com/ or call 706-259-8892.
About the Electric & Gas Industries Association (EGIA)
EGIA is a nonprofit organization that empowers home services contractors to get the most out of their businesses through industry-leading training, financing and marketplace solutions. Its OPTIMUS Financing, which has facilitated financing for 250,000+ residential and business projects valued at over $4.5 billion, provides contractors with a best-in-class suite of financing options. Contractor University powered by EGIA offers access to the industry's most recognized educators, who deliver innovative keys to success through online training systems, in-person workshops, conferences and webinars. Contractor Marketplace brings together some of the most in-demand vendors and products in the industry at exclusive pricing. To learn more about EGIA, visit www.egia.org.
MEDIA CONTACT:
Heather Ripley
Ripley PR
(865) 977-1973
hripley@ripleypr.com
View original content to download multimedia:
SOURCE The New Flat Rate | https://www.mysuncoast.com/prnewswire/2022/08/02/new-flat-rate-provides-contractors-with-instant-financing-options-through-partnership-with-optimus/ | 2022-08-02T12:54:55Z |
PITTSBURGH, Aug. 3, 2022 /PRNewswire/ --..."I wanted to create a new album that enables families to store important photos and information and then share it with current and future generations," said an inventor, from Lehigh Acres, Fla., "so I invented IMMEDIATE MEMORIES FOREVER. My design could help to keep the spirit of past family members alive and it ensures that family members always have access to their roots."
The invention provides a special album for celebrating one's family. In doing so, it enables a family to store and organize various fond photographs, information and memories. As a result, it ensures that deceased family members are not forgotten and it can be used to pay homage to the deceased by allowing you to see pictures, read about their professions, etc. This could help to bring family members together, connect generations and create a sense of belonging. The invention features a unique design that is easy to use so it is ideal for families. Additionally, a prototype is available.
The original design was submitted to the Naples sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 20-NPL-400, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
View original content to download multimedia:
SOURCE InventHelp | https://www.mysuncoast.com/prnewswire/2022/08/03/inventhelp-inventor-develops-special-album-celebrating-family-npl-400/ | 2022-08-03T16:14:52Z |
TAMPA, Fla., July 20, 2022 /PRNewswire/ -- Lazydays Holdings, Inc. ("Lazydays" or the "Company") (NasdaqCM: LAZY) provided preliminary results for the quarter ending June 30, 2022. It is important to note that results are preliminary and unaudited, and should be read in conjunction with the Company's annual report on Form 10-K for the year ended December 31, 2021, which the Company filed on March 11, 2022, and its quarterly report on Form 10-Q for the quarter ended March 31, 2022, which the Company filed on June 3, 2022. Preliminary Revenue for the second quarter ending June 30, 2022 is $373.6 million, up $50.8 million versus second quarter 2021. Preliminary net income for the quarter is $31.8 million, up $6.5 million versus second quarter 2021 net income of $25.3 million.
Preliminary key metrics for the quarter are provided below, along with a reconciliation of Adjusted EBITDA, a non-GAAP financial measure, to net income.
Quarter ending June 30, 2022 Preliminary Results:
- Adjusted EBITDA for the quarter was $38.4 million versus $44.3 million in the second quarter of 2021
- RV unit sales decreased 3.7% to 4,052 units versus 4,208 units in the second quarter of 2021
- Total Revenue increased 15.7% to $373.6 million compared to $322.8 million in the second quarter of 2021
- The Company ended the quarter with a cash balance of $105.4 million
ABOUT LAZYDAYS RV
As an iconic brand in the RV industry, Lazydays, The RV Authority, consistently provides the best RV sales, service, and ownership experience, which is why RVers and their families become Customers for Life. Lazydays continues to add locations at a rapid pace as it executes its geographic expansion strategy that includes both acquisitions and greenfields.
Since 1976, Lazydays RV has built a reputation for providing an outstanding customer experience with exceptional service excellence and unparalleled product expertise, along with being a preferred place to rest and recharge with other RVers. By offering the largest selection of RV brands from the nation's leading manufacturers, state-of-the-art service facilities, and thousands of accessories and hard-to-find parts, Lazydays RV provides everything RVers need and want.
Lazydays Holdings, Inc. is a publicly listed company on the Nasdaq stock exchange under the ticker "LAZY."
Forward‐Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements describe Lazydays future plans, projections, strategies and expectations, including statements regarding Lazydays' expectations for future operating results, its expectations regarding the impact of its recently acquired dealerships in Maryville, Tennessee, Portland, Oregon, Vancouver, Washington, Milwaukee, Wisconsin, and Tulsa, Oklahoma; and its greenfield start-ups in Monticello, Minnesota, Fort Pierce, Florida, near Omaha, Nebraska, Wilmington, Ohio, Surprise, Arizona and three dedicated Airstream locations in Ramsey, Minnesota and Knoxville and Nashville, Tennessee; and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of Lazydays. Actual results could differ materially from those projected due to various factors, including the impact of the conflict between Russia and Ukraine, including from current and future sanctions imposed by governments or other authorities, including economic conditions generally (including increasing fuel costs), conditions in the credit markets and changes in interest rates, conditions in the capital markets, the continuing impact of the coronavirus pandemic (COVID-19) and other factors described from time to time in Lazydays' SEC reports and filings, which are available at www.sec.gov and other factors that Lazydays may not have currently identified or quantified. Forward-looking statements contained in this news release speak only as of the date of this news release, and Lazydays undertakes no obligation to update these forward-looking statements to reflect subsequent events or circumstances, unless otherwise required by law.
Disclaimer
Information in this news release is not an offer to sell securities or the solicitation of an offer to buy securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
The preliminary results in this press release should not be read as an indication of the Company's future financial position or results of operations. The extent and duration of the COVID-19 pandemic, and its short- and long-term effects on the Company's business, financial position and results of operations is impossible to predict.
Non-GAAP Financial Measure
Adjusted EBITDA. Adjusted EBITDA is a not a U.S. Generally Accepted Accounting Principle ("GAAP") financial measure, but it is one of the primary non-GAAP measures management uses to evaluate the financial performance of the business. Adjusted EBITDA is also frequently used by analysts, investors, and other interested parties to evaluate companies in the recreational vehicle industry. The Company uses Adjusted EBITDA and Adjusted EBITDA Margin to supplement GAAP measures of performance as follows:
The Company believes Adjusted EBITDA can provide a more complete understanding of the underlying operating results and trends and an enhanced overall understanding of financial performance and prospects for the future. The Company defines Adjusted EBITDA as net income excluding depreciation and amortization of property and equipment, non-floor plan interest expense, amortization of intangible assets, income tax expense, stock-based compensation, transaction costs and other supplemental adjustments which for the periods presented includes LIFO adjustments, severance costs and other one-time charges, and gain on sale of property and equipment. The Company believes Adjusted EBITDA, when considered along with other performance measures, is a useful measure as it reflects certain operating drivers of the business, such as sales growth, operating costs, selling and administrative expense and other operating income and expense.
Adjusted EBITDA is not intended to be a measure of liquidity or cash flows from operations, or a measure comparable to net (loss) income as it does not take into account certain requirements such as non-recurring gains and losses which are not deemed to be a normal part of the underlying business activities. The Company's measure of Adjusted EBITDA is not necessarily comparable to similarly titled captions of other companies due to different methods of
Calculation. The Company compensates for these limitations by using Adjusted EBITDA as only one of several measures for evaluating business performance. In addition, capital expenditures, which impact depreciation and amortization, interest expense, and income tax expense, are reviewed separately by management.
A reconciliation of preliminary net income to preliminary EBITDA and preliminary Adjusted EBITDA for the periods presented follows:
News Contact:
+1 (813) 204-4099
investors@lazydays.com
View original content to download multimedia:
SOURCE Lazydays Holdings, Inc. | https://www.mysuncoast.com/prnewswire/2022/07/20/lazydays-holdings-inc-provides-preliminary-second-quarter-results/ | 2022-07-20T13:55:29Z |
New York City pension funds sue Activision Blizzard, seeking records on CEO Bobby Kotick
By Brian Fung, CNN
New York City pension fund officials sued Activision Blizzard late last month in a bid to force the company to disclose records that may uncover whether CEO Bobby Kotick breached his fiduciary duty to investors, according to a newly released copy of the complaint.
The complaint by the New York City Employees’ Retirement System, along with pension funds representing city teachers, police and firefighters, seeks to open up the books at Activision Blizzard to prove whether Kotick negotiated the company’s $68.7 billion sale to Microsoft as “a means to escape liability” stemming from allegations he turned a blind eye to years of staff harassment claims within the company. The funds are investors in Activision Blizzard, and claim that misconduct by Kotick and the company’s board have undercut shareholder value.
On Wednesday, Activision Blizzard told CNN in a statement: “We disagree with the allegations made in this complaint and look forward to presenting our arguments to the Court.”
CNN obtained a public version of the complaint dated May 2 from the Office of the New York City Comptroller. The original complaint, filed in the Court of Chancery in Delaware, was dated April 26. Asked for comment, the New York City comptroller’s office referred CNN to the New York City Law Department, which is handling the litigation. The department didn’t immediately respond to a request for comment.
The complaint was first reported by Axios.
Thanks to the Microsoft deal, the complaint alleged, “Kotick will be able to escape liability and accountability entirely, and will instead continue to serve as an executive after the Merger closes. Worse, despite his potential liability for breaches of fiduciary duty, the Board allowed Kotick himself to negotiate the transaction with Microsoft. The Board’s decision to entrust Kotick with the negotiation process is inexcusable for the additional reason that Kotick stands to personally receive substantial material benefits whose value is not directly aligned with the Merger price.”
Kotick stands to receive a $22 million bonus for meeting workplace culture goals that “almost identically track” the company’s settlement this year with the Equal Employment and Opportunity Commission, according to the complaint.
The suit is the latest legal headache for Activision Blizzard, which faces an array of federal probes and investor suits tied to the allegations of workplace misconduct.
The complaint follows multiple requests for Activision Blizzard records by NYC pension officials since October 2021, and it argues the company has been insufficiently responsive. Among the records now sought by the officials are board presentations, minutes, memos and other documents related to the Microsoft deal and specifically related to Kotick’s role in the matter.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://localnews8.com/news/2022/05/04/new-york-city-pension-funds-sue-activision-blizzard-seeking-records-on-ceo-bobby-kotick/ | 2022-05-05T00:50:32Z |
Analysis predicts 462 preventable deaths on U.S. roadways July 1-4
ITASCA, Ill., June 27, 2022 /PRNewswire/ -- The National Safety Council estimates 462 people may lose their lives on U.S. roads during Independence Day weekend in preventable crashes. According to newly released estimates from the National Highway Traffic Safety Administration, U.S. roads are the most dangerous they've been in 16 years. With Independence Day being one of the most risky driving holidays of the year, NSC urges not only drivers, but all road users, whether they're biking, walking or otherwise mobile, to be safe.
"On a typical day, more than 100 people die on our roads, and that number is climbing," said Mark Chung, executive vice president, roadway practice at NSC. "Please take safety personally and follow our safe driving tips to ensure you get to where you want to go as safely as possible. Your life and those you love may depend on it."
The National Safety Council implores all drivers to adhere to the following safe driving tips this weekend:
- Buckle up: Lack of seat belt use is a top cause of fatalities in crashes. Buckle up, while also making sure you have appropriate car seats installed correctly.
- Designate a sober driver or arrange alternate transportation: Holidays are a cause for celebration, but alcohol is only one cause of impaired driving. Drugs, including opioids, marijuana and some over-the-counter medicines, can cause drowsiness, alter visual functions and affect mental judgment and motor skills.
- Slow down: Speeding is a factor in more than a quarter of all traffic fatalities. Drive the speed limit or below it if conditions dictate. Be sure to pay close attention to those walking and biking in order to keep all road users safe.
- Prepare before you go: Before hitting the road, make sure your car is safe for driving. Vehicle owners should check the oil, put air in the tires, and check for and repair open recalls. Visit ChecktoProtect.org to see if your vehicle has an open recall, and get it repaired for free.
- Drive distraction-free: Thousands have died in car crashes involving cell phone use. Put your phones away and #JustDrive.
- Look before you lock: Pediatric vehicular heatstroke is still the leading cause of non-crash motor vehicle-related fatality for children. Since 1998, more than 900 children in the U.S. have died because of this completely preventable tragedy. Always check your back seat for children or animals when you reach your destination.
In addition to promoting safe driving behaviors among individuals, the National Safety Council recognizes the need for action to address the urgency of this national traffic safety crisis—because the onus of preventing deaths on our roads is not entirely on individual drivers.
NSC and its allies on Capitol Hill, at the U.S. Department of Transportation, and across safety and advocacy groups understand the commitment to a Safe System approach is necessary because much of our current roadway system is built to maximize throughput, not safety. To that end, on Wednesday, June 29 at 10 a.m. ET at the National Press Club in Washington, NSC will unveil the executive summary of its new report, Mobility, Technology and Safety: The Next 20 Years. This event highlights the findings of the report, announces new, related initiatives from the National Safety Council, and calls on policymakers to take decisive action around the troubling trend of traffic fatalities. NSC will utilize the conclusions of this new report to identify, track, and advocate for priority actions for the federal government. To register to attend this event virtually, click here.
For more safety tips, visit nsc.org/saferoads. Review supplemental information about the Independence Day holiday fatality estimates, and additional motor vehicle data and research at injuryfacts.nsc.org.
About the National Safety Council
The National Safety Council is America's leading nonprofit safety advocate–and has been for more than 100 years. As a mission-based organization, we work to eliminate the leading causes of preventable death and injury, focusing our efforts on the workplace, roadway and impairment. We create a culture of safety to not only keep people safer at work, but also beyond the workplace so they can live their fullest lives.
Connect with NSC:
Facebook
Twitter
LinkedIn
YouTube
Instagram
View original content to download multimedia:
SOURCE National Safety Council | https://www.mysuncoast.com/prnewswire/2022/06/27/national-safety-council-urges-safe-driving-this-independence-day-weekend/ | 2022-06-27T13:10:42Z |
SAN FRANCISCO, Sept. 15, 2022 /PRNewswire/ -- Dodge & Cox announced today the appointment of Luis Borgen as a new Independent Trustee to the Dodge & Cox Funds Board of Trustees.
Mr. Borgen is currently an independent member of the Board of Directors of Synopsys, Carter's, and Eastern Bankshares. From 2019 to April 2022, he served as Chief Financial Officer (CFO) of athenahealth and played a key role in the company's sale to Hellman & Friedman and Bain Capital. Over the preceding decade, he served as CFO of various publicly-traded companies including DaVita and DAVIDsTEA. Earlier in his career, he spent 13 years in increasingly senior finance roles at Staples, culminating as Senior Vice President and CFO for the U.S. Retail business. Mr. Borgen began his career in the U.S. Air Force, where he attained the rank of Captain.
The Dodge & Cox Funds Board of Trustees oversees all seven Funds in the Dodge & Cox Funds complex: the Dodge & Cox Stock Fund, Dodge & Cox Global Stock Fund, Dodge & Cox International Stock Fund, Dodge & Cox Emerging Markets Stock Fund, Dodge & Cox Balanced Fund, Dodge & Cox Income Fund, and Dodge & Cox Global Bond Fund.
Mr. Borgen joins eight current Independent Trustees of the Dodge & Cox Funds Board of Trustees. The Board is now comprised of 11 Trustees, nine of whom are independent.
Gary Roughead, Lead Independent Trustee of the Dodge & Cox Funds, commented on the appointment of Mr. Borgen, "We are pleased to welcome Luis Borgen to the Board of the Dodge & Cox Funds, and we look forward to benefitting from his deep experience and counsel on behalf of the Funds and their shareholders."
Founded in 1930, Dodge & Cox manages $327 billion for individual and institutional investors in mutual funds, UCITS, and private accounts as of June 30, 2022. For more information on Dodge & Cox, please visit our website: www.dodgeandcox.com.
Before investing in any Dodge & Cox Fund, you should carefully consider the Fund's investment objectives, risks, and charges and expenses. To obtain a Fund's prospectus and summary prospectus, which contain this and other important information, visit dodgeandcox.com or call 800-621-3979. Please read the prospectus and summary prospectus carefully before investing.
Dodge & Cox Funds are distributed by Foreside Fund Services, LLC, which is not affiliated with Dodge and Cox.
Investing involves risk. Loss of principal is possible.
View original content to download multimedia:
SOURCE Dodge & Cox | https://www.wibw.com/prnewswire/2022/09/15/dodge-amp-cox-funds-appoints-new-independent-trustee/ | 2022-09-15T19:52:38Z |
NEW YORK , May 26, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Oscar investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Oscar Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's March 2021 initial public offering. Follow the link below to get more information and be contacted by a member of our team:
OSCR investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Oscar was experiencing growing COVID-19 testing and treatment costs; (2) Oscar was experiencing growing net COVID costs; (3) Oscar would be negatively impacted by an unfavorable prior year Risk Adjustment Data Validation result relating to 2019 and 2020; (4) Oscar was on track to be negatively impacted by significant SEP membership growth; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
WHAT'S NEXT? If you suffered a loss in Oscar during the relevant time frame, you have until July 11, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:
SOURCE Levi & Korsinsky, LLP | https://www.kxii.com/prnewswire/2022/05/26/oscr-lawsuit-alert-levi-amp-korsinsky-notifies-oscar-health-inc-investors-class-action-lawsuit-upcoming-deadline/ | 2022-05-26T11:15:07Z |
BALTIMORE, Aug. 19, 2022 /PRNewswire/ -- JACS Solutions, a global provider of customized connectivity solutions for industrial and enterprise IoT applications, today announced that its TT1001 10" 4G LTE Android tablet platform has received certification from AT&T, T-Mobile, and Verizon (the three largest U.S. wireless service providers) to operate on their cellular networks.
Enterprises who employ connected solutions offered by the above-mentioned carriers and/or mobile virtual network operators (MVNO's) may now standardize on the TT1001 when deploying critical business applications, thus reducing the complexities associated with managing multiple device platforms across their organization. The TT1001 allows MVNO's and other technology solutions providers to build, test, deploy, and manage end-user solutions with common hardware regardless of their carrier contracts, resulting in shorter times to market and lower costs.
"We are thrilled to support our partners and enterprise customers with a customizable tablet platform that will reduce deployment time and lessen the burden on critical development and support resources," said Dr. Chang-gang Zhang, Vice President of Technology at JACS Solutions. "Completing multi-carrier certification of the TT1001 demonstrates JACS' commitment to give customers the flexibility they need from their IoT solutions provider."
Device certification is a rigorous process performed on cellular-enabled devices to verify they are compliant with carrier-specific standards related to performance and quality of service experienced by end users. The TT1001 is the latest JACS platform to be certified by one or more of the major U.S. mobile network operators. In addition to multiple JACS tablet platforms that are AT&T, T-Mobile, and/or Verizon certified, the JACS TD191 4G LTE USB Dongle (AT&T and T-Mobile) and TD0301 4G LTE mobile hotspot (T-Mobile) have long been certified to offer connectivity solutions for IoT devices and applications in healthcare, transportation, manufacturing, education, public sector, and other vertical markets that rely on secure, reliable, and cost-effective mobile communication.
The TT1001 Android tablet is built with a semi-rugged design to withstand heavy use and environmental hazards that may compromise performance in enterprise and industrial IoT use cases. The fully customizable platform features an LCD panel which adjusts for brightness even in direct sunlight, front and rear facing cameras, support of multiple GPS standards necessary in fleet and asset tracking applications, and Bluetooth® connectivity for easy pairing with third party devices.
View original content to download multimedia:
SOURCE JACS Solutions | https://www.wibw.com/prnewswire/2022/08/19/jacs-solutions-tt1001-10-4g-lte-android-platform-certified-use-top-three-us-cellular-carrier-networks/ | 2022-08-19T16:10:46Z |
Highly Versatile PACT^NV™ Non-Viral Gene Editing Platform Demonstrates Ability to Knock-Out, Knock-Down, Knock-In and Precisely Regulate Target Genes in Single Step
Technology Has Potential to Expand the Applicability of T Cell-Based Therapeutics and Other Cellular Therapies
SOUTH SAN FRANCISCO, Calif., May 16, 2022 /PRNewswire/ -- PACT Pharma, Inc., a clinical-stage company developing transformational personalized neoantigen-specific T cell receptor (neoTCR) T cell therapies for the eradication of solid tumors, today announced that new data on PACT^NV™, the company's non-viral precision gene editing technology, were highlighted in a poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting. Presented findings demonstrated the potential of the PACT^NV technology to enhance the functionality and applicability of T cell-based therapeutics, as well as other cellular therapies, through targeted gene editing. Specifically, researchers showed the ability of the versatile platform to knock-out, knock-down, knock-in and precisely regulate target genes in a single step to achieve desired activity for its neoTCR T cells. The ASGCT conference is being held May 16-19, 2022, in Washington, D.C.
The poster presentation reported research findings by PACT scientists demonstrating the ability to utilize the company's PACT^NV technology to generate TCR T cells in a single step. In creating these novel patient-specific neoTCR T cells, PACT highlighted the following capabilities of its gene editing platform:
- Insertion and expression of neoTCRs within T cells.
- Simultaneous elimination of the expression of the endogenous TCRs within same T cells.
- Knock-out of the transforming growth factor beta (TGF-β) receptor type 2 (TGFBR2) gene, generating a T cell that can both recognize a patient-specific tumor and is resistant to the immunosuppressive signaling by TGF-β.
- shRNA driven knock-down of multiple additional genes without any associated double-stranded break, generating enhanced T cells that can both recognize a patient-specific tumor and, depending on the targeted transcript, possess resistance to immunosuppression, increased persistence, and/or improved functional avidity.
- Development of T cell activation-induced promoters for conditional expression of payloads.
"Taken together, the powerful gene editing capabilities possessed by our PACT^NV platform offer the potential to expand the applicability of T cell therapeutics, while extending the potential use of the technology to other cellular therapies," said Stefanie Mandl, Ph.D., senior vice president, head of research at PACT Pharma. "We are particularly excited about the versatility to add, eliminate and/or precisely modulate multiple genes within our neoTCR T cells to create novel, personalized therapeutic candidates with the potential to address a range of solid tumors. We look forward to continuing our research and development efforts in support of our PACT^NV technology, while continuing our ongoing Phase 1 clinical trial of non-viral PACT^NV™ gene-edited autologous neoTCR T cells in advanced and metastatic solid tumors."
PACT is currently conducting a Phase 1 clinical trial evaluating the safety, tolerability and feasibility of adoptive cell therapy with its non-viral PACT^NV gene-edited autologous neoTCR T cells in advanced and metastatic solid tumors. This trial, in combination with extensive preclinical studies, has provided the company with unique data sets and insights derived from the core technologies that comprise its personalized adoptive T cell therapy platform for the treatment of solid tumors.
A copy of the poster presented at the ASGCT conference is available on the "Events" page of the PACT Pharma website at: https://www.pactpharma.com/news/?filter=events.
About PACT Pharma, Inc.
PACT is a clinical-stage biopharmaceutical company pioneering individualized, non-viral precision genome engineered, tumor-specific T cell therapies for the treatment of patients with solid cancers. PACT is now enrolling patients in its first-in-human Phase 1 clinical trial.
Each person's cancer emerges with a private signature of mutations. PACT identifies these cancer mutation targets (neoantigens) for each person, biochemically verifies and captures T cells from their blood and uses its proprietary, non-viral precision genome engineering technologies to manufacture a personalized immune cell therapy product for each person with cancer.
For more information, please visit www.pactpharma.com.
Contacts:
PACT Pharma
Atulya Agarwal
atulya@pactpharma.com
Vida Strategic Partners (on behalf of PACT Pharma)
Tim Brons (Media)
415-675-7402
tbrons@vidasp.com
View original content to download multimedia:
SOURCE PACT Pharma | https://www.wibw.com/prnewswire/2022/05/16/pact-pharma-highlights-capabilities-versatility-novel-non-viral-gene-editing-technology-presentation-american-society-gene-amp-cell-therapy-asgct-25th-annual-meeting/ | 2022-05-16T11:41:06Z |
Leading Swimming Pool Service Franchise Expands into New Communities Throughout Texas, Florida, New York, New Jersey and the Midwest
MACON, Ga., Sept. 8, 2022 /PRNewswire/ -- America's Swimming Pool Company (ASP), the nation's leading swimming pool service franchise, is expanding rapidly throughout the country, opening 10 new locations in the first half of 2022. This growth includes the brand's first-ever territory in Michigan and a second in New York, as well as new franchises in key states such as Texas, Florida, New Jersey and Missouri. Each location provides swimming pool maintenance, repair, remodeling and cleaning programs to its respective cities and surrounding communities.
ASP openings in the first half of 2022 include the following:
Texas
- ASP of Central Texas is owned and operated by Michael Blackburn and serves Temple and the surrounding area.
- ASP of East Fort Worth is owned and operated by Niyi Uthman and is serving the eastern area of Fort Worth.
- ASP of West Fort Worth is owned and operated by Jeff Jerousek and serves the western area of Fort Worth. Jerousek is also planning to open an ASP retail location in 2023.
- ASP of Flower Mound is owned and operated by Nick Makhani and is serving Flower Mound and the surrounding area. This is the third ASP franchise purchase for Makhani, who opened ASP of McKinney in fall 2019 and recently acquired the ASP of Dallas franchise.
Florida
- ASP of Lakeland is owned and operated by Tom and Danelle Geraci and is serving Lakeland and the surrounding area.
- ASP of Wesley Chapel is owned and operated by Joey Wilkinson and serves Wesley Chapel and the surrounding area.
New York
- ASP of Dutchess County is owned and operated by Lazare Pouani and is serving Dutchess County and the surrounding area. This is the second ASP to open in New York.
New Jersey
- ASP of Northeast Jersey Shore is owned and operated by Steve Fischetti and is serving the northeastern area of the New Jersey shore. This is the second ASP franchise purchase for Fischetti, who opened ASP of Monmouth County in spring 2021.
Midwest
- ASP of Innsbrook is owned and operated by Dustin Loeffler and is serving Innsbrook, Missouri, and the surrounding area.
- ASP of Troy is owned and operated by Dave and Danielle Boddington and is serving Troy, Michigan, and the surrounding area. This is the first location for ASP in Michigan.
"It has been a very successful 2022 summer season, but our momentum started even earlier in the year with these fantastic new franchise owners joining the ASP family," said Stewart Vernon, COO and founder of America's Swimming Pool Company. "We are thrilled to be expanding in the Midwest and doing business in Michigan for the first time, as well as continued growth in established states like Texas and Florida. It's a testament to the strength of the pool care industry and the ASP business model that continues to attract top-notch talent to seize the opportunities in their markets."
Since its inception in 2002, ASP has continued to set a higher standard of performance and stability within the industry. The company has since cemented itself as the largest and most trusted swimming pool service in the country, with over 382 franchise locations sprawling across 23 states. Swimming pool owners nationwide trust ASP for its affordable, reliable and knowledgeable service—including maintenance, inspections, repairs and renovations.
ASP is currently looking for qualified individuals who are ready to dive into a successful swimming pool service franchise opportunity. The company has regularly been featured as a best franchise to buy and publicly recognized for its leadership, performance, and growth. Franchise opportunities are available in markets throughout the United States. For more information and to find an open ASP market by state, visit aspfranchising.com/available-territories or call (800) 734-7886.
ASP is the largest swimming pool cleaning, repair, and renovation franchise system in the nation. Founded in 2002 by Stewart C. Vernon, the company is based on the belief that by providing a higher quality pool service at a reasonable price, the brand would raise the industry standards for pool service. In 2005, ASP began franchising and now covers 23 states across the nation. For more information on ASP's swimming pool franchise opportunities, click here. For more information on ASP - America's Swimming Pool Company, visit the website or find us on Facebook @asppoolco.
Headquartered in Columbia, Maryland, Authority Brands' companies include 12 leading home service franchisors: America's Swimming Pool Company, Benjamin Franklin Plumbing, The Cleaning Authority, Color World Housepainting, DoodyCalls, Homewatch CareGivers, Mister Sparky, Monster Tree Service, Mosquito Squad, One Hour Heating & Air Conditioning, STOP Restoration, and Woofie's. Together, these brands provide home services through more than 1,900 territories operated by more than 1,000 franchise owners. Authority Brands is dedicated to supporting individual franchise owner growth by providing strong marketing, technology, and operational support. See www.authoritybrands.com for more information.
CONTACT:
Stephanie Fritz
478-254-4495 EXT. 113 (Office)
478-320-1284 (Cell)
sfritz@asppoolco.com
View original content to download multimedia:
SOURCE America’s Swimming Pool Company | https://www.kxii.com/prnewswire/2022/09/08/americas-swimming-pool-company-continues-nationwide-growth-with-opening-10-new-locations-including-first-michigan/ | 2022-09-08T15:13:55Z |
NEW YORK, June 13, 2022 /PRNewswire/ -- Attention Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings ("Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings") (NYSE: BKKT) shareholders:
The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Bakkt securities between March 31, 2021 and November 19, 2021, both dates inclusive; and/or (b) Bakkt Class A common stock pursuant and/or traceable to documents issued in connection with the business combination between the Company and Bakkt Holdings, LLC completed on or about October 15, 2021.
If you suffered a loss on your investment in Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings, contact us about potential recovery by using the link below. There is no cost or obligation to you.
ABOUT THE ACTION: The class action against Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) the Company had defective financial controls; (ii) as a result, there were errors in the Company's financial statements related to the misclassification of certain shares issued prior to the business combination between the Company and Bakkt Holdings, LLC; (iii) accordingly, the Company would need to restate certain of its financial statements; (iv) the Company downplayed the true scope and severity of these issues; (v) the Company overstated its remediation of its defective financial controls; and (vi) as a result, the documents issued in connection with the business combination and defendants' public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.
DEADLINE: June 20, 2022
Aggrieved Bakkt Holdings, Inc. f/k/a VPC Impact Acquisition Holdings investors only have until June 20, 2022 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: vw@wongesq.com
View original content:
SOURCE The Law Offices of Vincent Wong | https://www.mysuncoast.com/prnewswire/2022/06/13/class-action-alert-law-offices-vincent-wong-remind-bakkt-holdings-inc-fka-vpc-impact-acquisition-holdings-investors-lead-plaintiff-deadline-june-20-2022/ | 2022-06-13T11:30:13Z |
WASHINGTON, June 2, 2022 /PRNewswire/ -- Heather Reams, president of Citizens for Responsible Energy Solutions (CRES), today released the following statement in response to the announcement of the first of the Energy, Climate, and Conservation Task Force's six part policy agenda:
"Since its inception, House Republican Leader Kevin McCarthy's Energy, Climate, and Conservation Task Force, under the leadership of Rep. Garret Graves, has brought a needed conservative perspective and voice to America's clean energy and environmental policy. The release of the Task Force's six-part policy strategy underscores what is fundamental to conservative principles— invest in America, unlock American resources, lower costs for American families, enhance our national security, and reduce global emissions.
"While the Biden administration continues to stand in the way of domestic production, Americans are left with high prices at the gas pump and supermarket. And because these commodities are being produced in less carbon efficient nations, global emissions go up. Decreasing our nation's dependence on Russia and China and investing in U.S. innovation are the building blocks to a better America. It's time we cut away the Washington red tape that stifles American growth, hurts American families, and increases global emissions. The policies put forth by the Republican Climate Task Force aim to do just that."
CRES Forum's white paper series "Understanding the Facts"—which examines solutions to America's most critical energy and environment issues—aligns with many policy proposals included in the Task Force's climate agenda.
Citizens for Responsible Energy Solutions (CRES) engages Republican policymakers and the public about responsible, conservative solutions to address our nation's energy, economic, and environmental security while increasing America's competitive edge. For more information, visit https://cresenergy.com.
View original content to download multimedia:
SOURCE Citizens for Responsible Energy Solutions | https://www.wibw.com/prnewswire/2022/06/02/cres-statement-announcement-energy-climate-conservation-task-forces-climate-agenda/ | 2022-06-02T23:59:51Z |
ST. LOUIS, Aug. 17, 2022 /PRNewswire/ -- Saint Louis University announced today that it has exceeded its $500 million goal for Accelerating Excellence: The Campaign for Saint Louis University. Thanks to extraordinary support from its donors, who include University trustees, alumni, parents, faculty, staff, foundations and corporations, the comprehensive campaign has raised a total of $604 million.
Gifts to the campaign--the most ambitious fundraising effort in the University's 203-year history--supported SLU's strategic priorities of academic excellence, scholarships, health sciences, athletics and business education.
"This is a historic achievement for Saint Louis University," said SLU President Fred P. Pestello, Ph.D. "The Accelerating Excellence campaign has built momentum for our mission-driven work and created new possibilities for groundbreaking initiatives in academics, medicine, research, athletics and service. The generosity of our donors will fuel an exciting, transformative future for SLU."
Led by University trustees and co-chairs Dr. Richard A. Chaifetz (A&S '75) and Rex A. Sinquefield (CSB '67), Accelerating Excellence launched its public phase in late 2018. Since then, the University has experienced four record-breaking fundraising years, the largest being the just-completed fiscal year 2022, in which SLU raised more than $139 million. It is followed by $119 million raised in fiscal year 2019, $98 million in fiscal year 2018 and $71 million in fiscal year 2021. Over the course of the campaign, which concluded on June 30, 2022, the University has received 98 gifts and pledges of $1 million or more.
Accelerating Excellence was designed to enable the realization of University leadership's vision for SLU: To be a global Jesuit university - one that is mission-focused, student- and patient-centered, and research-driven, working with the people of St. Louis to reimagine, transform and unify our city. Millions of dollars raised through the campaign have already been invested in every school and college at the University, providing greater resources, state-of-the-art facilities and more opportunities for SLU students, faculty and researchers. To date, Accelerating Excellence has:
- Created 416 new need- and merit-based scholarships and awards
- Enabled considerable investment in faculty recruitment, retention and development, including the creation of 36 newly endowed academic positions: 10 professorships, 7 chairs, 2 deanships, 7 lectureships and 10 fellowships
- Established 29 new research funds
- Created 19 new centers and institutes, 11 of which are research-related
Notable developments made possible by the campaign include:
- The launch of The Saint Louis University Research Institute, a focal point for growing SLU's research capabilities and increasing research output that was created by a historic gift from Dr. Jeanne and Rex Sinquefield
- The naming of The Richard A. Chaifetz School of Business, in honor of gifts made by Dr. Richard and Jill Chaifetz
- The naming of the Trudy Busch Valentine School of Nursing, in recognition of philanthropic support from University trustee and alumna Trudy Busch Valentine (Nurs '80)
- The creation of a $10 million endowment for Humanities education
- The establishment of The Taylor Geospatial Institute, a collaboration of eight research institutions focused on innovation in geospatial science and technology, supported by a legacy investment from Andrew C. Taylor
- The building of the Jesuit Center, a new residential facility and apostolic center on the University's north campus that supports SLU's community of Jesuit priests
- The under-construction O'Loughlin Family Champions Center, a 25,000-square-foot facility that will provide comprehensive interdisciplinary services to SLU's student-athletes and coaching staff
"The goal of this campaign was a bold one," said Vice President for Development Sheila Manion. "We asked our community to reach higher with us to strengthen SLU for decades to come, and our donors stepped up to support the University like never before. We are grateful for their enthusiastic participation and excited for the remarkable future their generosity enables. Any breakthroughs made possible by research funded by this campaign, any scholarships given to outstanding students who go forth to serve others, not only elevate SLU, they elevate the community. Every donor to the campaign shares in those successes."
Founded in 1818, Saint Louis University is one of the nation's oldest and most prestigious Catholic institutions. Rooted in Jesuit values and its pioneering history as the first university west of the Mississippi River, SLU offers nearly 13,000 students a rigorous, transformative education of the whole person. At the core of the University's diverse community of scholars is SLU's service-focused mission, which challenges and prepares students to make the world a better, more just place. For more information, visit slu.edu.
This news release was issued on behalf of Newswise™, online resource for knowledge-based news at www.newswise.com
View original content to download multimedia:
SOURCE Saint Louis University | https://www.mysuncoast.com/prnewswire/2022/08/17/saint-louis-universitys-historic-accelerating-excellence-campaign-tops-600-million-exceeding-goal-by-more-than-100-million/ | 2022-08-17T21:21:20Z |
TAMPA, Fla., June 9, 2022 /PRNewswire/ -- Smart Meter, continues to lead the way in the remote patient monitoring (RPM) sector because of its superior cellular-enabled devices and robust data that facilitate better care management. During Men's Health Month, Smart Meter wants to remind patients and providers that high blood pressure and obesity, which can lead to cardiovascular disease (CVD), can be controlled, but must be measured on a regular basis to spot trends and make diet and lifestyle adjustments.
Heart disease is the number one cause of death among American men1. Providing at-risk patients with an easy way to track their blood pressure and weight at home is the key to spotting concerning trends early. Smart Meter can provide the technology needed to help improve outcomes.
According to American Heart Association research2, "real-time monitoring programs can reduce systolic blood pressure (SBP) and diastolic blood pressure (DBP) significantly, compared to traditional self-monitoring. This can lower the incidence of hypertension-related acute events, cutting costs of hospital stays and ER visits."
With Smart Meter's cellular-enabled iBloodPressure® and iScale®, the measurement is sent immediately to the patient's provider with no extra steps required by the patient. One barrier to more equitable health care for minorities is the fact that many of today's at-home medical devices rely on Bluetooth® technology, requiring a smartphone and a wireless internet connection.
Recent research from the PEW Institute3 found minorities are almost 20 percent less likely to have access to broadband internet. The iBloodPressure and iScale from Smart Meter have proprietary cellular technology that utilizes the fast and secure 4/5G AT&T IoT network for reliable transmissions every time.
"The ability to track key factors that can lead to heart disease is now even easier than ever with the iBloodPressure and iScale", said Casey Pittock, Smart Meter's CEO. "Our cellular technology means that the patient isn't required to do anything after they test. We have seen firsthand the positive impact on patient outcomes when our iBloodPressure monitor and iScale is used in a remote patient monitoring (RPM) program."
Now serving more than 100,000 patients, Smart Meter is the leading supplier of cellular-enabled virtual care technologies that include the iGlucose®, iBloodPressure®, iPulseOx®, iScale®, and SmartRPMTM cloud platform, as well as data, and services. Smart Meter's remote patient monitoring solutions are recognized as the standard for the RPM industry and are regarded for their high patient retention and satisfaction. The unique combination of reliable health data, patient-friendly devices, and platform integrations enable and enhance RPM, CCM, Employee Wellness, Population Health, and Telehealth programs for more than 300 RPM distribution partners across the United States. For more information, visit SmartMeterRPM.com
1 Men and Heart Disease | cdc.gov
2remote-patient-monitoring-guidance-2019.pdf (heart.org)
View original content to download multimedia:
SOURCE Smart Meter, LLC | https://www.mysuncoast.com/prnewswire/2022/06/09/almost-1-every-4-adult-male-deaths-united-states-is-caused-by-heart-disease-african-american-men-account-100000-more-cardiovascular-disease-deaths-than-caucasian-men/ | 2022-06-09T18:42:53Z |
US inflation might have dipped last month from 40-year high
WASHINGTON (AP) — After a year of soaring prices for gas, food and other necessities, inflation may have eased slightly in April from a 40-year high, the first slowdown after seven consecutive months of worsening price increases.
The government is expected to report Wednesday that consumer prices jumped 8.1% last month compared with a year earlier, according to a survey of economists by data provider FactSet. That would be down from the 8.5% year-over-year surge in March, the highest since 1981.
The forecasted drop in annual inflation, if it occurs, would add to other signs that consumer inflation may finally be peaking. Month-to-month price increases are also easing, along with some other inflation gauges.
Yet the April rate would still mark the second-highest inflation in four decades and an ongoing burden for families, especially lower-income Americans. And it would be only a modest step in a likely long and arduous road back to the mild 2% inflation that the Fed has set as its target level. Many economists expect annual price increases to settle into a 5% to 6% range by year’s end, a historically high level that will probably exceed average wage gains.
“It’s too early to declare victory,” said Jose Torres, senior economist at Interactive Brokers. “It’s not going to get any worse, but it’s still at an uncomfortably high level.”
Beyond the financial strain for households, inflation is posing a serious political problem for President Joe Biden and congressional Democrats in the midterm election season, with Republicans arguing that Biden’s $1.9 trillion financial support package last March overheated the economy by flooding it with stimulus checks, enhanced unemployment aid and child tax credit payments.
Biden sought to take the initiative Tuesday and declared inflation “the No. 1 problem facing families today” and “my top domestic priority.”
Biden blamed chronic supply chain snarls related to the swift economic rebound from the pandemic, as well as Russia’s invasion of Ukraine, for igniting inflation. He said his administration will help ease price increases by shrinking the government’s budget deficit and by fostering competition in industries, like meatpacking, that are dominated by a few industry giants.
Still, new disruptions overseas or other unforeseen problems could always send U.S. inflation back up to new highs. If the European Union decides, for example, to cut off Russian oil, gas prices in the United States would likely accelerate. China’s COVID lockdowns are worsening supply problems and hurting growth in the world’s second-biggest economy.
Earlier signs that U.S. inflation might be peaking didn’t last. Price increases decelerated last August and September, suggesting at the time that higher inflation might be temporary, as many economists — and officials at the Federal Reserve — had suggested. But prices shot up again in October, prompting Fed Chair Jerome Powell to start shifting policy toward higher rates.
This time, though, several factors are pointing to an inflation peak. Gas costs, which soared in March after Russia’s invasion of Ukraine, fell on average in April and likely slowed inflation. Used car prices are also expected to have dropped last month. Automakers’ supply chains have unraveled a bit, and new car sales have risen.
Another factor will be how sharp price increases from a year ago affect the new inflation calculations. The prices of many goods spiked last spring as the economy reopened and a surge in demand overwhelmed supplies. But this year, monthly price increases for many goods have been slowing. That may have effect of easing the year-over-year inflation rate.
Furniture costs, for example, had jumped 1.8% just in March 2021 and 2.1% the next month. Yet this March, furniture rose only 0.6%, potentially lowering year-over-year inflation.
Excluding the especially volatile food and energy categories, economists have forecast that so-called core prices jumped 6% in the 12 months ending in April, down from 6.4% in March. That would be the first such slowdown since August. Overall inflation is also expected to have slowed from March to April.
While food and energy have endured some the worst price spikes of the past year, analysts often monitor the core figure to get a sense of underlying inflation. Core inflation also typically rises more slowly than the overall price increases but can also take longer to decline. Rents, for example, are rising at a historically fast pace, and there is little sign of that trend reversing anytime soon.
The unexpected persistence of high inflation has caused the Fed to embark on what may become its fastest series of interest rate increases in 33 years. Last week, the Fed raised its benchmark short-term rate by a half-point, its steepest increase in two decades. And Powell signaled that more such sharp rate hikes are coming.
The Powell Fed is seeking to pull off the notoriously difficult — and risky — task of cooling the economy enough to slow inflation without causing a recession. Economists say such an outcome is possible but unlikely with inflation this high.
In the meantime, by some measures Americans’ wages are rising at the fastest pace in 20 years. Their higher pay enables more people to at least partly keep up with higher prices. But employers typically respond by charging customers more to cover their higher labor costs, which, in turn, heightens inflationary pressures.
Last Friday’s jobs report for April included data on hourly pay that suggested that wage gains were slowing, which, if it continues, could help ease inflation this year.
Copyright 2022 The Associated Press. All rights reserved. | https://www.kxii.com/2022/05/11/us-inflation-might-have-dipped-last-month-40-year-high/ | 2022-05-11T10:55:14Z |
Senate passes DeSantis redistricting plan
TALLAHASSEE, Fla. (News Service of Florida) - Over the objections of Democrats who contend Republicans are being “bullied” by Gov. Ron DeSantis, the Senate on Wednesday approved a congressional redistricting plan that would favor the GOP.
The 24-15 party-line vote set the stage for final passage Thursday in the House. The most-controversial parts of the plan (SB 2-C), which DeSantis proposed, would diminish the chances of electing Black Democrats in districts in North and Central Florida.
Senate Reapportionment Chairman Ray Rodrigues, R-Estero, defended a decision by legislative leaders to take up the governor’s proposal, rather than allow an impasse that could result in new lines being drawn by a court. DeSantis called a special legislative session that started Tuesday.
“I’ve heard a number of objections that have said the Legislature is abdicating its responsibility by allowing the governor to have this role in redistricting,” Rodrigues said. “I disagree with that. We would abdicate our responsibility if we failed to pass a map and allow the courts to do it.”
Rodrigues maintained the map is a “compromise,” with the governor’s plan incorporating Senate proposals for districts in South Florida.
Overall, the governor’s plan is expected to increase the number of Republican-held congressional seats in the state from 16 to 20, based on 2020 voting patterns. It is almost certain to quickly face legal challenges, which likely won’t be resolved until after the 2022 elections.
Questioning a “racial” intent of the governor’s map, Democrats said it would violate the federal Voting Rights Act and what are known as the Fair Districts amendments in the Florida Constitution. Voters approved the Fair Districts amendments in 2010, at least in part to try to prevent gerrymandering.
“Looking at this map, one cannot even say that it works to respect geographical boundaries,” Sen. Janet Cruz, D-Tampa, said. “Sections of the Pinellas (County) portion of the map appear to cut neighborhoods in half. And, in one instance, even appears to cut a building in half.”
Sen. Randolph Bracy, an Ocoee Democrat who has made plans to run for Congress this year, warned that “bullying” by DeSantis that resulted in the special session “will get worse.”
“He will continue to threaten to primary endorsed candidates from the leadership of this (Senate) chamber,” Bracy said. “If you think that he’s going to endorse anybody’s candidacy because we’re doing his bidding, it’s not going to happen. It’s going to be something else. ‘OK, let’s see how you do in the next special session? Oh, well, let me just wait and see ‘til qualifying in June.’ That’s how they work. And you’re going to continue to play this game with him.”
When Senate President Wilton Simpson, R-Trilby, advised Bracy to “stay on the content of the bill and not the governor,” Bracy replied, “I think I made my point.”
DeSantis called the special session after vetoing a congressional redistricting plan passed by the Legislature last month.
DeSantis contended the Legislature’s plan violated the Equal Protection Clause of the U.S. Constitution, in part because of a sprawling North Florida district. DeSantis’s plan would redraw District 5, which now runs from Jacksonville to west of Tallahassee, to become a more-compact district in the Jacksonville area. The seat is currently held by U.S. Rep. Al Lawson, a Black Democrat.
Upcoming legal battles are anticipated to include debate about the Fair Districts amendments and how the U.S. Supreme Court has interpreted the Voting Rights Act.
The current configuration of District 5 emerged after a court fight about lines drawn in 2012. Rodrigues said the governor’s office determined that District 5 cannot be drawn as a majority-minority district with a Black voting-age population of greater than 50 percent in any configuration.
“It was also their position that it never should have been drawn that way in the first place by the previous court,” Rodrigues said. “And so, therefore, there’s no obligation to redraw it in the current manner that it exists.”
Sen. Loranne Ausley, D-Tallahassee, said the governor’s effort is intended to limit minority access in North Florida in the guise of “compactness.”
“While this body has not provided us with partisan performance data, the publicly available data shows that in the current version of the 5th District, this cohesive community of Black urban and rural voters makes up a Democratic primary that is 70 percent Black,” Ausley said. “In fact, all of the counties in this district but one are majority Black in the Democratic primary, allowing the historic African-American community of North Florida to elect the candidate of their choice.”
DeSantis’ plan also would make significant changes in Central Florida’s District 10, which has been held by U.S. Rep. Val Demings, a Black Democrat who is running for U.S. Senate.
Rodrigues said the governor’s office backed a House position that the Central Florida district was no longer a protected minority-opportunity district because the Black voting share of Democratic primary turnout had fallen below 50 percent during the past decade.
Sen. Kelli Stargel, R-Lakeland, called the governor’s proposed lines “constitutional” and “thoughtful.”
“I don’t think any of us who vote for them today are racists or following the direct will of the governor,” Stargel said. “We’re doing our constitutional requirement of drawing maps, submitting maps, discussing maps, working together with our branches of government and making sure we have a constitutional map.”
The Republican-dominated House took up DeSantis’ plan Wednesday and rejected two amendments proposed by Democrats. As an example, Minority Leader Evan Jenne, D-Dania Beach, proposed using lines the Senate initially put together during the regular legislative session.
“This amendment complies with the Florida (Constitution) and the federal Constitution,” Rep. Joe Geller, D-Aventura, said. “This amendment does not fly in the face of them.
Copyright 2022 WWSB. All rights reserved. | https://www.mysuncoast.com/2022/04/20/senate-passes-desantis-redistricting-plan/ | 2022-04-22T04:23:18Z |
The people believed to be affiliated with White nationalist group Patriot Front arrested in Idaho over the weekend appear to have been well-prepared with detailed plans and protective gear to "antagonize and cause disorder" at the Coeur d'Alene Pride event on Saturday, according to a new court filing.
Among the items seized in the arrests of 31 men who piled into a U-Haul box truck, were documents taken from the group leader, Thomas Rousseau, outlining the hate group's moral intentions, and an operational plan, as detailed in an affidavit of probable cause filed Monday in Kootenai County District Court.
"(One) document was typed and discussed the group being there to raise a voice against the moral depravity which permits events such as this to take place," writes Coeur d'Alene Police Officer Alan Gilbert. "There was also a typed organizational document outlining call locations, primary checkpoints, drill times, prep times and observation windows. There were also GPS coordinates for a drop point with two backup plans."
According to Gilbert's probable cause declaration, the group's plan was intended to "antagonize and cause disorder" and outlines an exit strategy to be implemented "once an appropriate amount of time and confrontational dynamic has been established."
Only two men questioned by police openly admitted to being part of the Patriot Front, an officer stated.
Items taken into evidence from the box truck and one other vehicle believed to be associated with the group included "fashioned metal shields, flags on abnormally long metal poles and voice amplification type devices," according to the affidavit. A smoke bomb/grenade was also recovered.
In addition to being dressed similarly in khaki cargo pants, navy blue T-shirts adorned with Patriot Front patches, and face masks, hats, and sunglasses, several of the men tucked "a hard plastic type insert, inside the hat, similar to a hard hat worn by constructions workers," the declaration states. Several men wore plastic shin guards and other protective gear and others carried tactical medical kits, radios, and cameras and digital recording devices on their persons.
"The adorned equipment was similar in nature to our law enforcement riot control equipment utilized when we are anticipating a physical altercation," Gilbert writes in the court document.
CNN has reached out to the Patriot Front and people believed to be associated with Rousseau but has not heard back. CNN has also not been able to identify legal representation for Rousseau at this time.
The men were released after posting bail, online court records and inmate rosters show, and are due back in court at a later date. Most are from out of state, including Rousseau, who is from Texas, according to the affidavit.
His next court date has been scheduled for August 1, according to online court records.
Group split from another after Charlottesville rally
The Patriot Front believes their White ancestors conquered America and "bequeathed it to them," according to the Anti-Defamation League. Members espouse fascist and anti-Semitic beliefs, which they spread through propaganda campaigns, the ADL says.
The Texas-based group was formed following the deadly 2017 Unite the Right rally in Charlottesville, Virginia, when members of the White supremacist group, Vanguard America, split off to form their own organization, the ADL says.
The 31 men were arrested after someone saw them gathering near a Pride parade and called 911 to report a group dressed like a "little army" getting into a moving truck.
The group was headed to a Pride in the Park event at Coeur d'Alene City Park, police have said. The event included a Pride walk and performances by local musicians, dancers and drag artists.
Local and state police were plentiful and on high alert Saturday because they wanted "to make sure this event went off safely," Mayor Jim Hammond told CNN's New Day on Monday.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://www.albanyherald.com/news/group-allegedly-affiliated-with-patriot-front-had-protective-gear-detailed-operational-plans-police-say/article_360aef43-3122-5e99-a170-878e8e368c5c.html | 2022-06-15T04:47:16Z |
NEW YORK, June 13, 2022 /PRNewswire/ -- Against the backdrop of rising inflation and global supply chain disruptions due to the ongoing spread of the COVID-19 pandemic and geopolitical tensions, Jerry Wang, founder and CEO of Haitou Global, recently participated in a seminar held by The Chinese Finance Association (TCFA), focusing on the outlook of global economy and investment opportunities in both developed and emerging markets.
At the event, Jerry, together with three other speakers, discussed the potential impact of rising inflation and the Fed's rate hike on the global economy and capital markets. Jerry also shared his insights on the current US stock market and how to manage investment portfolios under the current situations.
Speaking about the impact of the surging inflation in the US, Jerry said that an inflation rate higher than 8% is something to worry about and while the high inflation in the US may last for some time, the probability of a hyperinflation is small. Indeed, rising prices have caused some pain to American companies and individuals, but consumers' demand is still robust thanks in part to the increase of households' financial assets and the government's relief policies during the pandemic, according to Jerry.
While the Federal Reserve is working very hard to bring inflation back to normal, he noted that there is no need for investors to panic, because inflation and monetary policy may not be the sole causes of the recent turmoil in the US stock market.
Asked about investing strategies amid various challenges faced by the world today, Jerry said that one of the most important things is to balance and diversify your portfolio, while avoiding aggressive adjustments.
In the case of Haitou Global, the strategy is global asset allocation covering both traditional assets like stocks and bonds, and alternative assets such as venture capital and private equity. As an emerging asset class, digital assets are also becoming plausible options, he said.
Geographically, Haitou Global invests not just in the US, but also in emerging markets including Asia, Africa and Latin America. Given that the US is the largest economy in the world, it still accounts for a significant part in the company's portfolio, though emerging markets are also indispensible from the perspective of diversification.
What's more, a lot of opportunities are being seen in emerging markets as there are still many favorable factors in these markets such as demographic dividend and technology upgrade, according to Jerry who added that different economic realities in different markets have encouraged Haitou Global to target multiple regions instead of just one single region.
In regard to Haitou Global's reponse to the pandemic, Jerry said that the company has stuck to its long-term allocation principle focusing on balancing and diversification. As the US stock market continues to fluctuate, he said it would be wise to avoid heavy holdings and pay attention to hedging. But some of the tech stocks do look attractive at this point as their prices have retreated to the pre-pandemic level, he added.
View original content:
SOURCE HaitouGlobal | https://www.wibw.com/prnewswire/2022/06/13/haitou-global-participates-tcfa-seminar-outlook-global-economy/ | 2022-06-13T12:44:28Z |
JAKARTA, Indonesia, June 2, 2022 /PRNewswire/ -- Super, a leading Indonesian social commerce platform serving tier-2 and tier-3 cities and Indonesian rural areas, announced that it completed a US$70 million oversubscribed Series C round led by NEA with additional investment from Insignia Ventures Partners, SoftBank Ventures Asia, DST Global Partners, Amasia, B Capital, TNB Aura, the Chairman of Bain Capital Stephen Pagliuca, the Former General Partner of Kleiner Perkins Eric Feng's Goldhouse, and Xendit CEO Moses Lo. The start-up has raised US$106 million to date, making Super the most funded Indonesian social commerce company to date.
"Indonesia's tier-2, tier-3 cities, and rural area's GDP per capita are 3-5 times lower than Jakarta, yet the cost of consumer goods is higher by 20-200%. In fact, more than 30% of Indonesia's GDP came from East Java, Kalimantan, and East Indonesia. Super is going after a huge untapped market; thus, we will deploy this investment to enable equitable access for people in Kalimantan, Bali, West Nusa Tenggara, East Nusa Tenggara, Maluku, and Papua over the next few years. We will help more multinational, and provincial FMCG suppliers tap into new markets in rural areas and empower more community leaders to optimize their income and have a better quality of life," said Steven Wongsoredjo, CEO and Co-Founder of Super.
Founded in 2018, Super leverages a hyperlocal logistics platform to deliver consumer goods to thousands of agents within 24 hours of the order time. Super partners with thousands of community agents such as individuals and warungs to aggregate and distribute millions of US dollars' worth of goods to their communities each month. Super currently operates across 30 cities in East Java and South Sulawesi, mainly targeting the area that has a GDP per capita that is $5000 USD or lower.
"As Super is entering its 4th year in business, we understand the importance of data collection and analysis as one of the keys to success in launching new SKUs. Therefore, we are going to expand our engineering team to improve Super's warehouse management system by implementing machine learning to help Super better utilize data to expand its SKUs in the future," said Former Googler and Meta, Gisella Tjoanda, Super's Head of Strategy and Business Development.
Super has successfully launched two private-label brands that have realized product-market fit and will invest a portion of their new capital towards developing additional FMCG private-label brands in the next several years. In addition, the startup plans to use the new fund to launch cosmetics products, as the desire for this segment is rising across Indonesia. As Super grows its products, services, and experiences continuously, it will launch a feature for community agents to track end-consumer transactions to help community agents offer better-tailored experiences for the end customers.
"We are thrilled to back the whole Super team. Super is positioned to improve the lives of the 260 million Indonesians who reside outside of Indonesia's capital city. Super is going to continuously improve access to basic goods, create meaningful and rewarding jobs, and streamline supply chains for Indonesia's tier-2, tier-3, and rural regions," said NEA Partner Andrew Schoen.
Super is a leading social commerce application in Indonesia for 2nd tier, 3rd tier cities, and rural areas. Super enables community leaders to become retailers within their communities in tier 2, tier 3 cities, and rural Indonesia. Super is the first Indonesian consumer technology start-up to go through Y Combinator.
Super has earned several awards and is part of Forbes 30 under 30, World Economic Forum Global Shapers, Generation Tomorrow Tatler, and YouTube Silver Button.
Furthermore, Super has raised $106m USD to date, and is backed by prominent investors such as NEA, SoftBank, DST Global Partners, Y-Combinator Continuity Fund, B Capital, the World Bank Managing Director Mari Elka Pangestu, Jay-Z's Arrive, the owner of Boston Celtics, and top global investors.
View original content to download multimedia:
SOURCE Super | https://www.kxii.com/prnewswire/2022/06/02/nea-leads-70-m-usd-series-c-round-indonesian-social-commerce-platform-super/ | 2022-06-02T05:16:21Z |
Home management platform rapidly expanding to new markets, including Florida
MIAMI, Sept. 6, 2022 /PRNewswire/ -- Today, rental home management company Belong announced the move of its headquarters to Miami, Florida during a 'Cafecito Talk' hosted by Mayor Francis Suarez. The announcement comes amidst Belong's rapid expansion into the Florida market, highlighting Miami's appeal to start-ups and tech companies.
Belong calls itself a "residential network," and manages long-term rental homes for individuals and small real estate investors.
The network has expanded rapidly since announcing its $80M Series C funding round in May of this year and currently services metro areas in California, Washington, and Florida with plans to expand to several more through the end of 2023.
Belong CEO, Ale Resnik, emphasized the cultural fit between Miami and Belong: "Miami represents a glimpse at a possible future of the USA. One that's multicultural, more pragmatic, and less ideological. This is an ecosystem where consumer tech can blossom."
Mayor Francis Suarez at the Cafecito to welcome Belong to Miami said, "Belong's decision to set anchors in our city shows how strong the Miami Movement is. Our growing tech ecosystem will greatly benefit from having them here as they continue to provide better, innovative solutions for homeowners. I am looking forward to seeing how Belong unfolds in Miami and impacts the lives of our residents for the better."
Salomon Horowitz, Belong's general manager in Florida, says the move is good news for Miami rental owners: "Miami is one of the fastest growing rental and real estate markets in the country, so it makes sense for Belong to set up our HQ in the center of the action. We are committed to helping homeowners become financially free with no stress and excited to make that easier for Miami homeowners."
Belong has opened a hotline for homeowners who'd like to learn more about listing their rental homes. 786-786-1073 for Spanish and 786-628-0600 for English.
Backed by Andreessen Horowitz (a16z), Battery Ventures, GGV Capital, and Fifth Wall, the top technology and real estate investors in the United States, Belong is a residential network that makes owning a rental home easy and stress-free. Belong offers a one-stop-shop home management platform for homeowners so they never have to be a landlord. Instead, Belong homeowners get financial tools to manage their investment, guaranteed rent, and have their home taken care of by high-quality residents and an in-home maintenance team. Belong also enables residents to receive extraordinary service while they build towards homeownership with each on-time rent payment, helping them break the perpetual renting cycle.
https://belonghome.com/homeowners
View original content to download multimedia:
SOURCE Belong | https://www.mysuncoast.com/prnewswire/2022/09/06/belong-announces-hq-move-california-miami/ | 2022-09-06T20:35:15Z |
NEW YORK, April 14, 2022 /PRNewswire/ -- The Board of Directors of Nielsen Holdings plc (NYSE: NLSN) declared a quarterly cash dividend of $0.06 per share of Nielsen's common stock.
The dividend is payable on June 16, 2022 to shareholders of record at the close of business on June 2, 2022.
Nielsen shapes the world's media and content as a global leader in audience measurement, data and analytics. Through our understanding of people and their behaviors across all channels and platforms, we empower our clients with independent and actionable intelligence so they can connect and engage with their audiences—now and into the future.
An S&P 500 company, Nielsen (NYSE: NLSN) operates around the world in more than 55 countries. Learn more at www.nielsen.com or www.nielsen.com/investors and connect with us on social media.
Investor Relations: Sara Gubins, sara.gubins@nielsen.com
Media Relations: Connie Kim, connie.kim@nielsen.com
View original content:
SOURCE Nielsen Holdings plc | https://www.wibw.com/prnewswire/2022/04/14/nielsen-declares-quarterly-dividend/ | 2022-04-15T07:02:20Z |
UNION, N.J., June 15, 2022 /PRNewswire/ -- Bed Bath & Beyond Inc. (NASDAQ: BBBY) today announced that it will hold a conference call to discuss its fiscal 2022 first quarter financial results on Wednesday, June 29, 2022 at 8:15am EDT. The fiscal 2022 first quarter results press release and related materials, for the period ended May 28, 2022, will be issued approximately 45 minutes prior to the start of the conference call.
Bed Bath & Beyond Inc.'s fiscal 2022 first quarter conference call may be accessed by dialing 1-404-400-0571, or if international, 1-866-374-5140, and entering passcode ID number 80961020#. A live audio webcast of the conference call, along with the sales and earnings press release and supplemental financial disclosures, will also be available on the Investor Relations section of our website at http://bedbathandbeyond.gcs-web.com/investor-relations. The webcast will be available for replay after the call.
Bed Bath & Beyond Inc. and subsidiaries (the "Company") is an omnichannel retailer that makes it easy for our customers to feel at home. The Company sells a wide assortment of merchandise in the Home, Baby, Beauty and Wellness markets. Additionally, the Company is a partner in a joint venture which operates retail stores in Mexico under the name Bed Bath & Beyond.
The Company operates websites at bedbathandbeyond.com, bedbathandbeyond.ca, buybuybaby.com, buybuybaby.ca, harmondiscount.com, facevalues.com, and decorist.com.
View original content:
SOURCE Bed Bath & Beyond | https://www.mysuncoast.com/prnewswire/2022/06/15/bed-bath-amp-beyond-inc-announce-fiscal-2022-first-quarter-earnings-results-june-29-2022/ | 2022-06-15T21:25:01Z |
WHEELING, W.Va., June 2, 2022 /PRNewswire/ -- WesBanco, Inc. (Nasdaq:WSBC), a diversified, multi-state bank holding company, announces that during its Annual Meeting of Stockholders held April 20, 2022, Rosie Allen-Herring was elected to its Board of Directors. Ms. Allen-Herring brings 30 years of experience in finance, partnerships, and community involvement to the Board, and currently serves as a member of the Mid-Atlantic Advisory Board for WesBanco.
"Rosie Allen-Herring brings a significant level of expertise to our Board of Directors," said Christopher V. Criss, Chairman of the WesBanco, Inc. Board of Directors. "Having already served on our Mid-Atlantic Advisory Board, we know first-hand what type of impact she can have in her new role. I look forward to working with Rosie and seeing the positive impact of her leadership on WesBanco."
Since 2013, Ms. Allen-Herring has served as President and Chief Executive Officer of the United Way National Capital Area, Washington, D.C. She has helped to transform the non-profit into an innovative community partner and is responsible for raising approximately $245 million during her tenure there. Reflecting her incredible efforts with the United Way, she was named as a Washingtonian of the Year in 2020.
"Rosie is a highly-respected leader and member of her community," said Todd F. Clossin, President and Chief Executive Officer of WesBanco. "For more than 150 years, WesBanco has prided itself on serving our communities in order to help them succeed. Rosie's experience and success supporting the Washington, D.C. area will greatly enhance our community focus. Having known her for several years, I am thrilled to welcome Rosie to our Board of Directors and working with her to help WesBanco achieve our long-term growth strategies."
Formerly, Ms. Allen-Herring served as a Director of Old Line Bank, as well as Managing Director, Community Investment and Engagement Division for Fannie Mae, where she managed a $100 million annual budget. In addition to her role with WesBanco, she is a key leader within several organizations including the Board of Trustees at A.T. Still University, Greater Washington Partnership, and is the first African American female chair of the Greater Washington Board of Trade.
Ms. Allen-Herring holds a B.A. in Economics from Howard University and an M.B.A. (with honors) from Strayer University. She is also a graduate of the Harvard Business School Strategic Non-Profit Management Executive program, as well as a former fellow at both Duke University and the University of Cape Town.
With her wealth of experience, demonstrated leadership, and management of large organizations, as well as a background in corporate finance and equity investment, Allen-Herring is imminently qualified to serve on the WesBanco, Inc. Board of Directors.
About WesBanco, Inc.
Founded in 1870, WesBanco, Inc. (www.wesbanco.com) is a diversified and balanced financial services company that delivers large bank capabilities with a community bank feel. Our distinct long-term growth strategies are built upon unique sustainable advantages permitting us to span six states with meaningful market share. Built upon our 'Better Banking Pledge', our customer-centric service culture is focused on growing long-term relationships by pledging to serve all personal and business customer needs efficiently and effectively. Furthermore, our strong financial performance and employee focus has earned us recognition by Forbes as both one of America's Best Banks and Best Midsize Employers – the only midsize bank making the top ten of both rankings. In addition to a full range of online and mobile banking options and a full-suite of commercial products and services, WesBanco provides trust, wealth management, securities brokerage, and private banking services through our century-old Trust and Investment Services department, with approximately $5.4 billion of assets under management (as of March 31, 2022). WesBanco's banking subsidiary, WesBanco Bank, Inc., operates 205 financial centers in the states of Indiana, Kentucky, Maryland, Ohio, Pennsylvania, and West Virginia. Additionally, WesBanco operates an insurance agency, WesBanco Insurance Services, Inc., and a full service broker/dealer, WesBanco Securities, Inc.
View original content to download multimedia:
SOURCE WesBanco, Inc. | https://www.mysuncoast.com/prnewswire/2022/06/02/wesbanco-inc-elects-rosie-allen-herring-its-board-directors/ | 2022-06-02T14:30:04Z |
BRUSSELS (AP) — The European Union’s anti-trust watchdog announced on Tuesday that it is blocking the buyout of cancer-screening company GRAIL by biotech giant Illumina in a rare move by European regulators against two U.S. companies.
Illumina is a major supplier of next-generation sequencing (NGS) systems for genetic and genomic analysis, while GRAIL is a health company developing blood tests to try to catch cancer early. Illumina announced an $8 billion acquisition of GRAIL in 2020.
But the European Commission, which polices competition issues, said the buyout “would have enabled and incentivized Illumina to foreclose GRAIL’s rivals, who are dependent on Illumina’s technology, from access to an essential input they need to develop and market their own tests.”
Commission Executive Vice-President Margrethe Vestager said that “it is vital to preserve competition between early cancer detection test developers at this critical stage of development. As Illumina did not put forward remedies that would have solved our concerns, we prohibited the merger.”
The commission said it received feedback from several customers and competitors during its probe of the buyout, but Vestager declined to name any of GRAIL’s competitors whose interests might have been hurt.
The commission said market players were concerned that “Illumina would cut access to its NGS technology to GRAIL’s rivals, or otherwise disadvantage them, to gain control over the promising early cancer-detection testing market.”
Illumina said it intends to appeal the decision, which comes just days after a U.S. Federal Trade Commission judge ruled in favor of its acquisition of GRAIL.
“Illumina can make GRAIL’s life-saving multi-cancer early detection test more available, more affordable, and more accessible — saving lives and lowering healthcare costs,” said Charles Dadswell, General Counsel of Illumina.
“We continue to believe, this merger is pro-competitive and will accelerate innovation,” he said.
Vestager also said that Illumina appears to have broken EU merger rules by completing the buyout before the commission cleared the move.
“This is unheard of. Companies abide by our rules. They require them to not implement a merger before they have been notified and cleared by the commission,” she told reporters in Brussels.
Illumina’s actions, Vestager said, have created a “troublesome situation. Illumina now needs to undo the effects of its actions and unwind the acquisition.” | https://cw33.com/health/ap-health/ap-eu-blocks-merger-of-us-firms-in-cancer-screening-sector/ | 2022-09-07T01:26:34Z |
Generation Investment Management and Ascension Ventures co-led the round for Elation's primary care platform supporting practices in new payment models and more than 12.8 million patients
SAN FRANCISCO, July 26, 2022 /PRNewswire/ -- Elation Health, the clinical-first technology company powering innovation in primary care, today announced a Series D financing round of $50 million. Generation Investment Management, a firm established in 2004 to back businesses driving sustainability, co-led the round alongside Ascension Ventures with participation from Threshold Ventures, Ascend Partners, and individual investors including Fay Rotenberg and Jonathan Bush. This new round brings Elation Health to $108.5 million in venture funding to date.
Funding will be used to continue rapidly scaling Elation's market reach and platform features for high-value primary care success in all settings. In addition to being a market leader for independent primary care practices — including those taking insurance, in risk-bearing contracts, and in the direct primary care setting — Elation is the operating technology for many of the largest and fastest-growing primary care innovators such as Crossover Health, Cityblock Health, and Firefly Health.
Participant statements:
- Anthony Woolf, Growth Equity Partner at Generation Investment Management — "We believe Elation Health is powering primary care's value-based future, which needs to be more physician-managed and patient-centric and less administratively driven. We need to move away from a fee-for-service system to one where incentives align with long-term health outcomes for patients. Elation has built the leading cloud-hosted, API-enabled electronic health record system fit for the modern digital health environment. This funding round aims to accelerate what Elation offers to physicians and patients as the company continues to work with forward-thinking leaders to build a more sustainable primary care-driven healthcare system."
- John Kuelper, Senior Managing Director and head of Healthcare Technology at Ascension Ventures — "Ascension Ventures believes that independent primary care practices will continue to be a foundational component of care delivery, particularly as healthcare moves towards value-based care. Elation has demonstrated that it can enable these clinicians to operate at top-of-license by making clinical and practice management more intuitive and efficient with technology and automation. With this foundation in place, we are particularly excited by opportunities to further enable these practices to collaborate more deeply with insurers, specialists, and hospitals around value-based initiatives. Elation has the potential to make care delivery much more collaborative by empowering the primary care clinic with the information and tools needed to better coordinate complex care."
- Former athenahealth CEO and Founder Jonathan Bush, now CEO of Elation Health partner Zus Health — "athenahealth's original mission was to remove all the scut work from the practice of medicine so doctors could be doctors. Decades later, the industry still needs far better solutions to enable primary care to work best in support of clinicians doing just that and developing trusted relationships with their patients. This requires flexibility and space for listening, not checklists and a focus on CPT codes. I first met Kyna when she was automating her family's primary care practice and believe the sensibility she developed in that effort is what makes Elation such a unique technology platform. The bonus is that discerning engineers and builders love using Elation as well as clinicians. I can't wait to see what's next!"
- Kyna Fong, Ph.D., co-founder and CEO of Elation Health — "There is tremendous power in a primary care–led future. The concept of specialty-led, billing-first care from the last few decades, and the technologies that have enabled it, has delivered unsustainable costs, burnout, and declining health outcomes. We are in the midst of a major shift toward primary care returning to its leadership position, and Elation is honored to have a role in powering that change. Every patient deserves a primary care physician they can trust."
Designed from the start as a Collaborative Health Record, the Elation Health technology platform has a unified patient architecture that intuitively makes real-time shared data available to every clinician without overwhelming data noise. In 2021, the company was invited to work with the American Academy of Family Physicians (AAFP) on technology that can ease administrative burden on physicians. Elation Health has invested significantly in technology tools that make it easy for clinicians to get credit for the relationship-driven care they provide to patients. Today, millions of patients are being cared for by clinicians in value-based care arrangements using Elation.
Additionally, Elation has become the API-driven, EHR platform of choice for development teams at primary care organizations to accelerate innovative care models without creating technology systems from scratch. The platform currently supports more than a million API calls each day with connections to 300+ technology and healthcare organization collaborators including Dock Health, Hint Health, and Zus Health.
The company will continue to build for clinician delight. In an increasingly complex healthcare landscape, Elation is maintaining the highest NPS and KLAS scores while advancing primary care success across the wide variety of new practice and payment models. For more information about Elation Health's platform for primary care, visit elationhealth.com.
Elation Health is the most trusted technology platform for high-value primary care. Since 2010, the company has delivered clinical-first solutions — built on a collaborative EHR platform — that help practices start, grow, communicate, and succeed in delivering the highest-quality personalized care to patients. Elation Health supports primary care clinicians in upholding the craft of medicine, while thriving in an evolving healthcare landscape. Today, Elation Health serves 24,000 clinicians caring for millions of Americans. Learn more at elationhealth.com, LinkedIn, and Twitter
Generation Investment Management is dedicated to long-term investing, integrated sustainability research and client alignment. It is an independent, private, owner-managed partnership established in 2004 and headquartered in London, with a U.S. presence in San Francisco. Generation Investment Management LLP is authorised and regulated in the United Kingdom by the Financial Conduct Authority. In the U.S. Generation operates via Generation Investment Management US LLP, a Registered Investment Adviser with the Securities and Exchange Commission. www.generationim.com
Ascension Ventures is a strategic healthcare venture fund with more than $1 billion in capital under management. Our limited partners are some of the most respected, values-driven nonprofit healthcare systems in the U.S. As a strategic investor, Ascension Ventures adds value by sharing its portfolio companies' solutions across its limited partner base. The work we do at Ascension Ventures generates returns to our limited partners that help support their missions to provide care to the poor and vulnerable. http://www.ascensionventures.org/
View original content to download multimedia:
SOURCE Elation Health | https://www.mysuncoast.com/prnewswire/2022/07/26/elation-health-announces-50m-series-d-innovative-primary-care/ | 2022-07-26T13:22:08Z |
NEW YORK, May 3, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cano Health, Inc. f/k/a Jaws Acquisition Corp. (NYSE: CANO) (NYSE: CANO.WS) (NYSE: JWS) (NYSE: JWS.U) (NYSE: JWS WS) between May 18, 2020 and February 25, 2022, inclusive (the "Class Period"), of the important May 17, 2022 lead plaintiff deadline.
SO WHAT: If you purchased Cano Health securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Cano Health class action, go to https://rosenlegal.com/submit-form/?case_id=4271 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 17, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Cano Health overstated its due diligence efforts and expertise with respect to acquiring target businesses; (2) accordingly, Cano Health performed inadequate due diligence into whether the Company, post-Business Combination, could properly account for the timing of revenue recognition as prescribed by ASC 606, particularly with respect to Medicare risk adjustments; (3) as a result, Cano Health misstated its capitated revenue, direct patient expense, accounts receivable, net of unpaid service provider costs, and accounts payable and accrued expenses; (4) accordingly, Cano Health was at an increased risk of failing to timely file one or more of its periodic financial reports; and (5) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Cano Health class action, go to https://rosenlegal.com/submit-form/?case_id=4271 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com
View original content to download multimedia:
SOURCE Rosen Law Firm, P.A. | https://www.mysuncoast.com/prnewswire/2022/05/04/rosen-leading-law-firm-encourages-cano-health-inc-fka-jaws-acquisition-corp-investors-with-losses-secure-counsel-before-important-deadline-securities-class-action-cano-canows-jws-jwsu-jws-ws/ | 2022-05-04T03:00:57Z |
TARRYTOWN, N.Y. and PARIS, May 20, 2022 /PRNewswire/ --
Dupixent is the first and only medicine indicated to treat eosinophilic esophagitis in the United States; approval granted more than two months ahead of FDA's Priority Review action date
Dupixent 300 mg weekly significantly improved signs and symptoms of eosinophilic esophagitis compared to placebo in a Phase 3 trial, underscoring the role of type 2 inflammation in this complex disease
Eosinophilic esophagitis is a chronic, progressive inflammatory disease driven by type 2 inflammation that damages the esophagus and prevents it from working properly
Approval represents first indication for Dupixent in a gastrointestinal disease and fourth disease indicated overall
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) 300 mg weekly to treat patients with eosinophilic esophagitis (EoE) aged 12 years and older, weighing at least 40 kg. With this approval, Dupixent becomes the first and only medicine specifically indicated to treat EoE in the United States. A regulatory filing for EoE is under review by the European Medicines Agency, and submissions to regulatory authorities in additional countries are planned by the end of 2022.
"We have waited a long time for an FDA-approved treatment option for eosinophilic esophagitis – an underdiagnosed and misunderstood disease of the esophagus that can make it extremely challenging and uncomfortable to eat and swallow," said Mary Jo Strobel, Executive Director at the American Partnership for Eosinophilic Disorders (APFED). "Before today, there were no approved treatments specifically for eosinophilic esophagitis, resulting in many people needing to maintain a strict diet and live in constant fear of food getting stuck in their throat. We welcome therapeutic options that can provide much-needed relief for these patients."
EoE is a chronic inflammatory disease driven by type 2 inflammation that damages the esophagus and prevents it from working properly. For people with EoE, swallowing even small amounts of food can be a painful and worrisome choking experience. They are often left to contend with the frustration and anxiety of a constantly evolving list of foods to avoid, a poor quality of life and a higher risk of depression. In cases where EoE causes the esophagus to narrow, forced and potentially painful dilation (physical expansion) of the esophagus may be needed. In severe cases, a feeding tube may be the only option to ensure proper caloric intake and adequate nutrition. About 160,000 patients are living with EoE in the U.S. These individuals are currently treated with therapies not specifically approved for the disease, of whom approximately 48,000 continue to experience symptoms despite multiple treatments.
"It is gratifying that Dupixent, a medicine that we invented in our laboratories, is now approved in yet another disease marked by allergic or type 2 inflammation, namely eosinophilic esophagitis," said George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer at Regeneron, and a principal inventor of Dupixent. "Eosinophilic esophagitis can be debilitating for patients by inflaming and damaging the esophagus and limiting the ability to eat normally. Dupixent is the first and only medicine specifically indicated to treat eosinophilic esophagitis in the United States, and today's approval marks the fourth disease for which Dupixent is now indicated, reinforcing the promise of targeting IL-4 and IL-13 to effectively treat diseases with underlying type 2 inflammation."
"Eating regularly throughout the day is essential, yet significant difficulty swallowing food is a common symptom for people living with eosinophilic esophagitis. This can be incredibly upsetting and often leads to fear of pain or choking with every meal, every day," said John Reed, M.D., Ph.D., Global Head of Research and Development at Sanofi. "A large unmet need exists for treatment options that can provide meaningful symptom relief. Our Phase 3 clinical program showed that Dupixent weekly improved the ability to swallow and reduced inflammation in the esophagus, underscoring the role of type 2 inflammation in this complex disease. This is a landmark FDA approval for patients and their caregivers who now have a new option for treating this devastating disease."
The FDA approval is based on data from a Phase 3 trial with two parts (Part A and Part B) evaluating the efficacy and safety of Dupixent 300 mg weekly, compared to placebo, in patients aged 12 years and older with EoE, weighing at least 40 kg. After 24 weeks, patients treated with Dupixent 300 mg weekly experienced the following changes in Part A and Part B, respectively:
- 69% and 64% reduction in disease symptoms from baseline compared to 32% and 41% for placebo. Disease symptoms were measured by the Dysphagia Symptom Questionnaire (DSQ), where patients receiving Dupixent experienced a 21.9- and 23.8-point clinically meaningful improvement compared to 9.6- and 13.9-point improvement for placebo.
- Approximately 10 times as many patients achieved histological disease remission (peak esophageal intraepithelial eosinophil count of ≤6 eos/high power field [hpf]) compared to placebo: 60% and 59% compared to 5% and 6% of patients receiving placebo.
The safety results were generally consistent with the known safety profile of Dupixent in its approved indications. Pooled adverse events from Parts A and B that were more commonly (≥2%) observed with Dupixent than placebo were injection site reactions (38% Dupixent, 33% placebo), upper respiratory tract infections (18% Dupixent, 10% placebo), arthralgia (2% Dupixent, 1% placebo) and herpes viral infections (2% Dupixent, 1% placebo).
The FDA evaluated the Dupixent application under Priority Review, which is granted to therapies that have the potential to provide significant improvements in the treatment, diagnosis or prevention of serious conditions.
The Phase 3 randomized, double-blind, placebo-controlled trial evaluated the efficacy and safety of Dupixent in patients aged 12 years and older with EoE. Part A enrolled 81 patients and evaluated Dupixent 300 mg weekly (42 treated with Dupixent and 39 with placebo). Part B enrolled 159 patients and evaluated Dupixent 300 mg weekly (80 with Dupixent and 79 with placebo).
At 24 weeks, the co-primary endpoints in Parts A and B assessed patient-reported measures of difficulty swallowing (change from baseline in the DSQ on a 0-84 scale) and esophageal inflammation (proportion of patients achieving histological disease remission, defined as peak esophageal intraepithelial eosinophil count of ≤6 eos/hpf).
Dupixent is administered as an injection under the skin (subcutaneous injection) at different injection sites. In patients aged 12 years and older, weighing at least 40 kg, with EoE, Dupixent is administered as a 300 mg dose with a pre-filled syringe or pen every week. Dupixent is intended for use under the guidance of a healthcare professional and can be given in a clinic or at home by self-administration after training by a healthcare professional. In children aged 12 to 17 years, Dupixent should be administered under the supervision of an adult.
Dupixent, which was invented using Regeneron's proprietary VelocImmune® technology, is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not an immunosuppressant. The Dupixent development program has shown significant clinical benefit and a decrease in type 2 inflammation in Phase 3 trials, establishing that IL-4 and IL-13 are key and central drivers of the type 2 inflammation that plays a major role in multiple related and often co-morbid diseases. These diseases include approved indications for Dupixent such as asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyposis (CRSwNP) and eosinophilic esophagitis, as well as investigational diseases such as prurigo nodularis.
Regeneron and Sanofi are committed to helping patients in the U.S. who are prescribed Dupixent gain access to the medicine and receive the support they may need with the DUPIXENT MyWay® program. For more information, please call 1-844-DUPIXENT (1-844-387-4936) or visit www.DUPIXENT.com.
Dupixent is also approved for use in certain patients with atopic dermatitis, asthma or CRSwNP in different age populations in a number of countries around the world, including the U.S., European Union and Japan. Dupixent is currently approved for one or more of these indications in more than 60 countries, and more than 400,000 patients have been treated globally.
Regeneron's VelocImmune technology utilizes a proprietary genetically engineered mouse platform endowed with a genetically humanized immune system to produce optimized fully human antibodies. When Regeneron's President and Chief Scientific Officer George D. Yancopoulos was a graduate student with his mentor Frederick W. Alt in 1985, they were the first to envision making such a genetically humanized mouse, and Regeneron has spent decades inventing and developing VelocImmune and related VelociSuite® technologies. Dr. Yancopoulos and his team have used VelocImmune technology to create approximately a quarter of all original, FDA-approved or authorized fully human monoclonal antibodies currently available. This includes Dupixent, REGEN-COV® (casirivimab and imdevimab), Libtayo® (cemiplimab-rwlc), Praluent® (alirocumab), Kevzara® (sarilumab), Evkeeza® (evinacumab-dgnb) and InmazebTM (atoltivimab, maftivimab, and odesivimab-ebgn).
Dupilumab is being jointly developed by Regeneron and Sanofi under a global collaboration agreement. To date, dupilumab has been studied across more than 60 clinical trials involving more than 10,000 patients with various chronic diseases driven in part by type 2 inflammation.
In addition to the currently approved indications, Regeneron and Sanofi are studying dupilumab in a broad range of diseases driven by type 2 inflammation or other allergic processes including pediatric atopic dermatitis (6 months to 5 years of age, Phase 3), hand and foot atopic dermatitis (Phase 3), chronic obstructive pulmonary disease with evidence of type 2 inflammation (Phase 3), pediatric eosinophilic esophagitis (Phase 3), bullous pemphigoid (Phase 3), prurigo nodularis (Phase 3), chronic spontaneous urticaria (Phase 3), chronic pruritis of unknown origin (Phase 3), chronic inducible urticaria-cold (Phase 3), chronic rhinosinusitis without nasal polyposis (Phase 3), allergic fungal rhinosinusitis (Phase 3) and allergic bronchopulmonary aspergillosis (Phase 3). These potential uses of dupilumab are currently under clinical investigation, and the safety and efficacy in these conditions have not been fully evaluated by any regulatory authority.
DUPIXENT is a prescription medicine used:
- to treat adults and children 6 years of age and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. DUPIXENT can be used with or without topical corticosteroids. It is not known if DUPIXENT is safe and effective in children with atopic dermatitis under 6 years of age.
- with other asthma medicines for the maintenance treatment of moderate-to-severe eosinophilic or oral steroid dependent asthma in adults and children 6 years of age and older whose asthma is not controlled with their current asthma medicines. DUPIXENT helps prevent severe asthma attacks (exacerbations) and can improve your breathing. DUPIXENT may also help reduce the amount of oral corticosteroids you need while preventing severe asthma attacks and improving your breathing. DUPIXENT is not used to treat sudden breathing problems. It is not known if DUPIXENT is safe and effective in children with asthma under 6 years of age.
- with other medicines for the maintenance treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP) in adults whose disease is not controlled. It is not known if DUPIXENT is safe and effective in children with chronic rhinosinusitis with nasal polyposis under 18 years of age.
- to treat adults and children 12 years of age and older, who weigh at least 88 pounds (40 kg), with eosinophilic esophagitis (EoE). It is not known if DUPIXENT is safe and effective in children with eosinophilic esophagitis under 12 years of age and who weigh at least 88 pounds (40 kg).
IMPORTANT SAFETY INFORMATION
Do not use if you are allergic to dupilumab or to any of the ingredients in DUPIXENT®.
Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you:
- have eye problems
- have a parasitic (helminth) infection
- are scheduled to receive any vaccinations. You should not receive a "live vaccine" right before and during treatment with DUPIXENT.
- are pregnant or plan to become pregnant. It is not known whether DUPIXENT will harm your unborn baby.
- A pregnancy registry for women who take DUPIXENT during pregnancy collects information about the health of you and your baby. To enroll or get more information call 1-877-311-8972 or go to https://mothertobaby.org/ongoing-study/dupixent/.
- are breastfeeding or plan to breastfeed. It is not known whether DUPIXENT passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the- counter medicines, vitamins and herbal supplements.
Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines; have asthma and use an asthma medicine; or have atopic dermatitis or CRSwNP, and also have asthma. Do not change or stop your corticosteroid medicine or other asthma medicine without talking to your healthcare provider. This may cause other symptoms that were controlled by the corticosteroid medicine or other asthma medicine to come back.
DUPIXENT can cause serious side effects, including:
- Allergic reactions. DUPIXENT can cause allergic reactions that can sometimes be severe. Stop using DUPIXENT and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms: breathing problems or wheezing, swelling of the face, lips, mouth, tongue or throat, fainting, dizziness, feeling lightheaded, fast pulse, fever, hives, joint pain, general ill feeling, itching, skin rash, swollen lymph nodes, nausea or vomiting, or cramps in your stomach-area.
- Eye problems. Tell your healthcare provider if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision. Your healthcare provider may send you to an ophthalmologist for an exam if needed.
- Inflammation of your blood vessels. Rarely, this can happen in people with asthma who receive DUPIXENT. This may happen in people who also take a steroid medicine by mouth that is being stopped or the dose is being lowered. It is not known whether this is caused by DUPIXENT. Tell your healthcare provider right away if you have: rash, chest pain, worsening shortness of breath, a feeling of pins and needles or numbness of your arms or legs, or persistent fever.
- Joint aches and pain. Some people who use DUPIXENT have had trouble walking or moving due to their joint symptoms, and in some cases needed to be hospitalized. Tell your healthcare provider about any new or worsening joint symptoms. Your healthcare provider may stop DUPIXENT if you develop joint symptoms.
The most common side effects include:
- Atopic dermatitis: injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision, and cold sores in your mouth or on your lips.
- Asthma: injection site reactions, pain in the throat (oropharyngeal pain), high count of a certain white blood cell (eosinophilia), and parasitic (helminth) infections.
- Chronic rhinosinusitis with nasal polyposis: injection site reactions, eye and eyelid inflammation, including redness, swelling, and itching, sometimes with blurred vision, high count of a certain white blood cell (eosinophilia), trouble sleeping (insomnia), toothache, gastritis, and joint pain (arthralgia).
- Eosinophilic esophagitis: injection site reactions, upper respiratory tract infections, cold sores in your mouth or on your lips, and joint pain (arthralgia).
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of DUPIXENT. Call your doctor for medical advice about side
effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Use DUPIXENT exactly as prescribed by your healthcare provider. It's an injection given under the skin (subcutaneous injection). Your healthcare provider will decide if you or your caregiver can inject DUPIXENT. Do not try to prepare and inject DUPIXENT until you or your caregiver have been trained by your healthcare provider. In children 12 years of age and older, it's recommended DUPIXENT be administered by or under supervision of an adult. In children under 12 years of age, DUPIXENT should be given by a caregiver.
Please see accompanying full Prescribing Information including Patient Information.
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite technologies, such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people's lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY.
This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. These statements concern, and these risks and uncertainties include, among others, the impact of SARS-CoV-2 (the virus that has caused the COVID-19 pandemic) on Regeneron's business and its employees, collaborators, and suppliers and other third parties on which Regeneron relies, Regeneron's and its collaborators' ability to continue to conduct research and clinical programs, Regeneron's ability to manage its supply chain, net product sales of products marketed or otherwise commercialized by Regeneron and/or its collaborators or licensees (collectively, "Regeneron's Products"), and the global economy; the nature, timing, and possible success and therapeutic applications of Regeneron's Products and product candidates being developed by Regeneron and/or its collaborators or licensees (collectively, "Regeneron's Product Candidates") and research and clinical programs now underway or planned, including without limitation Dupixent® (dupilumab) for the treatment of eosinophilic esophagitis; uncertainty of the utilization, market acceptance, and commercial success of Regeneron's Products (such as Dupixent) and Regeneron's Product Candidates and the impact of studies (whether conducted by Regeneron or others and whether mandated or voluntary), including the studies discussed or referenced in this press release, on any of the foregoing or any potential regulatory approval of Regeneron's Products (such as Dupixent) and Regeneron's Product Candidates; the likelihood, timing, and scope of possible regulatory approval and commercial launch of Regeneron's Product Candidates and new indications for Regeneron's Products, such as Dupixent for the treatment of pediatric atopic dermatitis, chronic obstructive pulmonary disease with evidence of type 2 inflammation, pediatric eosinophilic esophagitis, bullous pemphigoid, prurigo nodularis, chronic spontaneous urticaria, chronic inducible urticaria-cold, chronic rhinosinusitis without nasal polyposis, allergic fungal rhinosinusitis, allergic bronchopulmonary aspergillosis, peanut allergy, and other potential indications; the ability of Regeneron's collaborators, licensees, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labeling, distribution, and other steps related to Regeneron's Products and Regeneron's Product Candidates; the ability of Regeneron to manage supply chains for multiple products and product candidates; safety issues resulting from the administration of Regeneron's Products (such as Dupixent) and Regeneron's Product Candidates in patients, including serious complications or side effects in connection with the use of Regeneron's Products and Regeneron's Product Candidates in clinical trials; determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize Regeneron's Products and Regeneron's Product Candidates, including without limitation Dupixent; ongoing regulatory obligations and oversight impacting Regeneron's Products, research and clinical programs, and business, including those relating to patient privacy; the availability and extent of reimbursement of Regeneron's Products from third-party payers, including private payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and government programs such as Medicare and Medicaid; coverage and reimbursement determinations by such payers and new policies and procedures adopted by such payers; competing drugs and product candidates that may be superior to, or more cost effective than, Regeneron's Products and Regeneron's Product Candidates; the extent to which the results from the research and development programs conducted by Regeneron and/or its collaborators or licensees may be replicated in other studies and/or lead to advancement of product candidates to clinical trials, therapeutic applications, or regulatory approval; unanticipated expenses; the costs of developing, producing, and selling products; the ability of Regeneron to meet any of its financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license, collaboration, or supply agreement, including Regeneron's agreements with Sanofi, Bayer, and Teva Pharmaceutical Industries Ltd. (or their respective affiliated companies, as applicable) to be cancelled or terminated; and risks associated with intellectual property of other parties and pending or future litigation relating thereto (including without limitation the patent litigation and other related proceedings relating to EYLEA® (aflibercept) Injection, Dupixent, Praluent® (alirocumab), and REGEN-COV® (casirivimab and imdevimab)), other litigation and other proceedings and government investigations relating to the Company and/or its operations, the ultimate outcome of any such proceedings and investigations, and the impact any of the foregoing may have on Regeneron's business, prospects, operating results, and financial condition. A more complete description of these and other material risks can be found in Regeneron's filings with the U.S. Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2021 and its Form 10-Q for the quarterly period ended March 31, 2022. Any forward-looking statements are made based on management's current beliefs and judgment, and the reader is cautioned not to rely on any forward-looking statements made by Regeneron. Regeneron does not undertake any obligation to update (publicly or otherwise) any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise.
Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible on Regeneron's media and investor relations website (http://newsroom.regeneron.com) and its Twitter feed (http://twitter.com/regeneron).
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates regarding the marketing and other potential of the product, or regarding potential future revenues from the product. Forward-looking statements are generally identified by the words "expects", "anticipates", "believes", "intends", "estimates", "plans" and similar expressions. Although Sanofi's management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, unexpected regulatory actions or delays, or government regulation generally, that could affect the availability or commercial potential of the product, the fact that product may not be commercially successful, the uncertainties inherent in research and development, including future clinical data and analysis of existing clinical data relating to the product, including post marketing, unexpected safety, quality or manufacturing issues, competition in general, risks associated with intellectual property and any related future litigation and the ultimate outcome of such litigation, and volatile economic and market conditions, and the impact that COVID-19 will have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. Any material effect of COVID-19 on any of the foregoing could also adversely impact us. This situation is changing rapidly and additional impacts may arise of which we are not currently aware and may exacerbate other previously identified risks. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi's annual report on Form 20-F for the year ended December 31, 2021. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.
View original content:
SOURCE Regeneron Pharmaceuticals, Inc. | https://www.mysuncoast.com/prnewswire/2022/05/20/fda-approves-dupixent-dupilumab-first-treatment-adults-children-aged-12-older-with-eosinophilic-esophagitis/ | 2022-05-20T20:22:03Z |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.